TSS:Rfhg 29920.1

Basic information about the TSS

---

TSS ID: rfhg_29920.1 Species: human Chr: chr2		Start: 99361343 End: 99361343 Strand: +
Source datasets	PRJNA597322
Protocol	STRIPE-seq
TSS cluster detected*	1

  * The number of TSS cluster called data-sets (maximum 17)

cCREs annotation

---

Description:	-
Category:	-

  * cCREs are candidates for cis regulatory elements generated from the subset of representative DNase hypersensitivity sites supported by either histone modifications or CTCF-binding data. Find more details here.

Gene and protein annotation

---

Nearest transcript id and distance: AL133563:-177 GeneID: 9669 HGNC/MGI_ID: HGNC:30793 UniProt_ID: Nearer transcript ids and distances:

Gene_name: EIF5B Gene_symbol: EIF5B Gene_synonyms: DKFZp434I036 FLJ10524 IF2 KIAA0741 Gene_source: HGNC:30793

TATA-Box annotation

---

Distance to TSS:	23954
Nearest PromoterID:	NM_015904
Entrez ID:	9669
Nearest Unigene:	Hs.158688
Nearest Refseq:	NM_015904
Nearest Ensembl:	ENSG00000158417
Gene Name:	EIF5B
Gene Alias:	IF2
Gene Type:	protein-coding
CpG%:	0.000000
GC%:	0.000000
TATA-Box(TBP)/Promoter/Homer Distance From Peak(sequence,strand,conservation):

TSS expression

Sample Category  All in vivo cell sample cell line sample tissue sample human bronchial epithelial cell sample CD19-positive B cell sample CD8-positive T cell sample CD4-positive T cell sample common myeloid progenitor sample human monocyte immature derived dendritic cell sample human endothelial cell of the aorta sample human cardiac fibroblast sample human dermal fibroblast sample human fibroblast of gingiva sample human fibroblast of periodontium sample granulocyte macrophage progenitor cell sample human hepatocyte sample human mesenchymal stem cell of umbilical cord-Sciencell sample human mesenchymal stem cell of adipose sample human mesenchymal stem cell of bone marrow sample mouse sample mouse granule cell sample mouse hepatocyte sample human neutrophil sample human osteoblast-Sciencell sample human osteoblast-Cell applications sample human renal glomerular endothelial cell sample human retinal pigment epithelial cell sample human skeletal muscle cell sample human aortic smooth muscle cell sample human smooth muscle cell of umbilical artery sample human urothelial cell sample cerebellar granule cell sample human sample mast cell- heparinase treated sample human mature adipocyte sample human cardiac mesenchymal precursor cell sample human mesenchymal precursor cell- ovarian cancer-left ovary sample human mesenchymal precursor cell- ovarian cancer-metastasis sample human mesenchymal precursor cell- ovarian cancer-right ovary sample human whole blood sample control treatment sample human adipose tissue - adult sample human brain - adult sample human parietal lobe - adult sample hippocampus - adult sample human CD14-CD16-positive Monocytes sample mouse cerebellum- embryo E13 sample mouse cerebellum- embryo E15 sample mouse cerebellum- embryo E18 sample human Monocyte-derived macrophages 0h after mock infection sample human Monocyte-derived macrophages 0h after udorn influenza infection sample human Monocyte-derived macrophages 2h after udorn influenza infection sample human Monocyte-derived macrophages 7h after udorn influenza infection sample human Monocyte-derived macrophages 24h after udorn influenza infection sample human Monocyte-derived macrophages 24h after mock infection sample mouse whole body- embryo E17.5 sample adenocarcinoma cell line sample small cell lung cancer cell sample carcinoma cell line sample teratocarcinoma cell line sample sarcoma cell line sample K-562 cell sample embryonic cell line sample epithelial cell line sample THP-1 cell sample gastrointestinal cancer cell sample acute myeloid leukemia cell line sample cervical cancer cell line sample squamous cell carcinoma cell line sample mesothelioma cell line sample NCI cell sample human nasal epithelial cell sample macrophage, TB infection sample iPS differentiation to neuron, control sample iPS differentiation to neuron, down-syndrome donor sample myoblast differentiation to myotubes, control sample H1 embryonic stem cells differentiation to CD34+ HSC sample 293SLAM rinderpest infection sample COBL-a rinderpest infection sample partial hepatectomy sample sham operation sample ES-OS25 embryonic stem cells sample ES-OS25 embryonic stem cells, untreated sample ES-46C embryonic stem cells, neuronal differentiation sample ES-OS25 embryonic stem cells, KD for exosomal component EXOSC3, biol_rep1 sample ARPE-19 EMT induced with TGF-beta and TNF-alpha sample hIPS sample

		Promoter select All p1@EIF5B p2@EIF5B p3@EIF5B p4@EIF5B p6@EIF5B p7@EIF5B p8@EIF5B
Sample		p1@EIF5B	p2@EIF5B	p3@EIF5B	p4@EIF5B	p6@EIF5B	p7@EIF5B	p8@EIF5B
293SLAM rinderpest infection, 00hr, biol_rep1	13541-145H4	77.92	7.99	4.68	5.06	2.34	1.36	1.56
293SLAM rinderpest infection, 00hr, biol_rep2	13542-145H5	68.79	6.27	1.82	4.45	2.02	1.01	0.40
293SLAM rinderpest infection, 00hr, biol_rep3	13543-145H6	82.56	8.87	4.24	7.33	1.93	2.31	0.96
293SLAM rinderpest infection, 06hr, biol_rep1	13544-145H7	67.15	5.41	3.12	4.16	1.66	1.25	1.25
293SLAM rinderpest infection, 06hr, biol_rep2	13545-145H8	75.14	6.75	4.95	4.05	2.70	2.47	1.57
293SLAM rinderpest infection, 06hr, biol_rep3	13546-145H9	78.49	8.53	6.40	6.40	2.71	1.16	1.16
293SLAM rinderpest infection, 12hr, biol_rep1	13547-145I1	104.37	9.15	6.32	9.37	5.01	1.96	1.31
293SLAM rinderpest infection, 12hr, biol_rep2	13548-145I2	90.11	7.02	2.91	4.60	3.15	1.70	0.73
293SLAM rinderpest infection, 12hr, biol_rep3	13549-145I3	71.17	4.49	2.78	5.98	1.07	0.64	1.50
293SLAM rinderpest infection, 24hr, biol_rep1	13550-145I4	80.57	4.64	4.06	4.64	2.32	1.16	0.00
293SLAM rinderpest infection, 24hr, biol_rep2	13551-145I5	71.55	4.45	4.85	5.66	0.81	0.40	0.40
293SLAM rinderpest infection, 24hr, biol_rep3	13552-145I6	70.33	4.07	4.88	2.85	1.22	0.81	0.41
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep1	13625-146H7	24.02	2.10	1.77	1.29	0.16	0.32	0.64
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep2	13626-146H8	26.76	1.95	1.80	1.65	1.20	0.45	0.15
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep3	13627-146H9	28.76	0.44	0.44	1.76	0.22	0.00	0.44
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep1	13628-146I1	20.87	1.01	1.01	0.75	0.25	0.00	0.75
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep2	13629-146I2	22.71	0.44	1.09	1.53	0.00	0.44	0.66
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep3	13630-146I3	26.57	1.27	1.69	2.95	0.42	0.00	1.27
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep1	13631-146I4	24.53	1.60	0.53	1.07	1.07	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep2	13632-146I5	25.12	1.20	0.75	1.05	0.30	0.15	0.60
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep3	13633-146I6	24.19	2.14	0.67	1.87	0.53	0.13	0.40
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep1	13634-146I7	24.34	2.07	0.69	1.04	0.35	0.35	0.17
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep2	13635-146I8	24.43	1.16	0.52	1.29	0.78	0.26	0.39
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep3	13636-146I9	19.41	0.49	1.94	1.70	0.49	0.49	0.97
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep1	13637-147A1	27.86	1.03	0.52	1.03	0.26	1.29	0.26
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep2	13638-147A2	24.69	2.22	0.95	0.63	0.32	0.32	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep3	13639-147A3	26.37	1.10	0.55	1.10	0.00	0.55	0.55
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep1	13640-147A4	35.13	3.06	1.89	2.12	0.47	0.71	1.65
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep2	13641-147A5	21.97	1.45	1.45	0.32	0.16	0.48	0.16
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep3	13642-147A6	26.24	0.54	1.81	1.45	0.72	0.54	0.18
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep1	13643-147A7	21.77	1.26	0.84	1.05	0.21	0.21	0.42
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep2	13644-147A8	18.37	0.20	1.37	0.20	0.00	0.39	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep3	13645-147A9	24.06	1.27	1.69	2.53	0.00	0.21	0.63
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep1	13646-147B1	28.53	1.81	1.98	2.47	0.82	0.99	1.15
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep2	13647-147B2	23.19	1.50	0.93	0.75	0.19	0.56	0.19
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep3	13648-147B3	24.34	1.15	1.34	1.72	0.00	0.57	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep1	13649-147B4	20.23	0.82	0.61	0.82	0.82	0.41	0.41
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep2	13650-147B5	21.76	1.41	0.20	0.40	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep3	13651-147B6	25.66	1.08	0.54	1.62	0.81	1.08	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep1	13652-147B7	24.25	0.72	0.48	1.44	0.96	0.24	0.24
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep2	13653-147B8	18.11	1.18	0.47	1.41	0.47	0.71	0.24
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep3	13654-147B9	23.86	1.32	0.15	0.73	0.29	0.29	0.73
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep1	13655-147C1	23.62	0.42	0.42	0.42	0.63	0.21	0.63
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep2	13656-147C2	24.83	1.22	0.70	1.05	0.17	0.35	0.17
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep3	13657-147C3	25.50	1.20	0.60	0.60	0.40	0.20	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep1	13658-147C4	21.40	1.86	0.70	1.40	1.16	0.47	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep2	13659-147C5	20.87	0.96	0.48	0.96	0.24	0.00	0.24
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep3	13660-147C6	23.55	1.19	0.89	0.60	0.60	0.60	0.30
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep1	13661-147C7	18.43	0.24	0.48	0.24	0.00	0.24	0.24
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep2	13662-147C8	21.64	1.01	0.20	0.61	1.01	0.00	0.20
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep3	13663-147C9	26.64	1.43	0.41	2.05	0.61	0.61	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep1	13664-147D1	26.68	2.00	0.89	1.78	0.44	0.67	0.44
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep2	13665-147D2	1021.43	223.87	223.87	405.77	181.90	55.97	55.97
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep3	13666-147D3	20.58	1.06	0.71	2.13	0.35	0.35	0.35
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep1	13667-147D4	22.87	0.66	0.33	0.33	0.33	0.00	0.33
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep2	13668-147D5	127.52	26.01	11.75	24.33	2.52	5.87	3.36
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep3	13669-147D6	45.46	6.43	2.30	5.05	2.30	0.00	0.92
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep1	13670-147D7	18.15	2.27	0.65	1.30	0.97	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep2	13671-147D8	15.74	2.25	0.32	1.28	0.64	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep3	13672-147D9	41.18	2.51	0.94	1.89	0.94	1.26	0.94
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 12hr00min, biol_rep2	13674-147E2	16.92	0.71	0.71	0.00	0.71	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 12hr00min, biol_rep3	13675-147E3	21.87	1.12	1.12	0.00	0.00	0.00	0.56
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep1	13676-147E4	88.37	4.78	5.57	4.78	1.59	2.39	0.80
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep2	13677-147E5	26.16	2.72	2.72	1.36	1.02	0.34	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep3	13678-147E6	12.35	1.62	0.65	1.62	0.65	0.00	0.65
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep1	13679-147E7	12.07	0.71	1.06	1.77	0.35	0.35	0.35
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep2	13680-147E8	1115.31	258.62	274.79	484.92	193.97	129.31	113.15
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep3	13681-147E9	616.00	189.54	173.74	181.64	55.28	55.28	47.38
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep1	13682-147F1	24.38	0.98	0.49	0.49	0.49	0.00	0.49
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep2	13683-147F2	24.79	0.00	0.50	0.50	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep3	13684-147F3	19.23	1.41	1.41	0.47	0.47	0.47	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep1	13685-147F4	38.09	2.65	2.32	1.99	0.66	0.99	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep2	13686-147F5	14.85	2.78	0.62	1.55	0.00	0.31	0.62
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep3	13687-147F6	22.01	2.14	0.31	0.00	0.00	0.31	0.31
Adipocyte - breast, donor1	11376-118A8	31.04	1.11	0.63	0.63	0.16	0.16	0.00
Adipocyte - breast, donor2	11327-117E4	35.61	6.26	2.41	2.25	0.80	0.96	0.00
Adipocyte - omental, donor1	11473-119C6	53.31	0.89	2.04	0.64	0.38	0.51	0.38
Adipocyte - omental, donor2	11474-119C7	28.40	0.75	0.75	0.00	0.00	0.00	0.75
Adipocyte - omental, donor3	11475-119C8	32.15	2.68	0.00	0.67	0.00	0.67	0.00
Adipocyte - perirenal, donor1	11476-119C9	34.45	1.28	0.00	0.64	3.19	0.00	0.00
Adipocyte - subcutaneous, donor1	11259-116F8	9.90	0.00	0.00	0.00	0.00	0.00	0.00
Adipocyte - subcutaneous, donor2	11336-117F4	48.32	2.71	1.81	0.90	0.45	0.90	0.00
Adipocyte - subcutaneous, donor3	11408-118E4	19.98	1.04	0.52	0.52	0.52	0.35	0.52
Adipocyte differentiation, day04, donor1	13019-139D4	59.26	1.17	0.00	0.20	0.20	0.20	0.20
Adipocyte differentiation, day04, donor2	13022-139D7	48.39	0.51	0.51	0.51	0.26	0.00	0.00
Adipocyte differentiation, day04, donor3	13025-139E1	50.18	0.28	0.84	0.56	0.00	0.00	0.00
Adipocyte differentiation, day04, donor4	13028-139E4	58.78	0.00	1.18	0.00	0.00	0.00	0.00
Adipocyte differentiation, day08, donor1	13020-139D5	74.72	1.29	1.69	2.17	0.64	0.48	0.24
Adipocyte differentiation, day08, donor2	13023-139D8	40.99	0.32	0.97	0.65	0.32	0.00	0.00
Adipocyte differentiation, day08, donor3	13026-139E2	35.72	0.53	1.60	1.07	0.00	0.00	0.53
Adipocyte differentiation, day08, donor4	13029-139E5	43.40	0.00	0.56	0.00	0.00	0.00	0.00
Adipocyte differentiation, day12, donor1	13021-139D6	16.64	0.42	0.42	0.00	0.00	0.00	0.00
Adipocyte differentiation, day12, donor2	13024-139D9	25.37	1.26	0.00	0.50	0.50	0.00	0.00
Adipocyte differentiation, day12, donor3	13027-139E3	34.36	0.98	0.00	0.33	0.33	0.33	0.00
Adipocyte differentiation, day12, donor4	13030-139E6	38.06	0.00	0.00	0.00	0.00	0.00	0.00
Alveolar Epithelial Cells, donor1	11510-119G7	11.71	0.88	0.44	0.66	0.00	0.00	0.22
Alveolar Epithelial Cells, donor2	11590-120G6	4.30	0.00	0.00	0.36	0.00	0.00	0.00
Alveolar Epithelial Cells, donor3	11671-122G6	3.59	0.00	0.00	0.00	0.00	0.00	0.00
Amniotic Epithelial Cells, donor1	11533-120A3	16.91	0.36	0.00	0.36	0.00	0.18	0.00
Amniotic Epithelial Cells, donor2	11613-122A2	6.69	0.00	0.00	0.00	0.00	0.00	0.00
Amniotic Epithelial Cells, donor3	11694-123A2	9.66	0.00	0.41	0.00	0.00	0.00	0.41
Anulus Pulposus Cell, donor1	11248-116E6	38.10	2.63	2.75	0.80	0.92	0.23	0.46
Anulus Pulposus Cell, donor2	11463-119B5	23.27	0.98	0.49	0.00	0.49	0.24	0.00
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep1 (LK1)	12642-134G5	45.38	2.25	1.80	0.90	0.45	0.90	0.00
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep2 (LK2)	12740-135I4	47.32	5.21	2.17	2.17	0.87	0.87	0.87
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep3 (LK3)	12838-137B3	14.98	4.28	6.42	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep1 (LK4)	12643-134G6	43.64	4.18	2.09	1.20	1.79	0.60	0.30
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep2 (LK5)	12741-135I5	48.06	5.06	1.26	3.79	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep3 (LK6)	12839-137B4	12.54	3.30	1.98	0.00	0.66	0.66	0.00
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep1 (LK7)	12644-134G7	33.14	2.60	0.97	0.00	0.65	0.32	0.32
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep2 (LK8)	12742-135I6	47.57	4.85	0.49	2.43	1.94	1.46	0.00
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep3 (LK9)	12840-137B5	26.13	1.78	1.78	0.00	1.19	0.00	0.59
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep1 (LK10)	12645-134G8	51.60	4.52	2.26	0.75	1.13	0.38	0.00
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep2 (LK11)	12743-135I7	41.36	5.81	0.73	0.73	0.00	0.73	0.73
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep3 (LK12)	12841-137B6	15.05	0.00	0.00	1.25	1.25	2.51	0.00
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep1 (LK13)	12646-134G9	30.81	0.49	0.16	0.33	0.33	0.00	0.00
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep2 (LK14)	12744-135I8	28.66	4.09	1.36	0.00	2.73	1.36	0.00
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep3 (LK15)	12842-137B7	19.45	0.60	0.30	0.30	0.00	0.15	0.00
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep1 (LK16)	12647-134H1	35.36	2.14	2.14	0.54	1.07	0.00	1.07
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep2 (LK17)	12745-135I9	24.94	1.32	0.76	0.94	0.19	0.00	0.19
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep3 (LK18)	12843-137B8	35.01	4.01	4.28	1.87	1.60	1.07	0.27
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep1 (LK19)	12648-134H2	24.39	3.90	0.98	0.98	0.00	0.98	0.00
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep2 (LK20)	12746-136A1	25.04	2.99	1.16	0.66	0.17	0.17	0.50
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep3 (LK21)	12844-137B9	24.01	0.00	2.40	0.00	0.00	0.00	1.20
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep1 (LK22)	12649-134H3	24.78	0.00	0.00	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep2 (LK23)	12747-136A2	39.97	3.77	3.09	0.69	0.86	0.17	0.69
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep3 (LK24)	12845-137C1	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep1 (LK25)	12650-134H4	42.72	6.31	1.94	1.46	1.46	0.00	0.49
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep2 (LK26)	12748-136A3	34.91	3.42	3.42	0.76	1.52	0.38	0.00
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep3 (LK27)	12846-137C2	33.92	2.42	1.21	2.42	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep1 (LK28)	12651-134H5	31.92	0.57	1.14	0.57	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep2 (LK29)	12749-136A4	31.21	2.14	2.14	1.07	0.86	0.64	0.43
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep3 (LK30)	12847-137C3	20.65	1.03	1.29	1.03	0.00	0.26	0.26
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep1 (LK31)	12652-134H6	29.56	2.35	2.35	0.47	0.00	0.94	0.00
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep2 (LK32)	12750-136A5	30.87	3.22	1.29	0.96	0.64	1.29	0.64
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep3 (LK33)	12848-137C4	13.56	1.43	1.43	0.00	2.14	0.00	0.00
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep1 (LK34)	12653-134H7	31.00	5.85	1.75	1.17	1.17	0.58	0.00
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep2 (LK35)	12751-136A6	29.20	2.41	1.51	0.60	2.11	0.00	0.30
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep3 (LK36)	12849-137C5	19.01	1.19	1.19	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep1 (LK37)	12654-134H8	37.12	3.56	1.02	0.51	0.51	0.51	0.00
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep2 (LK38)	12752-136A7	32.60	3.31	2.55	2.04	1.02	0.51	0.25
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep3 (LK39)	12850-137C6	13.34	0.64	0.00	0.64	0.00	0.64	0.00
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep1 (LK40)	12655-134H9	33.66	2.16	0.43	0.86	0.43	0.00	0.86
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep2 (LK41)	12753-136A8	26.04	2.12	1.06	0.64	0.00	0.21	0.21
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep3 (LK42)	12851-137C7	13.63	1.74	1.74	0.58	0.29	0.29	0.00
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep1 (LK43)	12656-134I1	49.13	6.61	3.78	0.00	0.94	0.00	0.94
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep2 (LK44)	12754-136A9	31.02	1.36	1.53	1.02	0.00	0.51	0.68
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep3 (LK45)	12852-137C8	30.11	2.32	0.00	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep1 (LK46)	12657-134I2	31.69	12.68	0.00	2.11	2.11	0.00	0.00
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep2 (LK47)	12755-136B1	34.95	1.29	1.93	1.07	1.07	0.21	0.43
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep3 (LK48)	12853-137C9	16.85	1.80	1.80	0.00	0.60	0.60	0.60
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep1 (LK49)	12658-134I3	35.72	3.64	0.73	1.46	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep2 (LK50)	12756-136B2	30.80	2.76	1.61	1.38	0.92	0.23	0.23
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep3 (LK51)	12854-137D1	33.15	7.65	7.65	0.00	0.00	2.55	0.00
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep1 (LK52)	12659-134I4	19.32	0.51	0.51	0.25	0.25	0.51	0.25
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep2 (LK53)	12757-136B3	39.64	3.92	1.86	1.24	1.86	0.21	0.62
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep3 (LK54)	12855-137D2	24.79	3.06	1.84	0.61	1.22	0.31	0.00
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep1 (LK55)	12660-134I5	43.50	2.87	3.35	0.00	1.43	0.48	0.48
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep2 (LK56)	12758-136B4	27.50	4.21	2.66	1.77	0.67	1.11	0.22
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep3 (LK57)	12856-137D3	16.78	1.53	0.00	1.53	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep1 (LK58)	12661-134I6	26.59	1.11	1.11	1.11	0.00	0.55	0.55
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep2 (LK59)	12759-136B5	34.95	3.44	0.79	1.32	1.32	1.06	0.00
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep3 (LK60)	12857-137D4	23.26	1.45	4.36	0.73	0.73	0.36	0.00
Astrocyte - cerebellum, donor1	11500-119F6	18.18	0.12	0.25	0.12	0.12	0.00	0.12
Astrocyte - cerebellum, donor2	11580-120F5	10.10	0.17	0.00	0.00	0.00	0.00	0.00
Astrocyte - cerebellum, donor3	11661-122F5	4.61	0.00	0.00	0.00	0.00	0.00	0.00
Astrocyte - cerebral cortex, donor1	11235-116D2	68.32	3.14	3.49	2.44	1.05	0.70	0.00
Astrocyte - cerebral cortex, donor2	11316-117D2	59.37	5.50	6.63	3.40	2.43	1.46	0.32
Astrocyte - cerebral cortex, donor3	11392-118C6	60.41	3.88	4.33	2.83	1.19	0.75	0.45
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep1	10821-111C2	173.75	20.53	19.61	14.22	5.39	5.05	3.90
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep2	10822-111C3	195.56	20.80	22.05	15.28	7.39	6.77	5.14
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep3	10823-111C4	204.26	19.00	21.85	14.22	7.40	5.35	3.98
Basophils, donor1	12241-129G9	8.63	0.00	0.00	0.00	0.00	0.00	0.00
Basophils, donor2	12242-129H1	40.77	0.36	0.36	0.00	0.00	0.00	0.00
Basophils, donor3	12243-129H2	22.20	0.00	0.44	0.29	0.15	0.00	0.00
Bronchial Epithelial Cell, donor1	11511-119G8	10.56	0.43	0.22	0.22	0.00	0.00	0.00
Bronchial Epithelial Cell, donor2	11591-120G7	3.66	0.46	0.00	0.00	0.00	0.00	0.00
Bronchial Epithelial Cell, donor3	11672-122G7	28.69	0.00	0.00	0.00	0.00	0.00	0.00
Bronchial Epithelial Cell, donor4	11453-119A4	31.38	1.88	0.00	0.00	0.00	0.00	0.00
Bronchial Epithelial Cell, donor5	11457-119A8	15.18	1.04	0.00	0.00	0.00	0.00	0.00
Bronchial Epithelial Cell, donor6	11461-119B3	10.59	0.00	0.00	0.23	0.00	0.00	0.00
Bronchial Epithelial Cell, donor7	11769-123I5	54.34	11.34	8.46	4.68	1.98	1.80	2.52
Burkitt's lymphoma cell line:DAUDI	10422-106C8	111.30	10.10	9.07	4.74	3.40	2.37	1.96
Burkitt's lymphoma cell line:RAJI	10476-106I8	205.89	20.73	22.36	14.67	6.75	6.75	3.03
CD133+ stem cells - adult bone marrow derived, pool1	12224-129F1	34.86	0.32	0.00	0.00	0.32	0.00	0.00
CD133+ stem cells - cord blood derived, pool1	12223-129E9	82.74	0.00	0.00	0.00	0.00	0.00	0.00
CD14+ Monocytes, donor1	11224-116B9	28.18	0.56	1.69	0.00	0.00	0.00	0.00
CD14+ Monocytes, donor2	11305-117B9	27.47	4.64	2.78	1.86	0.93	0.37	0.19
CD14+ Monocytes, donor3	11381-118B4	25.03	3.29	1.76	1.32	0.00	0.22	0.44
CD14+ monocyte derived endothelial progenitor cells, donor1	11229-116C5	45.29	0.85	0.57	0.57	0.85	0.28	0.00
CD14+ monocyte derived endothelial progenitor cells, donor2	11310-117C5	40.94	1.14	0.38	1.14	0.00	0.00	0.00
CD14+ monocyte derived endothelial progenitor cells, donor3	11386-118B9	50.30	0.33	0.33	1.31	0.00	0.33	0.00
CD14+ monocytes - mock treated, donor1	11863-125A9	30.21	3.32	2.31	1.45	1.45	1.01	0.58
CD14+ monocytes - mock treated, donor2	11873-125C1	25.95	1.81	0.60	1.81	1.21	0.60	0.00
CD14+ monocytes - mock treated, donor3	11883-125D2	43.11	1.42	2.84	0.95	0.24	0.95	0.71
CD14+ monocytes - treated with B-glucan, donor1	11869-125B6	15.07	2.34	1.17	1.17	0.17	0.00	0.50
CD14+ monocytes - treated with B-glucan, donor2	11879-125C7	22.08	2.21	1.10	0.83	0.83	0.28	0.00
CD14+ monocytes - treated with B-glucan, donor3	11889-125D8	26.03	2.23	1.74	1.74	0.74	0.50	0.25
CD14+ monocytes - treated with BCG, donor1	11860-125A6	15.66	1.17	0.98	0.59	0.39	0.39	0.20
CD14+ monocytes - treated with BCG, donor2	11870-125B7	14.07	0.36	0.36	0.71	0.18	0.18	0.18
CD14+ monocytes - treated with BCG, donor3	11880-125C8	17.19	0.44	0.00	0.00	0.22	0.00	0.00
CD14+ monocytes - treated with Candida, donor1	11868-125B5	6.79	0.23	1.17	0.23	0.23	0.23	0.23
CD14+ monocytes - treated with Candida, donor2	11878-125C6	24.29	0.00	1.06	1.06	0.00	0.53	0.00
CD14+ monocytes - treated with Candida, donor3	11888-125D7	7.77	0.00	0.00	1.11	0.00	0.00	0.00
CD14+ monocytes - treated with Cryptococcus, donor1	11867-125B4	20.08	1.78	1.49	1.04	0.74	0.45	0.15
CD14+ monocytes - treated with Cryptococcus, donor2	11877-125C5	24.94	2.99	0.80	1.40	0.60	0.00	0.40
CD14+ monocytes - treated with Cryptococcus, donor3	11887-125D6	31.85	0.62	0.21	0.21	0.42	0.00	0.00
CD14+ monocytes - treated with Group A streptococci, donor1	11864-125B1	17.16	1.14	0.92	0.46	0.23	0.23	0.00
CD14+ monocytes - treated with Group A streptococci, donor2	11874-125C2	25.79	0.68	0.90	0.45	0.68	0.23	0.00
CD14+ monocytes - treated with Group A streptococci, donor3	11884-125D3	20.08	0.44	3.06	0.87	0.44	1.75	0.00
CD14+ monocytes - treated with IFN + N-hexane, donor1	11861-125A7	21.25	1.61	0.81	0.27	0.00	0.27	0.54
CD14+ monocytes - treated with IFN + N-hexane, donor2	11871-125B8	26.34	2.44	2.27	1.40	0.70	0.70	0.52
CD14+ monocytes - treated with IFN + N-hexane, donor3	11881-125C9	32.82	2.10	1.68	0.84	0.00	0.00	0.00
CD14+ monocytes - treated with Salmonella, donor1	11866-125B3	9.74	1.29	1.29	1.10	0.55	0.55	0.18
CD14+ monocytes - treated with Salmonella, donor2	11876-125C4	15.50	1.41	0.70	0.00	0.70	0.70	0.35
CD14+ monocytes - treated with Salmonella, donor3	11886-125D5	27.64	1.75	0.44	0.44	0.44	0.44	0.44
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor1	11862-125A8	13.43	1.57	2.09	1.39	0.70	0.52	0.35
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor2	11872-125B9	16.73	1.12	2.60	4.09	0.37	0.37	1.12
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor3	11882-125D1	21.55	1.08	0.00	0.00	0.43	0.43	0.00
CD14+ monocytes - treated with lipopolysaccharide, donor1	11865-125B2	21.70	1.23	0.00	0.41	0.41	0.82	0.00
CD14+ monocytes - treated with lipopolysaccharide, donor2	11875-125C3	14.60	0.23	0.46	0.70	0.46	0.23	0.23
CD14+ monocytes - treated with lipopolysaccharide, donor3	11885-125D4	17.63	0.00	0.23	0.23	0.00	0.00	0.00
CD14+CD16+ Monocytes, donor1	11789-124B7	20.71	0.65	0.65	0.22	0.00	0.22	0.00
CD14+CD16+ Monocytes, donor2	11801-124D1	21.71	0.92	0.23	0.23	0.00	0.00	0.00
CD14+CD16+ Monocytes, donor3	11912-125G4	13.65	1.30	0.43	0.43	0.00	0.00	0.22
CD14+CD16- Monocytes, donor1	11788-124B6	24.29	0.16	0.93	0.47	0.16	0.00	0.00
CD14+CD16- Monocytes, donor2	11799-124C8	22.35	0.87	1.22	0.17	0.52	0.17	0.17
CD14+CD16- Monocytes, donor3	11910-125G2	68.45	1.56	0.89	2.90	0.22	0.45	0.22
CD14-CD16+ Monocytes, donor1	11790-124B8	19.90	0.51	0.26	0.00	0.00	0.51	0.26
CD14-CD16+ Monocytes, donor2	11800-124C9	17.13	0.44	0.00	0.00	0.44	0.22	0.00
CD14-CD16+ Monocytes, donor3	11911-125G3	17.48	0.42	0.21	0.21	0.00	0.00	0.00
CD19+ B Cells (pluriselect), donor090309, donation1	12189-129B2	34.55	0.00	0.00	0.00	0.00	0.00	0.00
CD19+ B Cells (pluriselect), donor090309, donation2	12194-129B7	40.00	0.68	0.68	0.68	0.00	0.00	0.00
CD19+ B Cells (pluriselect), donor090309, donation3	12199-129C3	40.39	1.04	1.04	0.00	0.00	0.00	0.00
CD19+ B Cells (pluriselect), donor090325, donation1	12151-128F9	30.38	1.60	0.00	0.00	0.00	0.00	0.00
CD19+ B Cells (pluriselect), donor090325, donation2	12174-128I5	40.21	0.00	2.14	0.54	0.00	0.00	0.00
CD19+ B Cells (pluriselect), donor090612, donation1	12204-129C8	44.22	0.00	1.40	0.70	0.00	0.00	0.00
CD19+ B Cells (pluriselect), donor090612, donation2	12209-129D4	37.65	0.78	0.78	0.00	0.00	0.00	0.00
CD19+ B Cells (pluriselect), donor090612, donation3	12214-129D9	42.19	5.27	0.00	0.00	1.32	0.00	0.00
CD19+ B Cells, donor1	11544-120B5	50.96	4.11	1.64	2.47	1.64	0.00	0.00
CD19+ B Cells, donor2	11624-122B4	51.51	3.63	3.63	1.45	0.00	0.00	0.00
CD19+ B Cells, donor3	11705-123B4	47.45	4.04	1.51	1.51	0.50	0.50	0.00
CD34 cells differentiated to erythrocyte lineage, biol_ rep1	11931-125I5	210.51	7.27	6.46	6.46	2.83	3.23	2.02
CD34 cells differentiated to erythrocyte lineage, biol_ rep2	11932-125I6	130.23	4.39	2.80	0.80	0.80	0.00	0.40
CD34+ Progenitors, donor1	11545-120B6	18.07	0.00	0.00	0.00	0.00	0.00	0.00
CD34+ Progenitors, donor2	11625-122B5	60.11	0.56	0.00	0.00	0.00	0.00	0.00
CD34+ stem cells - adult bone marrow derived, donor1, tech_rep1	12225-129F2	47.72	0.75	0.75	0.75	0.00	0.38	0.00
CD34+ stem cells - adult bone marrow derived, donor1, tech_rep2	12225-129F2	41.26	0.23	0.23	0.00	0.23	0.00	0.00
CD4+ T Cells, donor1	11225-116C1	132.11	5.71	5.71	3.21	1.07	1.79	1.43
CD4+ T Cells, donor2	11306-117C1	72.26	5.51	6.74	0.61	1.22	2.45	0.61
CD4+ T Cells, donor3	11382-118B5	66.18	6.10	4.27	2.74	0.00	0.00	1.22
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor1	11793-124C2	54.88	1.79	0.26	1.02	0.51	0.51	0.26
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor2	11915-125G7	61.09	1.12	3.14	1.35	0.22	0.45	0.00
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor3	11919-125H2	59.50	0.86	1.44	0.57	0.29	0.29	0.00
CD4+CD25+CD45RA+ naive regulatory T cells, donor1	11780-124A7	40.30	1.90	2.84	0.95	0.00	0.00	0.00
CD4+CD25+CD45RA+ naive regulatory T cells, donor2	11796-124C5	43.54	1.40	0.70	0.00	0.70	0.70	0.70
CD4+CD25+CD45RA+ naive regulatory T cells, donor3	11907-125F8	29.67	0.00	0.00	0.00	0.00	0.00	0.00
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor1	11794-124C3	55.35	0.43	0.72	0.14	0.00	0.00	0.00
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor2	11916-125G8	37.62	6.44	6.61	3.90	1.86	1.19	1.53
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor3	11920-125H3	36.27	5.80	4.03	3.22	1.45	0.81	0.32
CD4+CD25+CD45RA- memory regulatory T cells, donor1	11782-124A9	28.24	0.45	1.34	0.45	0.45	0.45	0.45
CD4+CD25+CD45RA- memory regulatory T cells, donor2	11797-124C6	33.54	1.05	0.35	0.00	0.00	0.35	0.00
CD4+CD25+CD45RA- memory regulatory T cells, donor3	11908-125F9	60.28	2.64	3.96	0.88	0.88	0.44	0.44
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor1	11791-124B9	69.57	1.69	0.84	1.69	0.42	0.42	0.42
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor2	11913-125G5	38.44	4.99	6.03	2.29	1.25	0.83	0.62
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor3	11917-125G9	22.39	2.67	3.68	1.00	1.67	0.67	0.00
CD4+CD25-CD45RA+ naive conventional T cells, donor1	11784-124B2	62.82	3.81	2.72	0.82	0.82	0.27	0.54
CD4+CD25-CD45RA+ naive conventional T cells, donor2	11795-124C4	55.20	0.00	1.61	0.00	1.07	0.54	0.00
CD4+CD25-CD45RA+ naive conventional T cells, donor3	11906-125F7	57.38	0.00	0.00	1.79	0.00	0.00	0.00
CD4+CD25-CD45RA- memory conventional T cells expanded, donor1	11792-124C1	66.57	3.52	3.71	1.85	1.30	0.19	0.74
CD4+CD25-CD45RA- memory conventional T cells expanded, donor2	11914-125G6	35.74	1.52	1.30	1.52	0.22	0.22	0.22
CD4+CD25-CD45RA- memory conventional T cells expanded, donor3	11918-125H1	32.15	1.47	1.68	0.42	0.42	0.63	0.00
CD4+CD25-CD45RA- memory conventional T cells, donor1	11786-124B4	38.93	4.04	2.02	0.00	0.51	0.00	0.00
CD4+CD25-CD45RA- memory conventional T cells, donor2	11798-124C7	35.53	1.30	0.00	0.43	0.43	0.00	0.43
CD4+CD25-CD45RA- memory conventional T cells, donor3	11909-125G1	81.50	3.05	1.31	3.05	0.87	1.74	0.87
CD8+ T Cells (pluriselect), donor090309, donation1	12186-129A8	54.93	0.49	2.97	0.49	0.00	0.00	0.00
CD8+ T Cells (pluriselect), donor090309, donation2	12191-129B4	48.01	0.92	0.92	0.00	0.00	0.00	0.00
CD8+ T Cells (pluriselect), donor090309, donation3	12196-129B9	50.25	1.40	1.40	1.40	1.40	1.40	0.00
CD8+ T Cells (pluriselect), donor090325, donation1	12148-128F6	111.33	0.28	0.28	0.55	0.00	0.00	0.00
CD8+ T Cells (pluriselect), donor090325, donation2	12171-128I2	129.81	2.21	0.25	0.25	0.00	0.00	0.00
CD8+ T Cells (pluriselect), donor090612, donation1	12201-129C5	41.58	1.54	0.00	0.00	0.00	0.00	0.00
CD8+ T Cells (pluriselect), donor090612, donation2	12206-129D1	87.38	0.36	1.07	1.07	0.00	0.36	0.00
CD8+ T Cells (pluriselect), donor090612, donation3	12211-129D6	65.09	2.77	2.77	0.00	0.00	0.00	0.00
CD8+ T Cells, donor1	11226-116C2	93.31	2.62	4.91	1.64	0.98	0.65	0.00
CD8+ T Cells, donor2	11307-117C2	71.33	4.51	4.88	4.88	3.00	1.13	0.00
CD8+ T Cells, donor3	11383-118B6	73.47	10.10	5.55	2.27	1.26	2.52	1.01
COBL-a rinderpest infection, 00hr, biol_rep1	13553-145I7	33.49	3.90	0.92	2.98	1.15	0.46	0.46
COBL-a rinderpest infection, 00hr, biol_rep2	13554-145I8	41.22	3.83	2.16	3.35	1.68	1.68	0.72
COBL-a rinderpest infection, 00hr, biol_rep3	13555-145I9	31.19	1.92	2.74	2.74	1.09	1.37	0.55
COBL-a rinderpest infection, 06hr, biol_rep1	13556-146A1	36.93	3.60	2.10	2.40	0.30	0.60	0.90
COBL-a rinderpest infection, 06hr, biol_rep2	13557-146A2	23.52	2.16	0.72	2.16	1.20	0.48	0.72
COBL-a rinderpest infection, 06hr, biol_rep3	13558-146A3	26.38	2.50	1.14	2.27	0.91	0.00	0.23
COBL-a rinderpest infection, 12hr, biol_rep1	13559-146A4	29.12	2.82	1.52	2.17	0.43	0.87	0.87
COBL-a rinderpest infection, 12hr, biol_rep2	13560-146A5	29.74	2.11	1.32	1.05	0.26	0.00	0.79
COBL-a rinderpest infection, 12hr, biol_rep3	13561-146A6	33.54	2.81	1.17	1.88	1.17	0.47	0.70
COBL-a rinderpest infection, 24hr, biol_rep1	13562-146A7	40.75	2.72	3.32	3.02	0.30	0.91	0.60
COBL-a rinderpest infection, 24hr, biol_rep2	13563-146A8	37.77	2.61	1.45	1.74	0.87	0.87	0.29
COBL-a rinderpest infection, 24hr, biol_rep3	13564-146A9	30.91	2.40	0.80	1.87	0.00	0.80	0.53
COBL-a rinderpest infection, 48hr, biol_rep1	13565-146B1	21.89	0.44	0.00	0.00	0.00	0.00	0.00
COBL-a rinderpest infection, 48hr, biol_rep2	13566-146B2	31.42	0.46	0.00	0.00	0.46	0.00	0.00
COBL-a rinderpest infection, 48hr, biol_rep3	13567-146B3	45.50	0.00	0.00	0.00	0.00	0.00	0.00
COBL-a rinderpest(-C) infection, 06hr, biol_rep1	13568-146B4	24.85	1.08	1.08	0.00	0.36	0.36	0.00
COBL-a rinderpest(-C) infection, 06hr, biol_rep2	13569-146B5	26.47	0.86	0.58	1.44	0.29	0.29	0.29
COBL-a rinderpest(-C) infection, 06hr, biol_rep3	13570-146B6	19.56	0.94	0.00	0.71	0.24	0.24	0.24
COBL-a rinderpest(-C) infection, 12hr, biol_rep1	13571-146B7	41.51	2.85	1.27	1.58	0.63	0.63	0.32
COBL-a rinderpest(-C) infection, 12hr, biol_rep2	13572-146B8	39.37	1.85	0.62	1.23	0.31	0.92	0.62
COBL-a rinderpest(-C) infection, 12hr, biol_rep3	13573-146B9	33.98	0.96	0.32	1.92	0.64	0.00	0.00
COBL-a rinderpest(-C) infection, 24hr, biol_rep1	13574-146C1	20.27	2.68	0.76	0.76	0.76	0.38	0.00
COBL-a rinderpest(-C) infection, 24hr, biol_rep2	13575-146C2	22.86	1.97	1.58	1.58	0.39	0.00	0.39
COBL-a rinderpest(-C) infection, 24hr, biol_rep3	13576-146C3	24.21	1.51	0.76	0.76	0.76	0.00	0.76
COBL-a rinderpest(-C) infection, 48hr, biol_rep1	13577-146C4	33.72	1.61	0.00	2.41	0.80	0.00	0.00
COBL-a rinderpest(-C) infection, 48hr, biol_rep2	13578-146C5	39.87	0.70	1.40	0.00	0.00	0.00	0.00
COBL-a rinderpest(-C) infection, 48hr, biol_rep3	13579-146C6	33.06	1.00	1.00	1.00	1.00	0.00	0.00
Cardiac Myocyte, donor1	11525-119I4	87.73	0.00	0.00	1.83	1.83	0.00	1.83
Cardiac Myocyte, donor2	11605-120I3	20.75	4.94	1.48	0.49	0.00	0.00	0.00
Cardiac Myocyte, donor3	11686-122I3	30.20	0.63	0.63	0.63	0.21	0.21	0.00
Chondrocyte - de diff, donor1	11261-116G1	42.99	4.85	1.04	2.08	0.35	0.69	0.35
Chondrocyte - de diff, donor2	11338-117F6	16.35	0.36	0.00	0.71	0.36	0.00	0.00
Chondrocyte - de diff, donor3	11410-118E6	29.92	4.10	5.23	3.75	1.93	0.68	1.02
Chondrocyte - re diff, donor2	11339-117F7	48.34	0.00	0.00	0.00	0.00	0.00	0.00
Chondrocyte - re diff, donor3	11411-118E7	16.18	0.00	0.00	0.40	0.00	0.00	0.00
Ciliary Epithelial Cells, donor1	11242-116D9	86.30	3.56	3.10	1.49	0.57	0.57	0.34
Ciliary Epithelial Cells, donor2	11323-117D9	51.09	5.56	4.06	1.28	1.50	0.64	0.00
Ciliary Epithelial Cells, donor3	11399-118D4	58.67	6.19	6.64	4.42	1.77	1.06	1.06
Clontech Human Universal Reference Total RNA, pool1	10000-101A1	28.79	1.01	0.83	0.64	0.28	0.18	0.09
Corneal Epithelial Cells, donor1	11526-119I5	7.25	0.00	0.00	0.00	0.00	0.00	0.00
Corneal Epithelial Cells, donor2	11606-120I4	15.93	2.28	0.00	0.00	0.00	1.14	0.00
Corneal Epithelial Cells, donor3	11687-122I4	16.62	0.77	0.77	0.00	0.51	0.00	0.00
Dendritic Cells - monocyte immature derived, donor1, rep2	11227-116C3	41.60	0.83	0.66	0.50	0.50	0.17	0.33
Dendritic Cells - monocyte immature derived, donor1, tech_rep1	11227-116C3	41.95	0.32	0.32	0.63	0.00	0.00	0.00
Dendritic Cells - monocyte immature derived, donor2	11308-117C3	41.41	0.00	0.00	0.00	0.00	0.00	3.45
Dendritic Cells - monocyte immature derived, donor3	11384-118B7	28.94	1.51	2.59	0.97	0.54	0.76	0.22
Dendritic Cells - plasmacytoid, donor1	11228-116C4	38.95	1.37	0.00	0.34	0.34	0.00	0.00
Dendritic Cells - plasmacytoid, donor2	11309-117C4	47.66	0.00	0.00	0.65	0.00	0.00	0.00
Dendritic Cells - plasmacytoid, donor3	11385-118B8	42.59	0.00	0.48	0.00	0.00	0.00	0.00
Endothelial Cells - Aortic, donor0	11207-116A1	18.84	0.17	0.00	0.33	0.00	0.00	0.00
Endothelial Cells - Aortic, donor1	11263-116G3	17.60	0.00	0.59	0.00	0.00	0.00	0.00
Endothelial Cells - Aortic, donor2	11340-117F8	8.48	0.00	0.00	0.00	0.00	0.00	0.28
Endothelial Cells - Aortic, donor3	11412-118E8	9.44	0.00	0.00	0.00	0.00	0.00	0.00
Endothelial Cells - Artery, donor1	11264-116G4	29.38	0.87	0.58	0.87	0.00	0.00	0.29
Endothelial Cells - Artery, donor2	11341-117F9	75.76	8.47	2.35	2.12	1.65	0.24	0.24
Endothelial Cells - Artery, donor3	11413-118E9	41.37	0.35	0.18	0.35	0.35	0.00	0.00
Endothelial Cells - Lymphatic, donor1	11236-116D3	65.83	1.33	0.89	0.66	0.22	0.22	0.22
Endothelial Cells - Lymphatic, donor2	11317-117D3	82.46	0.91	0.91	0.30	0.30	0.30	0.30
Endothelial Cells - Lymphatic, donor3	11393-118C7	74.99	1.41	0.56	0.85	0.00	0.28	0.28
Endothelial Cells - Microvascular, donor1	11265-116G5	17.23	0.59	0.00	0.00	0.30	0.00	0.00
Endothelial Cells - Microvascular, donor2	11342-117G1	29.68	0.52	0.00	0.52	0.00	0.00	0.00
Endothelial Cells - Microvascular, donor3	11414-118F1	14.18	2.98	1.28	0.71	0.14	0.85	0.14
Endothelial Cells - Thoracic, donor1	11266-116G6	110.83	4.40	1.60	0.80	0.40	0.80	0.40
Endothelial Cells - Thoracic, donor2	11343-117G2	22.54	0.52	0.52	0.52	0.00	0.00	0.00
Endothelial Cells - Umbilical vein, donor1	11243-116E1	162.51	2.61	3.60	1.86	1.12	0.37	0.75
Endothelial Cells - Umbilical vein, donor2	11324-117E1	93.42	2.17	1.30	0.87	0.87	0.22	0.22
Endothelial Cells - Umbilical vein, donor3	11400-118D5	123.72	1.95	1.59	1.10	0.73	0.37	0.00
Endothelial Cells - Vein, donor1	11267-116G7	15.93	0.00	0.00	0.00	0.00	0.00	0.00
Endothelial Cells - Vein, donor2	11344-117G3	10.48	0.00	0.00	0.00	0.00	0.00	0.00
Endothelial Cells - Vein, donor3	11416-118F3	25.12	0.94	0.63	0.31	0.16	0.31	0.00
Eosinophils, donor1	12244-129H3	45.74	0.00	0.00	0.00	0.00	0.00	0.00
Eosinophils, donor2	12245-129H4	19.80	1.65	0.00	0.00	1.65	1.65	0.00
Eosinophils, donor3	12246-129H5	17.83	0.00	0.00	0.00	0.00	0.00	0.00
Esophageal Epithelial Cells, donor1	11507-119G4	6.11	0.00	0.00	0.00	0.00	0.00	0.00
Esophageal Epithelial Cells, donor2	11587-120G3	2.08	0.00	0.00	0.00	0.00	0.00	0.00
Esophageal Epithelial Cells, donor3	11668-122G3	16.27	0.00	0.00	0.00	0.00	0.00	0.00
Ewing's sarcoma cell line:Hs 863.T	10705-109H3	38.59	4.93	3.28	0.41	0.82	0.00	0.82
Fibroblast - Aortic Adventitial donor2 (cytoplasmic fraction)	14331-155F2	15.88	0.99	0.55	0.66	0.33	0.00	0.44
Fibroblast - Aortic Adventitial donor3 (cytoplasmic fraction)	14310-155C8	15.49	1.84	0.54	0.76	0.11	0.00	0.11
Fibroblast - Aortic Adventitial, donor1	11245-116E3	56.76	6.06	4.37	1.82	1.09	0.61	0.73
Fibroblast - Aortic Adventitial, donor2 (nuclear fraction)	14332-155F3	144.25	4.23	2.59	3.00	0.55	0.96	0.55
Fibroblast - Aortic Adventitial, donor2	11326-117E3	36.07	5.06	2.32	1.90	0.84	0.84	0.63
Fibroblast - Aortic Adventitial, donor3 (nuclear fraction)	14311-155C9	77.47	5.27	2.11	1.58	1.58	2.11	0.79
Fibroblast - Aortic Adventitial, donor3	11401-118D6	55.81	4.32	5.65	4.65	1.99	1.33	2.33
Fibroblast - Cardiac, donor1	11268-116G8	26.31	0.00	0.45	0.00	0.00	0.45	0.00
Fibroblast - Cardiac, donor2	11345-117G4	15.92	0.76	0.00	0.00	0.00	0.76	0.00
Fibroblast - Cardiac, donor3	11417-118F4	34.54	2.84	1.58	1.42	0.95	0.16	0.16
Fibroblast - Cardiac, donor4	11452-119A3	107.60	1.21	0.30	0.61	0.00	0.61	0.00
Fibroblast - Cardiac, donor5	11456-119A7	50.76	1.52	0.13	0.76	0.25	0.13	0.13
Fibroblast - Cardiac, donor6	11460-119B2	62.61	1.67	0.45	1.06	0.45	0.00	0.30
Fibroblast - Choroid Plexus, donor1	11492-119E7	19.83	0.13	0.00	0.13	0.13	0.00	0.00
Fibroblast - Choroid Plexus, donor2	11572-120E6	38.83	1.29	0.43	0.00	0.86	0.43	0.00
Fibroblast - Choroid Plexus, donor3	11653-122E6	49.80	5.86	5.86	2.93	1.46	1.46	1.46
Fibroblast - Conjunctival, donor1	11531-120A1	18.45	0.00	0.23	0.23	0.00	0.00	0.23
Fibroblast - Conjunctival, donor3	11692-122I9	39.35	0.34	1.70	1.53	0.17	0.00	0.85
Fibroblast - Dermal, donor1	11269-116G9	66.91	2.35	2.82	2.35	0.94	0.47	0.47
Fibroblast - Dermal, donor2	11346-117G5	43.87	2.36	0.00	0.47	0.00	0.00	0.00
Fibroblast - Dermal, donor3	11418-118F5	61.77	11.24	9.91	7.25	2.90	3.26	1.93
Fibroblast - Dermal, donor4	11450-119A1	73.82	2.15	0.57	0.68	0.34	0.23	0.00
Fibroblast - Dermal, donor5	11454-119A5	90.19	1.74	1.22	0.00	0.00	0.17	0.00
Fibroblast - Dermal, donor6	11458-119A9	95.99	2.44	0.32	0.49	0.16	0.32	0.16
Fibroblast - Gingival, donor1	11237-116D4	105.36	1.87	1.67	1.25	0.42	0.00	0.21
Fibroblast - Gingival, donor10 (periodontitis)	11928-125I2	55.02	2.10	2.10	2.62	0.26	0.26	0.79
Fibroblast - Gingival, donor2	11318-117D4	64.71	9.09	5.93	3.82	1.98	1.84	0.79
Fibroblast - Gingival, donor3	11394-118C8	70.10	1.35	0.68	1.35	0.29	0.19	0.29
Fibroblast - Gingival, donor4 (GFH2)	11222-116B7	44.67	1.04	0.00	1.04	0.00	0.00	0.00
Fibroblast - Gingival, donor5 (GFH3)	11303-117B7	26.61	4.41	2.64	2.11	0.88	0.53	0.00
Fibroblast - Gingival, donor6 (aggressive periodontitis)	11921-125H4	60.80	5.30	5.14	2.65	1.40	1.56	0.47
Fibroblast - Gingival, donor6 (control)	11922-125H5	48.01	2.30	1.89	1.76	0.68	0.95	0.81
Fibroblast - Gingival, donor7 (aggressive periodontitis)	11923-125H6	20.11	0.00	0.00	0.00	0.00	0.00	0.00
Fibroblast - Gingival, donor7 (control)	11924-125H7	54.26	3.22	2.19	1.90	0.88	0.29	0.73
Fibroblast - Gingival, donor8 (chronic periodontitis)	11925-125H8	74.31	5.59	3.55	4.09	2.32	0.68	1.36
Fibroblast - Gingival, donor8 (control)	11926-125H9	71.74	2.74	2.96	1.76	1.21	0.66	0.66
Fibroblast - Gingival, donor9 (control)	11927-125I1	37.42	1.32	0.88	0.44	0.73	0.15	0.29
Fibroblast - Lung, donor1	11270-116H1	9.52	1.36	0.00	0.00	0.00	0.00	0.00
Fibroblast - Lung, donor2	11347-117G6	64.16	1.49	0.00	1.49	1.49	2.98	0.00
Fibroblast - Lung, donor3	11419-118F6	62.26	3.38	2.32	1.27	0.63	0.00	0.21
Fibroblast - Lymphatic, donor1	11506-119G3	15.83	0.00	0.00	0.00	0.00	0.00	0.00
Fibroblast - Lymphatic, donor2	11586-120G2	12.59	0.00	0.00	0.00	0.00	0.00	0.00
Fibroblast - Lymphatic, donor3	11667-122G2	1.40	0.00	0.00	0.00	0.00	0.00	0.00
Fibroblast - Mammary, donor1	11540-120B1	24.36	0.00	0.00	0.00	0.00	0.00	0.00
Fibroblast - Mammary, donor2	11620-122A9	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Fibroblast - Mammary, donor3	11701-123A9	23.83	0.00	0.00	0.00	0.00	0.00	0.00
Fibroblast - Periodontal Ligament, donor1	11238-116D5	89.81	3.88	5.63	2.91	0.78	0.97	0.58
Fibroblast - Periodontal Ligament, donor2	11319-117D5	129.38	4.55	1.67	2.73	1.06	0.46	0.46
Fibroblast - Periodontal Ligament, donor3	11395-118C9	207.77	0.92	0.92	0.31	0.31	0.00	0.31
Fibroblast - Periodontal Ligament, donor4 (PL29)	11223-116B8	45.41	0.76	0.76	1.14	0.38	0.38	0.00
Fibroblast - Periodontal Ligament, donor5 (PL30)	11304-117B8	33.48	1.35	0.27	1.08	0.54	0.00	0.27
Fibroblast - Periodontal Ligament, donor6 (PLH3)	11380-118B3	31.20	0.70	0.70	0.23	0.12	0.12	0.00
Fibroblast - Pulmonary Artery, donor1	11250-116E8	50.84	1.88	1.99	1.44	0.55	0.22	0.11
Fibroblast - Villous Mesenchymal, donor1	11535-120A5	13.61	0.00	0.00	0.00	0.00	0.00	0.00
Fibroblast - Villous Mesenchymal, donor2	11615-122A4	18.71	0.00	0.67	0.00	0.00	0.00	0.00
Fibroblast - Villous Mesenchymal, donor3	11696-123A4	25.70	1.98	1.58	0.79	0.00	0.40	0.00
Fibroblast - skin dystrophia myotonica, donor1 (nuclear fraction)	14329-155E9	109.94	11.31	4.17	5.56	3.37	2.58	1.19
Fibroblast - skin dystrophia myotonica, donor1	11556-120C8	42.27	4.09	3.02	1.78	1.95	1.24	0.53
Fibroblast - skin dystrophia myotonica, donor2	11557-120C9	61.29	6.11	3.35	2.17	0.39	0.79	0.39
Fibroblast - skin dystrophia myotonica, donor3 (nuclear fraction)	14308-155C6	68.59	6.32	2.11	3.31	0.90	0.30	0.30
Fibroblast - skin dystrophia myotonica, donor3	11560-120D3	77.73	5.40	0.86	1.08	0.65	0.32	0.43
Fibroblast - skin normal, donor1 (nuclear fraction)	14323-155E3	83.26	4.05	1.52	4.05	1.52	0.51	0.76
Fibroblast - skin normal, donor1	11553-120C5	37.25	2.63	0.82	0.98	0.33	0.49	0.49
Fibroblast - skin normal, donor2 (nuclear fraction)	14302-155B9	176.65	14.64	10.03	10.63	5.21	5.01	2.81
Fibroblast - skin normal, donor2	11561-120D4	57.26	3.21	0.20	0.80	0.70	0.30	0.00
Fibroblast - skin spinal muscular atrophy, donor1 (nuclear fraction)	14326-155E6	122.41	12.69	2.72	5.44	2.42	1.81	0.60
Fibroblast - skin spinal muscular atrophy, donor1	11555-120C7	53.35	1.49	1.82	0.75	0.33	0.33	0.25
Fibroblast - skin spinal muscular atrophy, donor2	11558-120D1	69.23	5.13	1.03	0.85	0.34	0.85	0.17
Fibroblast - skin spinal muscular atrophy, donor3 (nuclear fraction)	14305-155C3	87.36	5.58	1.31	3.61	1.64	1.64	0.66
Fibroblast - skin spinal muscular atrophy, donor3	11559-120D2	62.42	3.62	0.53	1.07	0.64	0.43	0.64
Fibroblast - skin walker warburg, donor1	11554-120C6	29.52	3.54	2.02	1.01	0.51	1.18	0.17
Fibroblast - skin, normal donor1 (cytoplasmic fraction)	14322-155E2	18.35	0.94	0.63	0.78	0.94	0.47	0.16
Fibroblast - skin, normal donor2 (cytoplasmic fraction)	14301-155B8	731.27	44.32	44.32	22.16	0.00	22.16	22.16
Fingernail (including nail plate, eponychium and hyponychium), donor2	10301-104H4	132.47	4.36	2.61	0.87	2.61	0.00	0.00
Gingival epithelial cells, donor1 (GEA11)	11221-116B6	27.22	0.17	0.35	0.17	0.00	0.00	0.17
Gingival epithelial cells, donor2 (GEA14)	11302-117B6	61.94	1.56	2.08	1.30	0.78	0.52	0.78
Gingival epithelial cells, donor3 (GEA15)	11379-118B2	77.16	0.26	0.77	0.00	0.26	0.00	0.26
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep1	13523-145F4	27.56	0.00	0.77	0.00	0.00	0.00	0.00
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep2	13524-145F5	27.44	1.28	1.91	0.00	0.00	0.00	0.00
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep3	13525-145F6	104.41	13.98	9.98	6.85	3.71	2.28	1.71
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep1	13526-145F7	63.15	8.82	9.10	2.76	1.38	1.65	0.83
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep2	13527-145F8	64.62	6.39	5.71	3.42	2.74	1.37	0.23
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep3	13528-145F9	87.18	11.10	6.54	3.57	3.37	1.39	1.78
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep1	13529-145G1	40.71	6.08	4.76	4.23	1.85	1.32	0.79
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep2	13530-145G2	66.21	4.57	4.24	2.94	2.28	0.98	0.33
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep3	13531-145G3	114.54	17.25	11.94	5.75	8.40	1.33	3.98
H9 Embryoid body cells, melanocytic induction, day00, biol_rep1 (H9EB-1 d0)	12627-134E8	83.95	5.23	4.38	5.23	1.84	0.57	0.85
H9 Embryoid body cells, melanocytic induction, day00, biol_rep2 (H9EB-2 d0)	12725-135G7	75.73	5.17	4.19	2.96	2.34	1.11	0.62
H9 Embryoid body cells, melanocytic induction, day00, biol_rep3 (H9EB-3 d0)	12823-136I6	73.60	8.33	7.25	2.95	2.95	1.34	0.54
H9 Embryoid body cells, melanocytic induction, day01, biol_rep1 (H9EB-1 d1)	12628-134E9	74.96	4.34	3.47	3.84	2.73	0.62	0.99
H9 Embryoid body cells, melanocytic induction, day01, biol_rep2 (H9EB-2 d1)	12726-135G8	66.44	5.26	3.18	2.63	1.38	1.11	0.97
H9 Embryoid body cells, melanocytic induction, day01, biol_rep3 (H9EB-3 d1)	12824-136I7	59.57	5.90	5.49	3.46	2.03	0.81	0.81
H9 Embryoid body cells, melanocytic induction, day03, biol_rep1 (H9EB-1 d3)	12629-134F1	47.00	3.42	2.51	2.05	0.68	1.37	0.23
H9 Embryoid body cells, melanocytic induction, day03, biol_rep2 (H9EB-2 d3)	12727-135G9	58.67	5.48	4.36	2.99	1.62	0.62	0.87
H9 Embryoid body cells, melanocytic induction, day03, biol_rep3 (H9EB-3 d3)	12825-136I8	64.70	5.03	2.84	5.25	1.97	1.75	0.44
H9 Embryoid body cells, melanocytic induction, day06, biol_rep1 (H9EB-1 d6)	12630-134F2	48.46	2.07	3.55	1.77	0.89	0.89	0.00
H9 Embryoid body cells, melanocytic induction, day06, biol_rep2 (H9EB-2 d6)	12728-135H1	64.38	8.11	5.56	3.50	2.38	1.27	1.27
H9 Embryoid body cells, melanocytic induction, day06, biol_rep3 (H9EB-3 d6)	12826-136I9	56.53	4.24	4.47	0.67	2.23	1.34	0.89
H9 Embryoid body cells, melanocytic induction, day09, biol_rep1 (H9EB-1 d9)	12631-134F3	56.05	4.23	3.02	3.63	1.41	1.61	0.81
H9 Embryoid body cells, melanocytic induction, day09, biol_rep2 (H9EB-2 d9)	12729-135H2	79.05	7.46	7.12	3.73	1.53	1.19	0.68
H9 Embryoid body cells, melanocytic induction, day09, biol_rep3 (H9EB-3 d9)	12827-137A1	89.91	3.55	2.13	2.57	1.24	0.89	0.44
H9 Embryoid body cells, melanocytic induction, day12, biol_rep1 (H9EB-1 d12)	12632-134F4	102.39	3.23	0.73	2.50	1.46	0.31	0.31
H9 Embryoid body cells, melanocytic induction, day12, biol_rep1 (H9EB-1 d12)	12632-134F4	100.76	2.05	0.17	2.73	0.85	0.00	0.00
H9 Embryoid body cells, melanocytic induction, day12, biol_rep2 (H9EB-2 d12)	12730-135H3	59.09	3.87	3.76	2.99	1.55	1.00	1.66
H9 Embryoid body cells, melanocytic induction, day12, biol_rep3 (H9EB-3 d12)	12828-137A2	70.55	3.41	3.99	1.00	1.58	0.75	0.75
H9 Embryoid body cells, melanocytic induction, day12, biol_rep3 (H9EB-3 d12)	12828-137A2	76.57	0.82	2.45	1.63	0.41	0.00	0.20
H9 Embryoid body cells, melanocytic induction, day15, biol_rep1 (H9EB-1 d15)	12633-134F5	49.72	4.95	2.48	1.24	1.24	1.24	0.62
H9 Embryoid body cells, melanocytic induction, day15, biol_rep2 (H9EB-2 d15)	12731-135H4	52.57	3.11	2.88	3.34	1.04	1.04	0.23
H9 Embryoid body cells, melanocytic induction, day15, biol_rep3 (H9EB-3 d15)	12829-137A3	45.03	4.34	3.50	2.33	1.33	0.17	0.33
H9 Embryoid body cells, melanocytic induction, day18, biol_rep1 (H9EB-1 d18)	12634-134F6	39.24	3.97	4.19	3.53	0.88	1.10	1.10
H9 Embryoid body cells, melanocytic induction, day18, biol_rep2 (H9EB-2 d18)	12732-135H5	58.30	5.29	4.55	3.32	1.72	1.23	0.86
H9 Embryoid body cells, melanocytic induction, day18, biol_rep3 (H9EB-3 d18)	12830-137A4	52.36	5.67	4.86	3.24	0.97	0.97	1.62
H9 Embryoid body cells, melanocytic induction, day21, biol_rep1 (H9EB-1 d21)	12635-134F7	52.60	4.81	5.45	2.25	2.25	1.60	1.28
H9 Embryoid body cells, melanocytic induction, day21, biol_rep2 (H9EB-2 d21)	12733-135H6	48.70	3.41	2.27	2.56	0.76	0.38	0.57
H9 Embryoid body cells, melanocytic induction, day21, biol_rep3 (H9EB-3 d21)	12831-137A5	46.82	3.48	3.16	1.90	2.06	1.11	0.63
H9 Embryoid body cells, melanocytic induction, day24, biol_rep1 (H9EB-1 d24)	12636-134F8	48.96	5.78	7.60	1.52	0.91	0.91	0.61
H9 Embryoid body cells, melanocytic induction, day24, biol_rep2 (H9EB-2 d24)	12734-135H7	54.46	4.50	4.70	3.87	1.78	0.63	0.42
H9 Embryoid body cells, melanocytic induction, day24, biol_rep3 (H9EB-3 d24)	12832-137A6	39.96	2.63	2.85	2.42	1.54	0.88	0.66
H9 Embryoid body cells, melanocytic induction, day27, biol_rep1 (H9EB-1 d27)	12637-134F9	49.66	5.89	5.05	1.96	3.09	1.96	0.28
H9 Embryoid body cells, melanocytic induction, day27, biol_rep2 (H9EB-2 d27)	12735-135H8	62.50	1.76	0.93	2.13	0.46	0.56	0.56
H9 Embryoid body cells, melanocytic induction, day27, biol_rep3 (H9EB-3 d27)	12833-137A7	42.78	6.15	2.67	2.94	1.07	1.34	1.34
H9 Embryoid body cells, melanocytic induction, day30, biol_rep1 (H9EB-1 d30)	12638-134G1	61.51	5.36	5.20	2.75	2.14	1.84	1.07
H9 Embryoid body cells, melanocytic induction, day30, biol_rep2 (H9EB-2 d30)	12736-135H9	49.48	3.76	3.50	2.46	0.65	0.91	0.26
H9 Embryoid body cells, melanocytic induction, day30, biol_rep3 (H9EB-3 d30)	12834-137A8	48.79	1.63	0.81	1.90	0.27	0.27	0.27
H9 Embryoid body cells, melanocytic induction, day34, biol_rep1 (H9EB-1 d34)	12639-134G2	50.33	5.71	7.01	4.24	1.66	1.66	0.74
H9 Embryoid body cells, melanocytic induction, day34, biol_rep2 (H9EB-2 d34)	12737-135I1	46.49	3.95	2.41	3.51	2.63	0.44	0.00
H9 Embryoid body cells, melanocytic induction, day34, biol_rep3 (H9EB-3 d34)	12835-137A9	113.06	6.94	1.98	7.93	1.98	0.00	1.98
H9 Embryoid body cells, melanocytic induction, day41, biol_rep1 (H9EB-1 d41)	12640-134G3	44.85	2.37	3.69	1.45	1.45	0.79	0.40
H9 Embryoid body cells, melanocytic induction, day41, biol_rep2 (H9EB-2 d41)	12738-135I2	42.57	2.02	2.22	1.82	1.01	1.21	0.61
H9 Embryoid body cells, melanocytic induction, day41, biol_rep3 (H9EB-3 d41)	12836-137B1	186.81	1.02	0.00	2.54	1.52	0.51	0.25
H9 Embryonic Stem cells, biol_rep1 (H9ES-1)	12626-134E7	171.39	6.57	2.79	3.58	2.79	1.99	1.00
H9 Embryonic Stem cells, biol_rep2 (H9ES-2)	12724-135G6	98.30	6.78	7.40	4.78	2.31	2.00	2.31
H9 Embryonic Stem cells, biol_rep3 (H9ES-3)	12822-136I5	124.80	6.34	8.59	4.30	2.86	0.82	1.43
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep1 (UH-1)	13364-143F7	19.09	0.63	0.31	0.00	0.31	0.63	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep2 (UH-2)	13365-143F8	22.89	0.28	0.00	0.28	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep3 (UH-3)	13366-143F9	82.09	7.38	3.23	2.31	0.92	0.92	1.84
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep1	13328-143B7	44.55	12.37	4.95	12.37	2.47	0.00	2.47
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep2	13340-143D1	75.81	6.19	5.80	3.87	1.16	1.93	0.39
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep3	13352-143E4	60.97	4.81	4.81	0.00	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep1	13329-143B8	52.16	8.69	1.74	5.22	0.00	1.74	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep2	13341-143D2	62.17	6.18	3.25	2.28	1.63	1.30	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep3	13353-143E5	72.48	7.82	7.41	2.88	2.88	0.00	0.82
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep1	13330-143B9	103.30	19.99	16.66	13.33	0.00	6.66	3.33
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep2	13342-143D3	57.33	8.11	4.19	2.52	1.12	1.68	1.12
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep3	13354-143E6	66.35	5.56	4.90	3.27	1.31	1.63	0.65
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep1	13331-143C1	77.17	14.26	17.62	6.71	5.03	0.00	2.52
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep2	13343-143D4	70.61	8.27	5.41	3.18	1.91	0.64	1.27
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep3	13355-143E7	51.97	4.42	1.70	3.06	1.02	0.00	0.68
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep1	13332-143C2	37.59	2.09	6.26	2.09	2.09	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep2	13344-143D5	55.55	2.86	0.57	0.57	0.57	1.72	0.57
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep3	13356-143E8	34.63	2.96	3.26	2.07	1.78	0.89	0.59
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep1	13333-143C3	52.52	11.86	5.08	5.08	1.69	3.39	1.69
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep2	13345-143D6	67.52	5.80	4.14	2.90	0.41	0.00	0.83
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep3	13357-143E9	67.20	5.29	3.45	1.61	1.61	2.53	0.46
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep1	13334-143C4	36.88	5.27	0.00	5.27	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep2	13346-143D7	42.67	3.84	5.77	2.69	0.00	0.38	0.77
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep3	13358-143F1	42.70	5.22	3.91	1.30	1.30	0.33	0.65
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep1	13335-143C5	20.07	0.67	0.00	2.01	0.00	0.00	0.67
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep2	13347-143D8	62.41	4.62	2.31	1.54	1.54	1.16	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep3	13359-143F2	79.77	6.50	8.56	4.79	2.05	2.05	0.34
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep1	13336-143C6	59.63	14.91	4.97	9.94	2.48	0.00	2.48
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep2	13348-143D9	46.71	6.13	2.36	1.89	1.89	1.89	2.36
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep3	13360-143F3	45.87	4.83	1.81	3.02	1.21	1.81	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep1	13337-143C7	46.80	4.07	1.02	1.02	0.51	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep2	13349-143E1	62.22	6.78	3.99	1.99	0.00	0.80	0.80
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep3	13361-143F4	69.56	7.40	2.96	1.48	0.49	3.95	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep1	13338-143C8	57.84	4.72	2.36	4.72	0.00	1.18	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep2	13350-143E2	38.51	3.50	5.25	2.33	1.17	1.17	1.17
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep3	13362-143F5	47.40	3.95	0.88	3.95	0.88	0.44	1.32
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep1	13339-143C9	43.23	6.78	5.93	0.85	3.39	0.85	0.85
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep2	13351-143E3	22.09	2.39	2.98	0.00	1.19	0.00	1.79
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep3	13363-143F6	40.76	2.91	4.85	0.49	0.49	0.97	0.97
Hair Follicle Dermal Papilla Cells, donor1	11271-116H2	6.85	0.00	0.00	0.00	0.00	0.00	0.00
Hair Follicle Dermal Papilla Cells, donor2	11348-117G7	28.28	4.16	0.00	0.83	1.25	1.25	0.00
Hair Follicle Dermal Papilla Cells, donor3	11420-118F7	6.75	2.25	0.00	0.00	0.00	0.00	0.00
Hair Follicle Outer Root Sheath Cells, donor1	11504-119G1	42.18	5.39	1.59	1.90	0.95	1.59	0.95
Hair Follicle Outer Root Sheath Cells, donor2	11584-120F9	28.82	2.09	0.84	0.84	0.00	0.42	0.00
Hep-2 cells mock treated, biol_rep1	11898-125E8	55.58	8.12	3.60	1.16	1.62	1.16	0.70
Hep-2 cells mock treated, biol_rep2	11899-125E9	66.68	7.60	5.40	3.04	1.52	1.18	1.18
Hep-2 cells mock treated, biol_rep3	11900-125F1	68.71	10.24	5.23	3.87	2.96	1.37	1.82
Hep-2 cells treated with Streptococci strain 5448, biol_rep1	11890-125D9	58.26	5.36	4.92	1.42	1.42	1.53	0.77
Hep-2 cells treated with Streptococci strain 5448, biol_rep2	11891-125E1	54.37	6.66	3.87	3.22	0.43	0.43	0.64
Hep-2 cells treated with Streptococci strain 5448, biol_rep3	11892-125E2	55.76	7.10	5.81	3.01	1.94	1.08	0.86
Hep-2 cells treated with Streptococci strain JRS4, biol_rep1	11894-125E4	55.67	8.59	4.48	1.74	1.49	1.12	0.37
Hep-2 cells treated with Streptococci strain JRS4, biol_rep2	11895-125E5	57.81	7.21	2.57	2.06	1.03	0.17	0.34
Hep-2 cells treated with Streptococci strain JRS4, biol_rep3	11896-125E6	52.54	5.45	3.52	2.56	0.64	0.32	0.00
Hepatic Sinusoidal Endothelial Cells, donor1	11521-119H9	8.39	0.56	0.00	0.00	0.00	0.00	0.00
Hepatic Sinusoidal Endothelial Cells, donor2	11601-120H8	6.06	0.00	0.43	0.00	0.00	0.00	0.00
Hepatic Sinusoidal Endothelial Cells, donor3	11682-122H8	42.30	7.93	7.93	2.64	5.29	2.64	2.64
Hepatic Stellate Cells (lipocyte), donor1	11524-119I3	15.17	0.35	0.00	0.00	0.00	0.00	0.00
Hepatic Stellate Cells (lipocyte), donor2	11604-120I2	9.44	0.73	0.00	0.00	0.00	0.00	0.00
Hepatic Stellate Cells (lipocyte), donor3	11685-122I2	32.35	2.97	2.10	1.05	0.87	0.87	0.87
Hepatocyte, donor1	11523-119I2	78.69	6.05	4.84	0.00	1.21	2.42	0.00
Hepatocyte, donor2	11603-120I1	49.56	2.15	3.23	4.31	0.00	0.00	0.00
Hepatocyte, donor3	11684-122I1	88.96	9.20	3.68	4.91	2.45	1.23	0.61
Hodgkin's lymphoma cell line:HD-Mar2	10435-106E3	55.48	1.96	1.96	0.65	0.00	1.31	0.65
Intestinal epithelial cells (polarized), donor1	11246-116E4	104.00	5.77	2.45	3.15	1.40	1.05	1.40
Iris Pigment Epithelial Cells, donor1	11530-119I9	49.94	2.74	4.12	2.20	0.69	0.69	0.69
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep1	13079-140B1	15.92	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep2	13145-140I4	13.35	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep3	13211-141G7	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep1	13080-140B2	23.53	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep2	13146-140I5	2.50	0.00	0.00	2.50	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep3	13212-141G8	11.87	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep1	13081-140B3	35.88	2.56	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep2	13147-140I6	18.28	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep3	13213-141G9	27.61	1.62	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep1	13082-140B4	13.34	0.00	1.67	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep2	13148-140I7	10.89	0.00	0.00	3.63	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep3	13214-141H1	25.15	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep1	13083-140B5	16.63	0.00	3.33	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep2	13149-140I8	10.48	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep3	13215-141H2	29.60	1.26	0.63	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep1	13084-140B6	15.47	1.55	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep2	13150-140I9	14.63	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep3	13216-141H3	29.07	0.65	0.65	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep1	13085-140B7	12.88	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep2	13151-141A1	35.84	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep3	13217-141H4	20.37	0.00	0.00	0.81	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep1	13086-140B8	14.69	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep2	13152-141A2	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep3	13218-141H5	19.29	2.41	0.00	0.80	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep1	13087-140B9	16.62	0.00	0.92	0.00	0.00	0.00	0.92
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep2	13153-141A3	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep3	13219-141H6	17.94	0.00	0.47	0.47	0.47	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep1	13088-140C1	20.86	0.91	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep2	13154-141A4	29.48	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep3	13220-141H7	26.90	2.15	1.08	1.08	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep1	13089-140C2	22.87	1.27	0.00	0.00	0.00	1.27	0.00
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep2	13155-141A5	16.43	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep3	13221-141H8	17.86	0.00	0.64	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep1	13090-140C3	25.52	1.82	0.00	1.82	1.82	0.00	0.00
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep2	13156-141A6	15.80	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep3	13222-141H9	23.56	1.43	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep1	13091-140C4	16.59	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep2	13157-141A7	41.70	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep3	13223-141I1	27.78	2.16	0.62	1.54	0.00	0.00	0.31
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep1	13092-140C5	29.85	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep2	13158-141A8	34.57	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep3	13224-141I2	40.33	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep1	13093-140C6	19.92	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep2	13159-141A9	25.94	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep3	13225-141I3	15.69	0.00	0.00	0.00	0.00	0.00	0.87
K562 erythroblastic leukemia response to hemin, day02, biol_rep1	13094-140C7	15.75	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day02, biol_rep2	13160-141B1	13.94	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day02, biol_rep3	13226-141I4	6.40	0.00	0.00	1.07	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day03, biol_rep1	13095-140C8	23.55	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day03, biol_rep2	13161-141B2	31.35	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day03, biol_rep3	13227-141I5	8.28	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day04, biol_rep1	13096-140C9	18.15	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day04, biol_rep2	13162-141B3	6.21	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day04, biol_rep3	13228-141I6	13.75	0.00	0.00	0.00	0.00	0.00	0.00
Keratinocyte - epidermal, donor1	11272-116H3	108.12	4.90	2.94	2.28	1.14	0.90	0.73
Keratinocyte - epidermal, donor2	11349-117G8	10.54	0.00	0.00	0.00	0.00	0.59	0.00
Keratinocyte - epidermal, donor3	11421-118F8	84.05	12.87	12.12	8.05	3.79	2.27	4.16
Keratinocyte - oral, donor1	11251-116E9	110.91	10.33	7.72	4.43	2.38	1.93	1.70
Keratocytes, donor1	11527-119I6	14.44	0.00	0.34	1.03	0.00	0.00	0.00
Keratocytes, donor2	11607-120I5	7.03	0.00	0.00	0.00	0.00	0.00	0.00
Keratocytes, donor3	11688-122I5	35.37	2.57	4.15	2.17	1.58	0.59	1.19
Krukenberg tumor cell line:HSKTC	10687-109F3	342.87	4.40	2.20	4.40	2.20	0.00	0.00
Lens Epithelial Cells, donor1	11529-119I8	52.86	5.39	4.31	5.39	2.16	1.08	0.00
Lens Epithelial Cells, donor2	11609-120I7	49.71	2.08	2.54	1.15	0.46	0.23	0.81
Lens Epithelial Cells, donor3	11690-122I7	68.21	1.31	0.61	0.40	0.30	0.71	0.61
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep1 (MM XIX - 1)	12260-130A1	13.75	0.36	1.19	0.47	0.24	0.12	0.24
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep2 (MM XIV - 1)	12382-131E6	5.02	0.84	0.56	0.56	0.28	0.28	0.28
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep3 (MM XXII - 1 )	12504-133A2	33.69	5.04	4.09	3.46	1.57	1.10	0.79
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep1 (MM XIX - 2)	12261-130A2	8.60	1.61	0.54	1.61	0.00	0.54	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep2 (MM XIV - 2)	12383-131E7	10.40	0.32	0.32	0.32	0.00	0.00	0.32
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep3 (MM XXII - 2)	12505-133A3	6.68	1.29	1.40	0.65	0.11	0.22	0.11
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep1 (MM XIX - 3)	12262-130A3	19.70	1.64	2.05	0.82	0.41	0.41	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep2 (MM XIV - 3)	12384-131E8	4.05	0.25	0.00	0.51	0.00	0.00	0.25
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep3 (MM XXII - 3)	12506-133A4	9.43	1.97	1.41	0.84	0.28	0.42	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep1 (MM XIX - 4)	12263-130A4	14.24	2.77	1.19	0.40	0.40	0.00	0.40
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep2 (MM XIV - 4)	12385-131E9	9.89	0.97	1.36	0.19	0.97	0.19	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep3 (MM XXII - 4)	12507-133A5	3.89	0.19	0.37	0.37	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep1 (MM XIX - 5)	12264-130A5	10.45	1.39	1.74	0.35	0.70	0.35	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep2 (MM XIV - 5)	12386-131F1	8.11	0.48	0.48	0.24	0.48	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep3 (MM XXII - 5)	12508-133A6	7.14	0.96	0.27	0.69	0.27	0.00	0.14
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep1 (MM XIX - 6)	12265-130A6	15.40	1.85	1.23	0.62	0.92	0.31	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep2 (MM XIV - 6)	12387-131F2	2.81	0.00	0.00	0.31	0.31	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep3 (MM XXII - 6)	12509-133A7	11.16	1.46	1.46	0.18	0.37	0.37	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep1 (MM XIX - 7)	12266-130A7	16.46	0.66	0.99	0.99	0.66	0.66	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep2 (MM XIV - 7)	12388-131F3	4.39	0.29	0.29	0.59	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep3 (MM XXII - 7)	12510-133A8	4.98	0.25	0.00	0.00	0.25	0.25	0.00
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep1 (MM XIX - 8)	12267-130A8	24.25	1.45	0.97	1.45	0.97	0.48	0.48
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep2 (MM XIV - 8)	12389-131F4	8.89	0.00	0.54	0.27	0.27	0.27	1.08
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep3 (MM XXII - 8)	12511-133A9	9.08	1.51	1.21	0.61	0.30	0.15	0.61
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep1 (MM XIX - 9)	12268-130A9	16.07	0.00	0.52	0.00	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep2 (MM XIV - 9)	12390-131F5	14.24	1.88	3.77	1.05	0.84	1.05	0.00
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep3 (MM XXII - 9)	12512-133B1	6.77	1.35	0.90	0.90	0.15	0.15	0.00
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep1 (MM XIX - 10)	12269-130B1	15.82	2.75	0.69	0.69	0.69	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep2 (MM XIV - 10)	12391-131F6	7.90	0.75	0.19	0.94	0.19	0.00	0.19
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep3 (MM XXII - 10)	12513-133B2	5.51	0.85	0.32	0.32	0.11	0.32	0.11
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep1 (MM XIX - 11)	12270-130B2	20.84	3.88	0.97	2.91	1.45	0.48	0.00
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep2 (MM XIV - 11)	12392-131F7	9.26	0.66	0.66	0.00	0.00	0.66	0.00
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep3 (MM XXII - 11)	12514-133B3	5.08	1.24	0.50	0.25	0.25	0.00	0.37
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep1 (MM XIX - 12)	12271-130B3	45.54	6.66	3.33	2.22	1.48	0.74	0.00
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep2 (MM XIV - 12)	12393-131F8	8.15	0.99	1.24	0.25	0.25	0.25	0.00
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep3 (MM XXII - 12)	12515-133B4	4.40	1.24	0.27	0.14	0.27	0.14	0.14
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep1 (MM XIX - 13)	12272-130B4	23.16	1.93	1.93	1.29	0.32	0.64	0.00
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep2 (MM XIV - 13)	12394-131F9	20.69	1.83	0.91	0.61	0.61	0.61	0.61
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep3 (MM XXII - 13)	12516-133B5	18.06	2.10	2.52	1.40	0.84	0.84	0.00
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep1 (MM XIX - 14)	12273-130B5	14.93	1.42	0.71	2.13	0.36	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep2 (MM XIV - 14)	12395-131G1	2.91	0.48	0.48	0.00	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep3 (MM XXII - 14)	12517-133B6	4.05	0.62	0.00	0.31	0.00	0.16	0.16
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep1 (MM XIX - 15)	12274-130B6	14.68	0.72	1.07	0.72	0.36	0.36	0.36
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep2 (MM XIV - 15)	12396-131G2	7.19	0.00	0.00	0.00	0.00	0.00	0.65
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep3 (MM XXII - 15)	12518-133B7	3.30	0.24	0.24	0.24	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep1 (MM XIX - 16)	12275-130B7	16.95	0.99	1.11	0.37	0.74	0.25	0.37
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep2 (MM XIV - 16)	12397-131G3	3.59	0.51	0.51	0.51	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep3 (MM XXII - 16)	12519-133B8	11.04	0.60	0.60	0.30	0.30	0.30	0.00
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep1	13031-139E7	4.53	0.00	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep2	13097-140D1	6.90	0.00	0.00	1.53	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep3	13163-141B4	5.94	0.00	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep1	13032-139E8	6.77	0.00	0.00	0.00	0.00	0.00	0.42
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep2	13098-140D2	4.22	0.70	1.41	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep3	13164-141B5	4.67	0.00	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep1	13033-139E9	5.15	1.03	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep2	13099-140D3	4.76	0.00	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep3	13165-141B6	8.37	0.00	0.23	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep1	13034-139F1	15.12	1.16	0.58	0.87	0.58	0.87	0.58
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep2	13100-140D4	15.76	0.90	3.60	1.35	0.00	0.45	0.00
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep3	13166-141B7	9.35	0.14	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep1	13035-139F2	8.22	0.51	0.00	0.00	0.51	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep2	13101-140D5	13.41	0.35	0.35	0.71	0.35	0.35	0.00
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep3	13167-141B8	12.66	0.67	0.00	0.00	0.00	0.00	0.67
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep1	13036-139F3	11.21	1.02	1.53	0.00	0.51	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep2	13102-140D6	16.28	2.13	0.80	0.53	0.80	0.27	0.00
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep3	13168-141B9	23.81	1.70	0.94	0.94	0.38	0.38	0.00
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep1	13037-139F4	9.20	0.00	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep2	13103-140D7	10.60	0.00	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep3	13169-141C1	23.95	2.29	1.46	0.62	1.04	0.62	0.21
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep1	13038-139F5	20.46	3.08	1.12	0.00	1.12	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep2	13104-140D8	11.33	0.00	1.03	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep3	13170-141C2	17.13	3.77	0.87	0.00	0.29	0.29	0.00
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep1	13039-139F6	16.74	1.20	0.00	0.00	0.30	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep2	13105-140D9	16.60	2.21	0.55	0.00	0.55	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep3	13171-141C3	11.31	0.00	0.35	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep1	13040-139F7	15.12	1.84	0.74	0.37	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep2	13106-140E1	6.91	0.00	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep3	13172-141C4	5.37	0.38	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep1	13041-139F8	6.23	1.13	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep2	13107-140E2	9.85	0.82	0.00	0.82	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep3	13173-141C5	8.59	0.00	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep1	13042-139F9	7.90	0.72	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep2	13108-140E3	20.17	0.75	0.00	1.49	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep3	13174-141C6	7.06	1.11	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep1	13043-139G1	12.49	0.43	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep2	13109-140E4	10.28	0.00	0.00	0.86	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep3	13175-141C7	13.33	0.00	0.00	0.33	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep1	13044-139G2	4.83	0.00	0.60	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep2	13110-140E5	4.98	0.71	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep3	13176-141C8	9.62	0.34	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep1	13045-139G3	5.37	0.00	0.00	0.54	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep2	13111-140E6	3.37	0.00	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep3	13177-141C9	9.26	0.74	0.74	0.37	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep1	13046-139G4	9.30	1.16	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep2	13112-140E7	4.23	1.06	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep3	13178-141D1	15.21	0.80	0.40	0.00	0.00	0.40	0.00
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep1	13048-139G6	6.54	0.00	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep2	13114-140E9	4.60	0.00	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep3	13180-141D3	8.39	0.00	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep1	13049-139G7	9.41	0.00	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep2	13115-140F1	3.52	0.00	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep3	13181-141D4	11.27	0.45	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep1	13050-139G8	5.16	0.00	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep2	13116-140F2	7.57	0.00	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep3	13182-141D5	10.17	0.78	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep1	13051-139G9	5.94	0.00	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep2	13117-140F3	6.75	0.00	0.00	0.00	0.00	0.52	0.00
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep3	13183-141D6	5.25	0.00	0.00	0.44	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep1	13052-139H1	8.95	0.56	0.56	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep2	13118-140F4	11.04	0.00	0.44	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep3	13184-141D7	10.03	0.77	0.77	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep1	13053-139H2	11.14	1.01	1.01	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep2	13119-140F5	10.57	0.48	0.96	0.48	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep3	13185-141D8	13.91	1.19	1.19	0.00	0.80	0.00	0.00
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep1	13054-139H3	9.72	0.00	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep2	13120-140F6	6.23	0.69	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep3	13186-141D9	10.26	0.76	0.38	0.38	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep1	13055-139H4	8.26	0.00	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep2	13121-140F7	7.26	0.60	0.00	0.00	0.00	0.00	0.60
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep3	13187-141E1	12.68	1.27	0.00	0.00	0.00	0.32	0.00
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep1	13056-139H5	6.93	0.00	0.00	0.53	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep2	13122-140F8	9.77	0.57	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep3	13188-141E2	11.83	0.00	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep1	13057-139H6	4.95	0.00	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep2	13123-140F9	12.48	0.00	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep3	13189-141E3	11.65	0.00	0.00	0.42	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep1	13058-139H7	4.70	0.00	0.78	0.00	0.78	0.00	0.00
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep2	13124-140G1	5.43	0.00	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep3	13190-141E4	8.36	0.46	0.00	0.00	0.00	0.46	0.00
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep1	13059-139H8	10.70	0.00	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep2	13125-140G2	10.16	1.60	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep3	13191-141E5	5.25	0.40	0.40	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep1	13060-139H9	7.34	0.00	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep2	13126-140G3	5.33	1.78	0.00	0.00	0.89	0.00	0.00
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep3	13192-141E6	6.84	1.14	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep1	13061-139I1	3.07	0.00	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep2	13127-140G4	12.04	0.55	0.00	0.00	0.00	0.55	0.00
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep3	13193-141E7	6.68	0.00	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep1	13062-139I2	4.16	0.00	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep2	13128-140G5	5.30	0.00	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep3	13194-141E8	8.31	0.00	0.00	0.00	0.00	0.00	0.00
Macrophage - monocyte derived, donor1	11232-116C8	42.62	1.14	0.91	0.23	0.23	0.00	0.00
Macrophage - monocyte derived, donor2	11313-117C8	37.99	0.18	1.10	0.73	0.18	0.00	0.00
Macrophage - monocyte derived, donor3	11389-118C3	33.03	1.05	1.84	0.92	0.39	0.52	0.39
Mallassez-derived cells, donor1 (MZH3)	12142-128E9	22.30	0.53	0.00	0.00	0.00	0.00	0.00
Mallassez-derived cells, donor2	11929-125I3	86.99	9.98	4.44	3.64	1.90	0.95	1.27
Mallassez-derived cells, donor3	11930-125I4	95.35	6.39	3.20	2.22	1.39	0.69	0.56
Mammary Epithelial Cell, donor1	11273-116H4	108.81	10.66	11.66	8.57	3.39	2.99	2.49
Mammary Epithelial Cell, donor2	11350-117G9	99.03	9.56	7.53	4.63	2.61	0.87	1.74
Mammary Epithelial Cell, donor3	11422-118F9	16.46	1.00	0.25	0.00	0.25	0.25	0.00
Mast cell - stimulated, donor1	11487-119E2	1244.69	16.95	2.03	14.91	0.00	0.68	0.00
Mast cell, donor1	11563-120D6	74.08	3.14	2.27	3.57	1.73	1.19	1.30
Mast cell, donor2	11565-120D8	70.73	0.59	0.30	1.19	0.59	0.00	0.30
Mast cell, donor3	11566-120D9	98.60	0.90	0.68	0.23	0.68	0.45	0.45
Mast cell, donor4	11567-120E1	79.96	0.35	0.35	0.89	0.35	0.00	0.00
Mast cell, expanded and stimulated, donor5	11940-126A5	97.59	5.77	4.66	5.77	1.22	1.00	1.22
Mast cell, expanded and stimulated, donor8	11942-126A7	87.55	1.75	2.92	1.75	1.75	1.17	0.00
Mast cell, expanded, donor5	11939-126A4	42.33	1.49	1.72	0.92	0.46	0.11	0.00
Mast cell, expanded, donor8	11941-126A6	43.01	0.50	1.34	0.67	0.33	0.84	0.17
Melanocyte - dark, donor1	11502-119F8	39.10	2.19	2.39	1.09	0.90	0.40	0.10
Melanocyte - dark, donor2	11582-120F7	22.50	1.38	0.00	0.00	0.69	0.35	0.35
Melanocyte - dark, donor3	11663-122F7	90.41	8.77	5.36	3.40	2.25	1.30	0.51
Melanocyte - light, donor1	11274-116H5	11.28	0.00	0.47	0.24	0.00	0.00	0.00
Melanocyte - light, donor2	11351-117H1	4.09	0.00	0.00	0.00	0.00	0.00	0.00
Melanocyte - light, donor3	11423-118G1	10.41	0.87	0.87	0.87	0.00	0.00	0.00
Melanocyte, donor1 (MC+1)	12641-134G4	71.12	4.58	4.48	2.71	1.56	0.94	0.73
Melanocyte, donor2 (MC+2)	12739-135I3	54.06	5.11	4.30	1.34	2.15	2.42	0.00
Melanocyte, donor3 (MC+3)	12837-137B2	92.41	3.75	3.75	4.02	0.27	1.07	0.27
Meningeal Cells, donor1	11493-119E8	37.09	0.25	0.00	0.00	0.00	0.00	0.00
Meningeal Cells, donor2	11573-120E7	20.25	0.44	0.00	0.00	0.00	0.44	0.44
Meningeal Cells, donor3	11654-122E7	98.37	6.36	3.18	2.69	1.14	0.90	0.98
Mesenchymal Stem Cells - Vertebral, donor1	11219-116B4	53.04	1.14	2.57	0.57	0.86	0.57	0.00
Mesenchymal Stem Cells - Wharton's Jelly, donor1	11548-120B9	40.35	0.81	0.50	0.50	0.20	0.20	0.00
Mesenchymal Stem Cells - adipose, donor1	11537-120A7	5.26	0.00	0.00	0.00	0.00	0.00	0.00
Mesenchymal Stem Cells - adipose, donor2	11617-122A6	10.47	0.00	0.00	0.00	0.00	0.00	1.31
Mesenchymal Stem Cells - adipose, donor3	11698-123A6	51.67	5.74	12.92	4.31	0.00	0.00	1.44
Mesenchymal Stem Cells - amniotic membrane, donor1	11547-120B8	40.66	2.96	1.69	0.85	0.21	0.21	0.21
Mesenchymal Stem Cells - amniotic membrane, donor2	11627-122B7	35.69	4.02	1.51	3.02	0.50	1.51	0.50
Mesenchymal Stem Cells - bone marrow, donor1	11536-120A6	21.10	1.10	0.88	0.44	0.22	0.44	0.22
Mesenchymal Stem Cells - bone marrow, donor2	11616-122A5	21.19	0.73	0.73	0.73	0.00	0.00	0.00
Mesenchymal Stem Cells - bone marrow, donor3	11697-123A5	13.91	0.20	0.00	0.20	0.20	0.00	0.20
Mesenchymal Stem Cells - bone marrow, donor4	11464-119B6	51.80	1.66	0.69	1.11	0.55	0.28	0.14
Mesenchymal Stem Cells - hepatic, donor1	11538-120A8	5.58	0.00	0.37	0.00	0.00	0.00	0.00
Mesenchymal Stem Cells - hepatic, donor2	11618-122A7	46.58	3.29	6.84	4.08	1.05	0.79	0.79
Mesenchymal Stem Cells - umbilical, donor1	11539-120A9	9.20	0.89	0.30	0.30	0.00	0.00	0.00
Mesenchymal Stem Cells - umbilical, donor2	11619-122A8	11.68	0.00	0.00	4.67	0.00	0.00	0.00
Mesenchymal Stem Cells - umbilical, donor3	11700-123A8	13.45	0.00	0.64	0.00	0.64	0.00	0.00
Mesenchymal stem cells - adipose, donor0	11217-116B2	70.18	2.84	2.48	0.35	0.35	0.35	0.35
Mesenchymal stem cells - hepatic, donor0	11218-116B3	36.28	0.94	1.25	0.31	0.31	0.00	0.00
Mesenchymal stem cells - umbilical, donor0	11214-116A8	32.66	1.45	2.90	0.00	2.18	0.73	0.00
Mesothelial Cells, donor1	11247-116E5	48.53	1.86	1.86	0.53	1.33	0.53	0.53
Mesothelial Cells, donor2	12156-128G5	29.53	0.50	0.50	0.00	0.00	0.00	0.00
Mesothelial Cells, donor3	11402-118D7	49.07	7.15	6.36	5.49	2.89	1.73	1.52
Monocyte-derived macrophages response to LPS, 00hr00min, donor1 (t1 Subject1)	12698-135D7	369.99	0.00	0.00	0.00	1.35	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr00min, donor2 (t1 Subject2)	12796-136F6	56.15	0.99	0.99	0.99	0.49	0.00	0.49
Monocyte-derived macrophages response to LPS, 00hr00min, donor3 (t1 Subject3)	12894-137H5	42.99	1.47	0.59	0.29	0.00	0.00	0.29
Monocyte-derived macrophages response to LPS, 00hr15min, donor1 (t2 Subject1)	12699-135D8	121.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr15min, donor2 (t2 Subject2)	12797-136F7	34.40	1.24	0.31	0.31	0.31	0.31	0.31
Monocyte-derived macrophages response to LPS, 00hr15min, donor3 (t2 Subject3)	12895-137H6	23.85	1.66	2.07	2.07	1.04	1.24	0.00
Monocyte-derived macrophages response to LPS, 00hr30min, donor1 (t3 Subject1)	12700-135D9	122.75	0.00	0.00	2.32	2.32	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr30min, donor2 (t3 Subject2)	12798-136F8	36.79	1.00	1.00	1.00	0.25	0.25	0.00
Monocyte-derived macrophages response to LPS, 00hr30min, donor3 (t3 Subject3)	12896-137H7	45.62	0.93	0.93	1.40	1.40	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr45min, donor1 (t4 Subject1)	12701-135E1	175.20	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr45min, donor2 (t4 Subject2)	12799-136F9	28.86	1.02	1.02	0.20	0.41	0.41	0.61
Monocyte-derived macrophages response to LPS, 00hr45min, donor3 (t4 Subject3)	12897-137H8	27.72	1.58	1.98	0.79	0.40	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr00min, donor1 (t5 Subject1)	12702-135E2	307.85	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr00min, donor2 (t5 Subject2)	12800-136G1	17.70	0.88	0.00	0.00	0.88	0.00	0.88
Monocyte-derived macrophages response to LPS, 01hr00min, donor3 (t5 Subject3)	12898-137H9	29.26	4.18	1.52	0.38	1.52	0.38	0.00
Monocyte-derived macrophages response to LPS, 01hr20min, donor1 (t6 Subject1)	12703-135E3	96.06	0.00	1.32	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr20min, donor2 (t6 Subject2)	12801-136G2	27.59	2.97	2.12	2.55	0.85	0.21	0.21
Monocyte-derived macrophages response to LPS, 01hr20min, donor3 (t6 Subject3)	12899-137I1	45.12	0.92	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr40min, donor1 (t7 Subject1)	12704-135E4	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr40min, donor2 (t7 Subject2)	12802-136G3	28.32	0.60	0.60	0.00	0.00	0.30	0.00
Monocyte-derived macrophages response to LPS, 01hr40min, donor3 (t7 Subject3)	12900-137I2	139.16	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 02hr00min, donor1 (t8 Subject1)	12705-135E5	407.39	0.00	0.00	0.00	0.00	0.00	67.90
Monocyte-derived macrophages response to LPS, 02hr00min, donor2 (t8 Subject2)	12803-136G4	26.85	2.26	1.25	1.25	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 02hr00min, donor3 (t8 Subject3)	12901-137I3	33.27	3.33	4.99	1.66	0.48	0.48	0.24
Monocyte-derived macrophages response to LPS, 02hr30min, donor1 (t9 Subject1)	12706-135E6	96.20	0.55	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 02hr30min, donor2 (t9 Subject2)	12804-136G5	34.54	2.07	1.61	1.38	0.69	0.23	0.23
Monocyte-derived macrophages response to LPS, 02hr30min, donor3 (t9 Subject3)	12902-137I4	26.71	1.26	1.47	2.31	0.63	0.63	0.21
Monocyte-derived macrophages response to LPS, 03hr00min, donor1 (t10 Subject1)	12707-135E7	27.11	0.61	0.82	1.22	0.20	0.00	0.00
Monocyte-derived macrophages response to LPS, 03hr00min, donor2 (t10 Subject2)	12805-136G6	27.25	0.86	0.64	1.07	0.86	0.00	0.00
Monocyte-derived macrophages response to LPS, 03hr00min, donor3 (t10 Subject3)	12903-137I5	30.68	0.67	0.89	0.22	0.89	0.00	0.44
Monocyte-derived macrophages response to LPS, 03hr30min, donor1 (t11 Subject1)	12708-135E8	196.05	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 03hr30min, donor2 (t11 Subject2)	12806-136G7	25.62	1.53	0.88	1.10	0.44	0.22	0.00
Monocyte-derived macrophages response to LPS, 03hr30min, donor3 (t11 Subject3)	12904-137I6	58.30	1.52	0.51	1.01	0.00	0.51	0.00
Monocyte-derived macrophages response to LPS, 04hr, donor1 (t12 Subject1)	12709-135E9	132.56	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 04hr, donor2 (t12 Subject2)	12807-136G8	48.38	1.63	0.27	1.36	0.00	0.27	0.27
Monocyte-derived macrophages response to LPS, 04hr, donor3 (t12 Subject3)	12905-137I7	38.82	1.18	1.76	1.18	0.88	0.29	0.00
Monocyte-derived macrophages response to LPS, 05hr, donor1 (t13 Subject1)	12710-135F1	123.21	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 05hr, donor2 (t13 Subject2)	12808-136G9	20.18	0.96	0.96	0.00	0.48	0.00	0.00
Monocyte-derived macrophages response to LPS, 05hr, donor3 (t13 Subject3)	12906-137I8	23.61	0.40	1.60	1.60	0.40	0.80	0.40
Monocyte-derived macrophages response to LPS, 06hr, donor1 (t14 Subject1)	12711-135F2	165.92	2.74	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 06hr, donor2 (t14 Subject2)	12809-136H1	29.53	3.00	1.50	0.00	0.50	0.50	0.50
Monocyte-derived macrophages response to LPS, 06hr, donor3 (t14 Subject3)	12907-137I9	26.95	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 07hr, donor1 (t15 Subject1)	12712-135F3	222.20	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 07hr, donor2 (t15 Subject2)	12810-136H2	33.72	0.88	1.31	0.00	0.88	0.00	0.00
Monocyte-derived macrophages response to LPS, 07hr, donor3 (t15 Subject3)	12908-138A1	140.16	1.10	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 08hr, donor1 (t16 Subject1)	12713-135F4	135.76	0.64	0.64	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 08hr, donor2 (t16 Subject2)	12811-136H3	55.53	2.23	1.49	2.23	0.00	0.74	0.50
Monocyte-derived macrophages response to LPS, 08hr, donor3 (t16 Subject3)	12909-138A2	91.16	0.00	0.70	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 10hr, donor1 (t17 Subject1)	12714-135F5	212.15	0.00	0.00	4.42	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 10hr, donor2 (t17 Subject2)	12812-136H4	31.11	2.74	1.37	1.37	0.68	0.34	0.00
Monocyte-derived macrophages response to LPS, 10hr, donor3 (t17 Subject3)	12910-138A3	77.02	0.44	0.88	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 12hr, donor1 (t18 Subject1)	12715-135F6	153.76	1.07	0.00	0.71	0.00	0.36	0.36
Monocyte-derived macrophages response to LPS, 12hr, donor2 (t18 Subject2)	12813-136H5	33.67	0.84	1.68	0.84	0.00	0.28	0.00
Monocyte-derived macrophages response to LPS, 12hr, donor3 (t18 Subject3)	12911-138A4	60.27	0.83	0.00	0.42	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 14hr, donor1 (t19 Subject1)	12716-135F7	113.64	0.00	0.58	0.00	0.00	0.58	0.00
Monocyte-derived macrophages response to LPS, 14hr, donor2 (t19 Subject2)	12814-136H6	32.58	1.81	2.41	2.11	0.00	0.00	0.30
Monocyte-derived macrophages response to LPS, 14hr, donor3 (t19 Subject3)	12912-138A5	43.41	2.50	0.00	1.25	0.42	0.42	0.42
Monocyte-derived macrophages response to LPS, 16hr, donor1 (t20 Subject1)	12717-135F8	202.13	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 16hr, donor2 (t20 Subject2)	12815-136H7	34.17	4.62	0.92	0.92	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 16hr, donor3 (t20 Subject3)	12913-138A6	67.16	1.71	1.14	0.57	0.00	0.00	0.57
Monocyte-derived macrophages response to LPS, 18hr, donor1 (t21 Subject1)	12718-135F9	53.89	0.97	0.28	1.66	0.14	0.14	0.69
Monocyte-derived macrophages response to LPS, 18hr, donor2 (t21 Subject2)	12816-136H8	30.84	1.30	0.78	0.78	0.78	0.26	0.52
Monocyte-derived macrophages response to LPS, 18hr, donor3 (t21 Subject3)	12914-138A7	45.04	0.43	0.43	0.86	0.00	0.00	0.86
Monocyte-derived macrophages response to LPS, 20hr, donor1 (t22 Subject1)	12719-135G1	76.22	0.00	0.64	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 20hr, donor2 (t22 Subject2)	12817-136H9	43.24	0.53	0.53	0.80	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 20hr, donor3 (t22 Subject3)	12915-138A8	35.62	0.30	0.60	0.00	0.60	0.30	0.60
Monocyte-derived macrophages response to LPS, 22hr, donor1 (t23 Subject1)	12720-135G2	40.82	0.85	0.57	0.28	0.00	0.14	0.00
Monocyte-derived macrophages response to LPS, 22hr, donor2 (t23 Subject2)	12818-136I1	23.57	0.96	0.00	0.64	0.32	0.00	0.00
Monocyte-derived macrophages response to LPS, 22hr, donor3 (t23 Subject3)	12916-138A9	42.68	1.11	0.44	0.88	0.22	0.44	0.22
Monocyte-derived macrophages response to LPS, 24hr, donor1 (t24 Subject1)	12721-135G3	56.88	0.00	0.76	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 24hr, donor2 (t24 Subject2)	12819-136I2	38.64	0.57	1.42	0.85	0.57	0.57	0.00
Monocyte-derived macrophages response to LPS, 24hr, donor3 (t24 Subject3)	12917-138B1	29.00	0.98	0.25	0.74	0.00	0.74	0.49
Monocyte-derived macrophages response to LPS, 36hr, donor1 (t25 Subject1)	12722-135G4	66.47	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 36hr, donor2 (t25 Subject2)	12820-136I3	34.11	0.88	0.29	0.88	0.29	0.00	0.59
Monocyte-derived macrophages response to LPS, 36hr, donor3 (t25 Subject3)	12918-138B2	27.97	0.58	0.29	0.00	0.58	0.00	0.29
Monocyte-derived macrophages response to LPS, 48hr, donor1 (t26 Subject1)	12723-135G5	52.75	0.41	0.00	0.41	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 48hr, donor2 (t26 Subject2)	12821-136I4	40.80	0.89	1.49	0.60	0.00	0.00	0.00
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor1 (868_121:MI_0h)	13304-142I1	15.07	3.77	3.77	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor2 (150_120:MI_0h)	13316-143A4	7.13	0.00	0.00	1.78	0.00	0.00	0.00
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor3 (536_119:MI_0h)	13322-143B1	33.84	4.60	2.63	3.29	0.66	0.66	0.33
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor4 (227_121:MI_0h)	13310-142I7	19.99	2.10	1.05	2.10	1.05	0.00	0.00
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor1 (868_121:MI_24h)	13309-142I6	17.00	0.20	0.59	0.20	0.20	0.00	0.00
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor2 (150_120:MI_24h)	13321-143A9	15.83	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor3 (536_119:MI_24h)	13327-143B6	34.55	1.50	4.13	4.88	0.75	0.75	0.38
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor4 (227_121:MI_24h)	13315-143A3	17.05	1.33	0.27	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor1 (868_121:Ud_0h)	13305-142I2	26.24	0.34	0.34	0.00	0.11	0.11	0.00
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor2 (150_120:Ud_0h)	13317-143A5	13.26	0.74	0.74	0.74	0.00	0.00	0.74
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor3 (536_119:Ud_0h)	13323-143B2	27.48	2.93	0.73	4.03	0.37	2.56	1.47
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor4 (227_121:Ud_0h)	13311-142I8	32.67	9.33	7.78	3.11	6.22	0.00	1.56
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor1 (868_121:Ud_2h)	13306-142I3	20.84	0.00	0.00	0.00	0.53	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor2 (150_120:Ud_2h)	13318-143A6	3.86	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor3 (536_119:Ud_2h)	13324-143B3	16.16	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor4 (227_121:Ud_2h)	13312-142I9	18.13	0.84	0.84	0.42	0.42	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor1 (868_121:Ud_7h)	13307-142I4	17.71	1.36	0.00	1.36	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor2 (150_120:Ud_7h)	13319-143A7	8.90	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor3 (536_119:Ud_7h)	13325-143B4	17.01	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor4 (227_121:Ud_7h)	13313-143A1	12.08	0.00	1.51	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor1 (868_121:Ud_24h)	13308-142I5	125.62	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor2 (150_120:Ud_24h)	13320-143A8	78.30	3.26	3.26	3.26	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor3 (536_119:Ud_24h)	13326-143B5	61.78	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor4 (227_121:Ud_24h)	13314-143A2	62.75	0.00	0.00	0.00	0.00	0.00	0.00
Multipotent Cord Blood Unrestricted Somatic Stem Cells, donor1	11549-120C1	48.90	5.39	1.51	1.29	0.22	0.43	0.22
Multipotent Cord Blood Unrestricted Somatic Stem Cells, donor2	11629-122B9	38.67	3.14	3.14	2.61	1.05	0.52	1.05
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor1	13496-145C4	34.71	0.67	0.00	1.33	0.00	0.00	0.00
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor2	13505-145D4	32.55	0.00	0.00	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor3	13514-145E4	76.06	1.14	0.00	0.95	0.00	0.19	0.00
Myoblast differentiation to myotubes, day00, control donor1	13469-144I4	384.60	3.19	1.60	4.79	0.00	0.00	0.00
Myoblast differentiation to myotubes, day00, control donor2	13478-145A4	15.64	0.68	0.00	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day00, control donor3	13487-145B4	249.92	3.68	7.35	7.35	3.68	0.00	1.84
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor1	13497-145C5	10.88	0.00	0.00	0.42	0.00	0.00	0.42
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor2	13506-145D5	22.08	0.46	0.23	1.16	0.00	0.00	0.00
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor3	13515-145E5	18.38	0.81	0.00	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day01, control donor1	13470-144I5	47.51	1.89	1.05	1.47	0.63	0.21	0.00
Myoblast differentiation to myotubes, day01, control donor2	13479-145A5	1358.44	55.67	33.40	100.21	22.27	0.00	22.27
Myoblast differentiation to myotubes, day01, control donor3	13488-145B5	12.41	0.00	0.00	0.00	0.99	0.00	0.00
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor1	13498-145C6	24.09	0.54	0.54	0.54	0.54	0.00	0.27
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor2	13507-145D6	13.15	0.68	0.00	0.91	0.45	0.00	0.23
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor3	13516-145E6	10.45	0.33	0.33	0.16	0.16	0.00	0.16
Myoblast differentiation to myotubes, day02, control donor1	13471-144I6	28.61	0.91	0.73	1.46	0.18	0.18	0.18
Myoblast differentiation to myotubes, day02, control donor2	13480-145A6	21.22	1.06	0.00	1.06	0.00	0.00	1.06
Myoblast differentiation to myotubes, day02, control donor3	13489-145B6	22.21	0.00	0.00	0.60	0.00	0.00	0.00
Myoblast differentiation to myotubes, day03, Duchenne Muscular Dystrophy donor1	13499-145C7	78.76	0.98	0.66	0.98	0.98	0.66	0.66
Myoblast differentiation to myotubes, day03, Duchenne Muscular Dystrophy donor2	13508-145D7	14.64	0.00	0.33	0.00	0.33	0.16	0.00
Myoblast differentiation to myotubes, day03, control donor1	13472-144I7	77.43	3.70	1.59	1.59	0.88	0.53	0.53
Myoblast differentiation to myotubes, day03, control donor2	13481-145A7	8.44	0.70	0.00	0.70	0.00	0.00	0.70
Myoblast differentiation to myotubes, day03, control donor3	13490-145B7	15.17	0.46	0.00	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor1	13500-145C8	16.71	0.00	0.32	0.32	0.64	0.00	0.32
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor2	13509-145D8	68.29	1.38	1.38	1.03	0.00	0.00	0.00
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor3	13518-145E8	622.00	5.06	2.53	5.06	0.00	0.00	0.00
Myoblast differentiation to myotubes, day04, control donor1	13473-144I8	71.29	2.45	0.45	0.89	0.67	0.00	0.00
Myoblast differentiation to myotubes, day04, control donor2	13482-145A8	16.51	0.42	0.85	0.85	0.00	0.85	0.00
Myoblast differentiation to myotubes, day04, control donor3	13491-145B8	22.31	0.47	0.24	0.24	0.00	0.24	0.24
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor1	13501-145C9	15.45	0.43	0.00	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor2	13510-145D9	2302.08	36.11	18.06	45.14	0.00	0.00	9.03
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor3	13519-145E9	23.33	1.00	0.00	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day06, control donor1	13474-144I9	70.79	0.45	0.00	0.90	0.00	0.00	0.00
Myoblast differentiation to myotubes, day06, control donor2	13483-145A9	8.33	0.40	1.19	0.79	0.00	0.40	0.40
Myoblast differentiation to myotubes, day06, control donor3	13492-145B9	27.86	0.93	0.00	0.93	0.00	0.93	0.00
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor1	13502-145D1	18.16	0.00	0.00	0.76	0.00	0.00	0.00
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor2	13511-145E1	14.34	0.65	0.98	0.33	0.33	0.00	0.00
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor3	13520-145F1	26.58	0.87	0.44	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day08, control donor1	13475-145A1	85.48	2.71	2.26	0.90	0.45	0.00	0.45
Myoblast differentiation to myotubes, day08, control donor2	13484-145B1	13.23	1.76	0.00	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day08, control donor3	13493-145C1	13.30	0.00	0.66	0.66	0.66	0.00	0.00
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor1	13503-145D2	19.35	0.50	0.50	0.00	0.50	0.50	0.00
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor2	13512-145E2	21.82	0.38	0.38	0.38	0.00	0.00	0.38
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor3	13521-145F2	23.59	0.60	0.00	0.91	0.60	0.00	0.00
Myoblast differentiation to myotubes, day10, control donor1	13476-145A2	43.54	1.99	1.11	0.88	1.33	0.22	0.00
Myoblast differentiation to myotubes, day10, control donor2	13485-145B2	15.59	0.00	0.00	0.68	0.00	0.68	0.00
Myoblast differentiation to myotubes, day10, control donor3	13494-145C2	413.87	20.44	15.33	5.11	10.22	0.00	0.00
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor1	13504-145D3	10.36	0.00	0.00	0.00	0.00	0.00	0.61
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor2	13513-145E3	19.51	0.63	0.31	0.00	0.00	0.31	0.31
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor3	13522-145F3	17.25	0.00	0.00	1.21	0.00	0.00	0.30
Myoblast differentiation to myotubes, day12, control donor1	13477-145A3	15.03	0.00	0.00	3.96	0.79	0.00	0.00
Myoblast differentiation to myotubes, day12, control donor2	13486-145B3	117.90	3.40	1.13	2.27	1.13	0.00	2.27
Myoblast differentiation to myotubes, day12, control donor3	13495-145C3	343.94	30.35	10.12	0.00	0.00	5.06	10.12
Myoblast, donor1	11241-116D8	69.20	3.35	1.49	1.12	0.62	0.50	0.62
Myoblast, donor2	11322-117D8	67.32	7.48	3.84	2.30	1.34	1.53	0.19
Myoblast, donor3	11398-118D3	78.70	2.35	1.51	1.18	0.17	0.50	0.34
NK T cell leukemia cell line:KHYG-1	10777-110G3	70.05	7.44	7.73	5.40	2.33	1.02	1.46
Natural Killer Cells, donor1	11230-116C6	79.03	4.31	6.77	2.46	0.92	0.00	0.62
Natural Killer Cells, donor2	11311-117C6	61.22	6.33	5.73	2.71	2.41	1.21	0.90
Natural Killer Cells, donor3	11387-118C1	60.00	8.47	4.97	2.58	2.02	0.92	1.47
Neural stem cells, donor1	11275-116H6	140.82	1.81	1.09	2.90	1.09	0.00	0.00
Neural stem cells, donor2	11352-117H2	179.08	0.00	0.00	0.00	0.00	0.00	0.00
Neurons, donor1	11494-119E9	53.48	6.83	3.41	1.14	1.14	0.00	0.00
Neurons, donor2	11574-120E8	37.87	0.88	1.10	1.98	0.22	0.44	0.44
Neurons, donor3	11655-122E8	37.00	3.29	2.47	1.64	0.00	0.00	0.82
Neutrophils, donor1	11233-116C9	14.85	0.93	0.00	0.93	0.00	0.00	0.00
Neutrophils, donor2	11314-117C9	8.70	0.00	0.00	2.90	0.00	0.00	0.00
Neutrophils, donor3	11390-118C4	17.71	0.00	0.00	0.00	0.00	0.00	0.00
Nucleus Pulposus Cell, donor1	11252-116F1	53.43	5.22	3.09	2.26	0.71	0.36	1.31
Nucleus Pulposus Cell, donor2	11409-118E5	18.88	0.98	0.33	0.33	0.00	0.65	0.00
Nucleus Pulposus Cell, donor3	11462-119B4	26.07	1.80	0.40	0.60	0.40	0.00	0.00
Olfactory epithelial cells, donor1	11933-125I7	31.80	3.85	4.40	1.10	1.93	0.83	1.10
Olfactory epithelial cells, donor2	11934-125I8	36.19	5.79	5.07	3.18	1.30	0.72	0.29
Olfactory epithelial cells, donor3	11935-125I9	29.97	2.95	3.18	2.72	1.59	0.68	0.57
Olfactory epithelial cells, donor4	11936-126A1	51.62	4.97	3.51	2.34	1.07	0.88	0.58
Oligodendrocyte - precursors, donor1	11496-119F2	79.44	6.62	3.61	6.02	0.60	0.00	3.61
Osteoblast - differentiated, donor1	11276-116H7	28.71	0.21	0.00	0.21	0.00	0.00	0.21
Osteoblast - differentiated, donor2	11353-117H3	12.57	1.14	0.00	0.00	0.00	0.00	0.00
Osteoblast - differentiated, donor3	11425-118G3	13.03	0.00	1.24	0.00	0.00	0.00	0.00
Osteoblast, donor1	11277-116H8	10.16	0.20	0.39	0.20	0.20	0.00	0.20
Osteoblast, donor2	11354-117H4	76.55	9.83	4.21	3.51	0.70	2.11	0.70
Osteoblast, donor3	11426-118G4	15.46	0.89	0.71	0.00	0.18	0.18	0.00
Pancreatic stromal cells, donor1	11249-116E7	64.78	5.64	4.89	2.61	1.94	0.84	1.01
Pericytes, donor1	11491-119E6	5.56	0.11	0.00	0.11	0.00	0.00	0.00
Pericytes, donor2	11571-120E5	4.98	0.00	0.23	0.00	0.00	0.00	0.00
Pericytes, donor3	11652-122E5	5.49	0.20	0.00	0.20	0.00	0.00	0.00
Perineurial Cells, donor1	11499-119F5	61.94	5.65	4.29	2.26	0.23	0.23	1.24
Perineurial Cells, donor2	11579-120F4	43.61	1.56	1.38	0.55	0.00	0.64	0.28
Peripheral Blood Mononuclear Cells, donor1	11231-116C7	92.12	1.91	1.91	3.19	0.32	0.96	0.32
Peripheral Blood Mononuclear Cells, donor2	11312-117C7	37.22	1.96	0.98	0.49	0.00	0.24	0.00
Peripheral Blood Mononuclear Cells, donor3	11388-118C2	44.13	1.04	0.00	0.65	0.39	0.00	0.39
Placental Epithelial Cells, donor1	11278-116H9	23.92	0.48	0.00	0.00	0.00	0.00	0.24
Placental Epithelial Cells, donor2	11355-117H5	27.72	0.00	0.00	0.00	0.00	0.00	0.00
Placental Epithelial Cells, donor3	11427-118G5	18.06	0.59	1.18	0.59	0.20	0.20	0.20
Preadipocyte - breast donor2 (cytoplasmic fraction)	14319-155D8	13.61	0.63	0.63	1.27	0.32	0.00	0.32
Preadipocyte - breast, donor1	11467-119B9	38.64	0.38	0.56	0.56	0.56	0.19	0.75
Preadipocyte - breast, donor2 (nuclear fraction)	14320-155D9	94.11	3.39	2.87	2.22	1.96	0.39	1.04
Preadipocyte - breast, donor2	11328-117E5	35.57	5.18	0.68	0.90	0.68	0.45	0.23
Preadipocyte - omental, donor1	11468-119C1	49.55	1.39	1.39	1.60	0.53	0.32	0.43
Preadipocyte - omental, donor2	11329-117E6	44.08	3.93	0.87	1.31	0.44	0.00	0.44
Preadipocyte - omental, donor3	11403-118D8	50.85	6.02	4.44	3.58	2.01	1.15	1.29
Preadipocyte - perirenal, donor1	11469-119C2	9.84	0.98	0.00	0.00	0.00	0.00	0.00
Preadipocyte - subcutaneous, donor1	11279-116I1	14.74	0.00	0.00	0.00	0.00	0.00	0.00
Preadipocyte - subcutaneous, donor2	11356-117H6	89.78	12.22	9.92	7.97	3.19	2.48	1.77
Preadipocyte - subcutaneous, donor3	11428-118G6	42.74	3.58	2.38	2.72	1.02	0.34	0.34
Preadipocyte - visceral, donor1	11280-116I2	111.96	3.91	3.91	4.28	1.49	0.65	0.75
Preadipocyte - visceral, donor2	11357-117H7	47.40	3.68	1.84	2.76	1.84	1.38	1.38
Preadipocyte - visceral, donor3	11429-118G7	65.83	4.28	1.46	1.99	0.84	0.52	0.42
Prostate Epithelial Cells (polarized), donor1	11253-116F2	112.23	11.16	14.63	5.73	3.62	2.87	1.81
Prostate Epithelial Cells, donor2	11331-117E8	42.93	2.71	1.08	1.35	0.41	0.14	0.68
Prostate Epithelial Cells, donor3	11404-118D9	57.01	7.84	8.63	6.67	2.20	2.27	1.84
Prostate Stromal Cells, donor1	11254-116F3	38.73	2.39	2.96	0.80	1.03	0.46	0.68
Prostate Stromal Cells, donor2	11332-117E9	49.13	9.32	5.02	4.48	1.79	2.33	1.08
Prostate Stromal Cells, donor3	11405-118E1	32.53	5.01	3.86	1.98	0.83	1.36	0.63
Renal Cortical Epithelial Cells, donor1	11516-119H4	8.76	0.36	0.00	0.00	0.00	0.00	0.00
Renal Cortical Epithelial Cells, donor2	11596-120H3	60.44	5.48	5.75	3.05	1.25	1.25	0.21
Renal Epithelial Cells, donor1	11517-119H5	8.12	0.00	0.00	0.00	0.00	0.00	0.00
Renal Epithelial Cells, donor2	11597-120H4	6.40	1.42	0.00	0.00	0.00	0.00	0.00
Renal Epithelial Cells, donor3	11678-122H4	62.46	4.66	5.50	3.60	1.06	1.38	1.06
Renal Glomerular Endothelial Cells, donor1	11514-119H2	2.04	1.36	0.00	0.00	0.00	0.00	0.00
Renal Glomerular Endothelial Cells, donor2	11594-120H1	14.02	1.21	0.27	0.13	0.13	0.00	0.13
Renal Glomerular Endothelial Cells, donor3	11675-122H1	65.72	4.88	3.55	2.44	0.67	0.44	0.89
Renal Glomerular Endothelial Cells, donor4	11783-124B1	2.66	0.00	0.00	0.00	0.00	0.00	0.00
Renal Mesangial Cells, donor1	11518-119H6	13.21	0.66	0.22	0.00	0.22	0.00	0.00
Renal Mesangial Cells, donor2	11598-120H5	11.29	1.25	0.00	0.00	0.00	0.00	0.00
Renal Mesangial Cells, donor3	11679-122H5	3.61	0.00	0.00	0.28	0.28	0.00	0.00
Renal Proximal Tubular Epithelial Cell, donor1	11515-119H3	25.23	1.88	0.81	0.81	0.00	0.27	0.00
Renal Proximal Tubular Epithelial Cell, donor2	11595-120H2	8.43	0.84	0.84	0.84	0.00	0.00	0.00
Renal Proximal Tubular Epithelial Cell, donor3	11676-122H2	11.19	0.77	0.39	0.19	0.19	0.00	0.39
Retinal Pigment Epithelial Cells, donor0	11215-116A9	49.78	4.15	5.19	2.33	0.78	0.26	0.26
Retinal Pigment Epithelial Cells, donor1	11528-119I7	13.08	0.57	0.00	0.00	0.00	0.28	0.00
Retinal Pigment Epithelial Cells, donor2	11608-120I6	14.41	0.00	0.00	0.00	0.00	0.00	0.00
Retinal Pigment Epithelial Cells, donor3	11689-122I6	46.17	2.51	1.00	1.00	0.50	0.75	0.25
SABiosciences XpressRef Human Universal Total RNA, pool1	10002-101A5	93.41	4.28	2.67	1.47	0.40	1.07	0.67
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep1 (B1 T17)	12697-135D6	105.42	1.79	1.79	2.68	0.89	0.00	0.89
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep2 (B2 T17)	12795-136F5	194.28	59.99	51.18	50.63	17.61	12.11	18.71
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep3 (B3 T17)	12893-137H4	589.34	22.62	9.86	31.32	8.70	1.16	2.90
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep1 (A1 T0)	12662-134I7	220.39	9.75	1.56	2.60	1.95	1.04	0.65
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep2 (A2 T0)	12760-136B6	96.92	10.03	9.83	9.24	2.28	1.99	1.99
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep3 (A3 T0)	12858-137D5	111.20	4.24	3.68	3.01	0.67	0.45	0.78
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep1 (A1 T1)	12663-134I8	150.96	24.56	6.95	8.43	4.22	2.85	2.73
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep2 (A2 T1)	12761-136B7	107.80	13.52	11.19	7.58	4.08	2.56	1.98
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep3 (A3 T1)	12859-137D6	151.85	31.90	19.65	16.64	7.40	5.08	4.16
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep1 (A1 T2)	12664-134I9	112.13	9.45	2.88	3.70	2.46	2.05	1.10
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep2 (A2 T2)	12762-136B8	123.44	17.40	12.86	9.08	4.08	4.54	2.27
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep3 (A3 T2)	12860-137D7	107.69	1.25	1.08	0.36	0.72	0.36	0.18
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep1 (A1 T3)	12665-135A1	90.95	12.77	3.59	6.17	2.44	1.29	1.29
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep2 (A2 T3)	12763-136B9	82.63	8.80	5.79	4.83	2.25	2.79	0.97
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep3 (A3 T3)	12861-137D8	97.58	10.62	9.74	6.42	3.54	1.33	2.21
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep1 (A1 T4)	12666-135A2	113.75	6.88	1.34	2.49	1.72	0.76	0.57
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep2 (A2 T4)	12764-136C1	99.87	6.43	5.40	3.82	2.24	1.58	0.56
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep3 (A3 T4)	12862-137D9	165.73	15.78	13.53	13.53	5.64	3.19	3.38
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep1 (A1 T5)	12667-135A3	126.47	7.83	1.33	1.46	1.59	1.19	0.27
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep2 (A2 T5)	12765-136C2	131.31	18.20	12.17	9.44	4.96	3.99	2.14
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep3 (A3 T5)	12863-137E1	118.01	16.23	14.32	13.94	4.01	2.29	1.72
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep1 (A1 T6)	12668-135A4	105.62	9.61	2.14	2.99	0.96	1.17	0.32
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep2 (A2 T6)	12766-136C3	102.31	16.54	9.81	5.61	3.92	1.96	1.12
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep3 (A3 T6)	12864-137E2	126.29	11.96	9.91	8.20	3.25	3.08	2.39
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep1 (A1 T7)	12669-135A5	98.28	4.38	0.91	1.09	0.55	0.36	0.73
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep2 (A2 T7)	12767-136C4	114.78	14.84	11.28	5.76	3.56	3.07	1.59
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep3 (A3 T7)	12865-137E3	104.10	13.30	10.34	7.79	2.96	1.75	1.61
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep1 (A1 T8)	12670-135A6	104.96	15.10	1.89	3.77	3.54	3.30	1.18
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep2 (A2 T8)	12768-136C5	100.99	13.29	10.52	5.95	4.17	1.98	2.18
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep3 (A3 T8)	12866-137E4	113.88	12.16	12.63	7.02	3.04	2.81	3.04
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep1 (A1 T9)	12671-135A7	87.50	7.26	2.28	3.32	2.07	1.45	0.62
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep2 (A2 T9)	12769-136C6	93.79	11.50	5.53	3.98	1.99	0.88	0.66
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep3 (A3 T9)	12867-137E5	109.46	7.94	4.39	6.27	2.09	0.84	1.25
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep1 (A1 T10)	12672-135A8	115.47	9.69	3.36	6.33	1.88	1.88	1.48
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep2 (A2 T10)	12770-136C7	139.30	5.11	3.75	6.13	2.21	1.02	0.51
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep3 (A3 T10)	12868-137E6	132.84	17.16	15.42	10.80	5.01	4.24	3.08
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep1 (A1 T11)	12673-135A9	108.49	14.79	3.27	5.16	4.13	1.89	1.38
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep2 (A2 T11)	12771-136C8	110.97	5.35	3.84	3.70	1.92	1.37	0.69
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep3 (A3 T11)	12869-137E7	138.72	15.76	10.84	7.72	2.46	2.63	2.96
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep1 (A1 T12)	12674-135B1	100.72	8.69	2.22	3.07	2.05	2.05	1.36
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep2 (A2 T12)	12772-136C9	103.87	22.49	15.54	12.87	3.99	3.11	3.11
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep3 (A3 T12)	12870-137E8	120.21	6.66	8.26	4.26	2.40	0.00	0.80
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep1 (A1 T13)	12675-135B2	96.23	5.95	1.66	1.80	0.69	1.38	0.69
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep2 (A2 T13)	12773-136D1	66.43	8.10	8.57	5.24	2.86	2.14	2.14
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep3 (A3 T13)	12871-137E9	163.05	7.05	7.05	4.03	2.82	1.81	1.21
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep1 (A1 T14)	12676-135B3	63.10	6.31	1.41	2.26	1.41	0.85	0.94
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep2 (A2 T14)	12774-136D2	100.27	39.48	13.97	22.71	3.49	7.34	3.84
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep3 (A3 T14)	12872-137F1	99.73	6.35	4.84	4.53	0.91	0.30	1.21
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep1 (A1 T15)	12677-135B4	73.19	5.63	0.86	2.45	1.59	0.73	0.24
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep2 (A2 T15)	12775-136D3	168.26	1.16	3.20	1.89	1.16	0.44	0.44
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep3 (A3 T15)	12873-137F2	71.19	1.83	1.22	3.04	1.22	1.22	1.22
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep1 (A1 T16)	12678-135B5	65.70	2.71	1.51	0.30	0.90	0.30	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep2 (A2 T16)	12776-136D4	71.48	8.14	3.62	5.43	1.58	1.13	1.13
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep3 (A3 T16)	12874-137F3	83.87	11.08	11.38	8.69	1.20	3.00	3.29
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep1 (A1 T17)	12679-135B6	76.75	3.07	0.24	1.77	0.71	0.83	0.59
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep2 (A2 T17)	12777-136D5	58.06	1.92	0.21	1.49	0.43	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep3 (A3 T17)	12875-137F4	93.75	4.21	3.61	1.20	0.00	0.00	0.60
Schwann Cells, donor1	11498-119F4	10.16	0.38	0.19	0.75	0.19	0.00	0.00
Schwann Cells, donor2	11578-120F3	17.01	0.00	0.00	3.40	0.00	0.00	0.00
Schwann Cells, donor3	11659-122F3	31.99	1.97	1.97	1.10	0.44	0.88	0.22
Sebocyte, donor1	11220-116B5	25.75	0.00	1.10	0.00	0.00	0.00	0.00
Sebocyte, donor2	11301-117B5	20.68	0.92	0.00	0.46	0.00	0.00	0.46
Sebocyte, donor3	11378-118B1	7.63	0.41	0.82	0.21	0.00	0.00	0.00
Sertoli Cells, donor1	11255-116F4	57.98	4.97	0.00	4.97	0.00	0.00	0.00
Sertoli Cells, donor2	11333-117F1	36.72	5.65	8.47	2.82	2.82	0.00	0.00
Skeletal Muscle Cells, donor1	11281-116I3	49.18	2.11	1.50	1.06	0.70	0.62	0.53
Skeletal Muscle Cells, donor2	11358-117H8	9.40	0.72	0.00	0.00	0.00	0.00	0.00
Skeletal Muscle Cells, donor3	11430-118G8	10.87	2.51	0.84	0.00	0.00	0.00	0.00
Skeletal Muscle Cells, donor4	11451-119A2	67.86	2.67	0.31	1.41	0.31	0.63	0.16
Skeletal Muscle Cells, donor5	11455-119A6	65.25	4.46	0.74	0.45	0.59	0.30	0.30
Skeletal Muscle Cells, donor6	11459-119B1	80.95	3.85	1.39	0.92	0.77	0.46	0.46
Skeletal Muscle Satellite Cells, donor1	11240-116D7	96.52	5.17	4.41	2.52	1.64	1.01	0.76
Skeletal Muscle Satellite Cells, donor2	11321-117D7	67.78	4.42	4.42	2.00	1.43	1.28	0.29
Skeletal Muscle Satellite Cells, donor3	11397-118D2	102.68	6.75	7.04	3.17	1.49	1.79	0.89
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor1	11282-116I4	66.22	4.55	2.86	3.12	1.35	1.18	0.67
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor2	11359-117H9	10.86	0.72	0.00	0.00	0.00	0.00	0.00
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor3	11431-118G9	8.53	0.28	0.00	0.28	0.00	0.00	0.00
Skin - palm, donor1	10286-104F7	402.92	2.69	0.00	5.37	2.69	0.00	0.00
Small Airway Epithelial Cells donor2 (cytoplasmic fraction)	14334-155F5	37.05	1.01	0.58	0.72	0.00	0.14	0.14
Small Airway Epithelial Cells donor2 (nuclear fraction)	14335-155F6	195.48	3.27	2.45	2.45	1.64	0.00	0.00
Small Airway Epithelial Cells donor3 (cytoplasmic fraction)	14316-155D5	29.73	1.30	0.39	1.04	0.52	0.00	0.26
Small Airway Epithelial Cells, donor1	11256-116F5	55.88	3.48	3.20	1.11	1.25	0.56	0.97
Small Airway Epithelial Cells, donor2	11334-117F2	52.32	2.25	1.55	1.13	0.98	0.28	0.42
Small Airway Epithelial Cells, donor3 (nuclear fraction)	14317-155D6	194.32	3.17	2.75	5.07	1.48	0.63	0.21
Small Airway Epithelial Cells, donor3	11406-118E2	45.57	3.30	3.75	2.70	0.97	1.20	0.67
Smooth Muscle Cells - Aortic, donor0 (cytoplasmic fraction)	14313-155D2	18.52	0.62	0.31	1.23	0.31	0.31	0.00
Smooth Muscle Cells - Aortic, donor0 (nuclear fraction)	14314-155D3	71.81	4.89	1.78	2.89	1.11	0.44	0.22
Smooth Muscle Cells - Aortic, donor0	11210-116A4	32.33	0.59	0.59	0.00	0.00	0.00	0.00
Smooth Muscle Cells - Aortic, donor1	11283-116I5	24.53	0.44	0.00	0.22	0.00	0.00	0.00
Smooth Muscle Cells - Aortic, donor2	11360-117I1	24.41	0.39	0.00	0.00	0.00	0.00	0.00
Smooth Muscle Cells - Aortic, donor3	11432-118H1	23.95	0.00	0.00	0.77	0.00	0.00	0.00
Smooth Muscle Cells - Bladder, donor1	11519-119H7	23.02	2.00	2.00	0.00	0.00	1.00	0.00
Smooth Muscle Cells - Brachiocephalic, donor1	11284-116I6	27.01	0.13	0.27	0.00	0.00	0.13	0.00
Smooth Muscle Cells - Brachiocephalic, donor2	11361-117I2	51.87	11.30	11.08	7.54	2.22	1.11	2.22
Smooth Muscle Cells - Brachiocephalic, donor3	11433-118H2	16.52	0.26	0.00	0.13	0.00	0.00	0.00
Smooth Muscle Cells - Brain Vascular, donor1	11234-116D1	51.44	0.98	0.33	1.63	0.00	0.00	0.00
Smooth Muscle Cells - Brain Vascular, donor2	11315-117D1	60.84	1.48	1.48	0.89	0.30	0.59	0.00
Smooth Muscle Cells - Brain Vascular, donor3	11391-118C5	33.46	0.71	0.71	1.00	0.28	0.00	0.57
Smooth Muscle Cells - Bronchial, donor1	11512-119G9	5.69	0.16	0.16	0.00	0.00	0.00	0.00
Smooth Muscle Cells - Bronchial, donor2	11592-120G8	76.72	2.44	2.74	0.61	0.91	0.30	0.30
Smooth Muscle Cells - Carotid, donor1	11285-116I7	18.44	0.25	0.00	0.00	0.00	0.00	0.00
Smooth Muscle Cells - Carotid, donor2	11362-117I3	48.97	0.00	0.00	0.00	0.00	0.00	0.00
Smooth Muscle Cells - Carotid, donor3	11434-118H3	12.40	0.48	0.00	0.00	0.00	0.00	0.00
Smooth Muscle Cells - Colonic, donor1	11239-116D6	52.80	0.59	0.88	0.74	0.59	0.15	0.15
Smooth Muscle Cells - Colonic, donor2	11320-117D6	47.14	3.23	1.29	0.65	0.00	0.43	0.65
Smooth Muscle Cells - Colonic, donor3	11396-118D1	51.85	1.89	1.26	1.68	0.42	0.52	0.31
Smooth Muscle Cells - Coronary Artery, donor1	11286-116I8	22.74	0.00	0.00	0.00	0.00	0.00	0.15
Smooth Muscle Cells - Coronary Artery, donor2	11363-117I4	17.25	0.00	0.00	0.00	0.00	0.00	0.00
Smooth Muscle Cells - Coronary Artery, donor3	11435-118H4	27.49	0.90	0.30	0.00	0.00	0.00	0.00
Smooth Muscle Cells - Esophageal, donor1	11508-119G5	6.83	0.34	0.34	0.00	0.00	0.00	0.00
Smooth Muscle Cells - Esophageal, donor2	11588-120G4	55.76	6.36	6.52	2.98	1.41	1.26	0.71
Smooth Muscle Cells - Internal Thoracic Artery, donor1	11287-116I9	103.46	2.82	1.81	4.83	1.41	0.91	1.51
Smooth Muscle Cells - Internal Thoracic Artery, donor2	11364-117I5	48.01	5.46	4.55	2.50	0.91	0.91	0.46
Smooth Muscle Cells - Internal Thoracic Artery, donor3	11436-118H5	10.87	0.60	0.00	0.00	0.00	0.60	0.00
Smooth Muscle Cells - Intestinal, donor1	11509-119G6	131.40	5.03	4.50	5.56	0.79	1.06	1.32
Smooth Muscle Cells - Prostate, donor1	11257-116F6	74.30	3.86	0.93	1.20	0.93	0.27	1.07
Smooth Muscle Cells - Prostate, donor2	11335-117F3	51.09	8.89	4.51	4.88	1.38	1.38	0.63
Smooth Muscle Cells - Prostate, donor3	11465-119B7	19.53	0.25	0.51	0.25	0.00	0.25	0.51
Smooth Muscle Cells - Pulmonary Artery, donor1	11288-117A1	46.14	2.26	0.60	0.15	0.00	0.15	0.00
Smooth Muscle Cells - Pulmonary Artery, donor2	11365-117I6	12.00	1.50	0.00	0.00	0.00	0.00	0.00
Smooth Muscle Cells - Pulmonary Artery, donor3	11437-118H6	24.55	0.00	0.00	0.00	0.00	0.00	0.00
Smooth Muscle Cells - Subclavian Artery, donor1	11289-117A2	17.21	0.47	0.00	0.00	0.00	0.00	0.00
Smooth Muscle Cells - Subclavian Artery, donor2	11366-117I7	37.36	2.02	1.01	0.50	0.00	1.01	1.01
Smooth Muscle Cells - Subclavian Artery, donor3	11438-118H7	25.70	1.25	0.00	0.00	0.31	0.00	0.00
Smooth Muscle Cells - Tracheal, donor1	11513-119H1	4.42	0.29	0.00	0.00	0.00	0.00	0.00
Smooth Muscle Cells - Tracheal, donor2	11593-120G9	114.46	1.00	1.00	0.42	0.08	0.33	0.17
Smooth Muscle Cells - Tracheal, donor3	11674-122G9	41.11	2.34	1.40	1.87	1.40	0.93	0.00
Smooth Muscle Cells - Umbilical Artery, donor1	11290-117A3	18.28	0.14	0.00	0.14	0.00	0.14	0.00
Smooth Muscle Cells - Umbilical Artery, donor2	11367-117I8	21.93	1.02	1.02	0.51	0.25	0.00	0.51
Smooth Muscle Cells - Umbilical Artery, donor3	11439-118H8	11.09	0.38	0.00	0.00	0.00	0.00	0.00
Smooth Muscle Cells - Umbilical Vein, donor1	11541-120B2	85.66	6.29	5.17	4.05	0.98	1.96	1.68
Smooth Muscle Cells - Umbilical Vein, donor2	11621-122B1	47.76	1.34	0.67	0.67	0.50	0.34	0.42
Smooth Muscle Cells - Umbilical Vein, donor3	11702-123B1	7.14	0.48	0.00	0.48	0.00	0.00	0.00
Smooth Muscle Cells - Umbilical artery, donor0	11212-116A6	18.59	0.49	0.49	0.00	0.00	0.00	0.00
Smooth Muscle Cells - Uterine, donor1	11258-116F7	58.99	5.08	1.10	2.43	1.10	0.88	0.00
Smooth Muscle Cells - Uterine, donor3	11466-119B8	31.31	1.46	0.59	0.88	0.59	0.00	0.29
Smooth muscle cells - airway, asthmatic, donor1	11960-126C7	39.26	2.92	2.72	0.97	0.58	0.00	0.39
Smooth muscle cells - airway, asthmatic, donor2	11961-126C8	49.45	5.29	1.85	4.23	1.06	0.00	0.53
Smooth muscle cells - airway, asthmatic, donor3	11962-126C9	75.88	11.90	1.86	5.21	1.12	1.49	0.74
Smooth muscle cells - airway, asthmatic, donor4	11963-126D1	69.71	12.58	4.67	3.59	1.44	0.36	0.72
Smooth muscle cells - airway, asthmatic, donor5	11964-126D2	53.66	0.57	0.28	0.00	0.85	0.00	0.00
Smooth muscle cells - airway, asthmatic, donor6	11965-126D3	69.71	4.73	1.58	2.76	1.58	0.79	0.39
Smooth muscle cells - airway, control, donor1	11966-126D4	57.39	7.11	3.81	4.57	2.29	0.51	0.76
Smooth muscle cells - airway, control, donor2	11967-126D5	39.93	3.59	2.00	1.60	0.40	0.80	0.00
Smooth muscle cells - airway, control, donor3	11968-126D6	22.99	1.25	2.09	1.67	1.25	0.42	0.42
Smooth muscle cells - airway, control, donor4	11969-126D7	28.88	0.46	1.38	1.38	0.46	0.46	0.46
Synoviocyte, donor1	11291-117A4	46.96	3.53	3.03	3.53	1.01	0.17	0.34
Synoviocyte, donor2	11368-117I9	29.33	3.02	2.51	1.34	0.84	1.17	0.50
Synoviocyte, donor3	11440-118H9	32.39	4.92	1.34	2.46	1.12	2.01	0.22
Trabecular Meshwork Cells, donor1	11532-120A2	15.72	0.00	0.00	0.00	0.00	0.00	0.00
Trabecular Meshwork Cells, donor2	11612-122A1	17.84	0.00	0.00	0.00	0.00	0.00	0.00
Trabecular Meshwork Cells, donor3	11693-123A1	15.28	0.00	0.00	0.00	0.00	0.00	0.00
Tracheal Epithelial Cells, donor1	11292-117A5	36.85	0.29	0.36	0.72	0.43	0.43	0.22
Tracheal Epithelial Cells, donor2	11369-118A1	10.82	0.00	0.77	0.39	0.39	0.00	0.00
Tracheal Epithelial Cells, donor3	11441-118I1	9.74	0.00	0.00	0.00	0.00	0.00	0.00
Universal RNA - Human Normal Tissues Biochain, pool1	10007-101B4	94.36	5.04	3.57	2.21	1.48	0.74	0.98
Urethra, donor2	10319-105A4	224.80	5.40	0.00	3.60	1.80	1.80	0.00
Urothelial Cells, donor1	11520-119H8	8.24	0.27	0.27	0.00	0.00	0.00	0.00
Urothelial Cells, donor2	11600-120H7	7.61	0.00	0.00	0.00	0.40	0.40	0.00
Urothelial Cells, donor3	11681-122H7	7.11	0.69	0.23	0.46	0.00	0.23	0.00
Urothelial cells, donor0	11216-116B1	80.91	7.58	3.79	1.78	2.45	1.34	0.89
Whole blood (ribopure), donor090309, donation1	12179-129A1	51.61	1.78	0.00	0.00	0.00	0.00	0.00
Whole blood (ribopure), donor090309, donation2	12180-129A2	50.04	0.00	0.00	1.43	1.43	0.00	0.00
Whole blood (ribopure), donor090309, donation3	12181-129A3	23.96	0.00	0.68	0.00	0.00	0.00	0.00
Whole blood (ribopure), donor090325, donation1	12176-128I7	56.13	0.69	0.34	0.34	0.00	0.00	0.00
Whole blood (ribopure), donor090325, donation2	12177-128I8	40.09	0.00	0.58	0.00	0.58	0.58	0.00
Whole blood (ribopure), donor090612, donation1	12182-129A4	57.27	0.00	0.00	1.04	1.04	0.00	0.00
Whole blood (ribopure), donor090612, donation2	12183-129A5	60.57	1.84	0.00	0.92	0.00	0.92	0.00
Whole blood (ribopure), donor090612, donation3	12184-129A6	29.21	0.00	0.91	0.00	0.00	0.00	0.00
Wilms' tumor cell line:G-401	10809-111A8	68.47	5.80	4.19	5.30	2.10	0.49	1.11
Wilms' tumor cell line:HFWT	10597-108E3	96.80	0.88	0.88	0.88	0.00	0.00	0.00
acantholytic squamous carcinoma cell line:HCC1806	10717-109I6	46.09	3.35	3.07	2.23	1.40	0.28	0.00
achilles tendon, donor2	10292-104G4	97.13	0.00	6.20	0.00	0.00	0.00	0.00
acute lymphoblastic leukemia (B-ALL) cell line:BALL-1	10455-106G5	120.08	23.71	21.16	15.04	9.18	5.10	3.57
acute lymphoblastic leukemia (B-ALL) cell line:NALM-6	10534-107G3	146.04	11.14	8.13	5.57	3.48	2.32	1.86
acute lymphoblastic leukemia (T-ALL) cell line:HPB-ALL	10429-106D6	138.89	8.55	9.85	9.50	4.39	3.21	3.32
acute lymphoblastic leukemia (T-ALL) cell line:Jurkat	10464-106H5	182.04	30.48	29.12	21.77	13.06	6.26	9.25
acute myeloid leukemia (FAB M0) cell line:KG-1	10827-111C8	129.86	19.39	17.15	10.40	7.59	2.81	3.94
acute myeloid leukemia (FAB M0) cell line:Kasumi-3	10789-110H6	57.95	1.90	2.33	0.63	0.63	0.00	0.21
acute myeloid leukemia (FAB M1) cell line:HYT-1	10828-111C9	79.21	7.08	4.63	6.81	4.90	1.91	0.54
acute myeloid leukemia (FAB M2) cell line:Kasumi-1	10788-110H5	120.29	11.02	7.93	10.58	5.29	2.20	0.44
acute myeloid leukemia (FAB M2) cell line:Kasumi-6	10792-110H9	103.31	16.74	14.70	12.25	6.94	5.31	2.45
acute myeloid leukemia (FAB M2) cell line:NKM-1	10765-110E9	78.05	7.77	7.77	6.21	1.94	4.27	3.11
acute myeloid leukemia (FAB M3) cell line:HL60	10829-111D1	170.02	28.15	23.00	17.30	8.28	4.97	3.31
acute myeloid leukemia (FAB M4) cell line:FKH-1	10830-111D2	120.92	0.00	0.00	0.00	0.00	0.00	3.90
acute myeloid leukemia (FAB M4) cell line:HNT-34	10831-111D3	123.86	22.08	13.01	11.39	5.34	3.95	2.32
acute myeloid leukemia (FAB M4eo) cell line:EoL-1	10832-111D4	179.16	27.96	16.31	15.02	7.77	5.70	4.14
acute myeloid leukemia (FAB M4eo) cell line:EoL-3	10833-111D5	134.72	33.32	20.46	26.01	9.06	5.55	4.97
acute myeloid leukemia (FAB M5) cell line:NOMO-1	10764-110E8	98.53	4.65	2.79	3.72	0.46	0.93	1.39
acute myeloid leukemia (FAB M5) cell line:P31/FUJ	10770-110F5	64.57	4.94	3.70	3.29	2.47	1.23	0.82
acute myeloid leukemia (FAB M5) cell line:THP-1 (cytoplasmic fraction)	14298-155B5	63.23	1.23	0.92	0.61	0.31	0.00	0.00
acute myeloid leukemia (FAB M5) cell line:THP-1 (fresh)	10399-106A3	90.46	8.53	5.12	5.12	0.85	1.28	1.28
acute myeloid leukemia (FAB M5) cell line:THP-1 (revived)	10400-106A4	102.82	2.73	3.34	3.64	1.21	1.21	0.91
acute myeloid leukemia (FAB M5) cell line:THP-1 (thawed)	10405-106A9	126.61	5.30	5.30	3.37	1.44	1.68	0.48
acute myeloid leukemia (FAB M5) cell line:U-937 DE-4	10834-111D6	212.49	26.51	20.27	16.26	6.01	6.01	3.34
acute myeloid leukemia (FAB M6) cell line:EEB	10835-111D7	132.75	7.34	4.34	4.00	3.00	0.33	1.00
acute myeloid leukemia (FAB M6) cell line:F-36E	10836-111D8	1088.91	9.29	7.43	5.57	7.43	0.00	0.00
acute myeloid leukemia (FAB M6) cell line:F-36P	10837-111D9	88.14	9.42	6.78	3.01	3.39	1.51	3.01
acute myeloid leukemia (FAB M7) cell line:M-MOK	10699-109G6	167.91	5.67	9.16	5.67	0.44	0.44	0.87
acute myeloid leukemia (FAB M7) cell line:MKPL-1	10802-111A1	807.89	5.62	0.00	9.37	1.87	0.00	1.87
adenocarcinoma cell line:IM95m	10796-110I4	29.20	2.59	3.30	1.41	0.47	0.94	0.47
adipose tissue, adult, pool1	10010-101C1	73.22	2.79	2.17	1.86	0.78	0.16	0.00
adipose, donor1	10184-103D4	130.18	16.42	15.83	5.86	2.35	2.35	2.93
adipose, donor2	10185-103D5	19.87	3.24	2.84	0.00	1.62	0.00	0.00
adipose, donor3	10186-103D6	71.34	5.17	3.54	3.81	1.91	1.09	1.63
adipose, donor4	10187-103D7	182.88	9.53	6.93	4.33	2.60	4.33	1.73
adrenal cortex adenocarcinoma cell line:SW-13	10810-111A9	163.19	6.79	6.15	4.42	1.89	0.79	1.26
adrenal gland, adult, pool1	10081-102A9	21.83	3.64	0.00	0.00	0.00	0.00	0.00
adult T-cell leukemia cell line:ATN-1	10421-106C7	88.98	6.40	5.34	3.74	2.27	2.00	1.60
alveolar cell carcinoma cell line:SW 1573	10708-109H6	60.74	5.72	8.58	5.36	2.50	0.71	0.00
amniotic membrane cells, donor1	12235-129G3	61.67	1.85	1.39	0.70	0.23	0.23	0.23
amniotic membrane cells, donor2	12236-129G4	39.90	0.34	0.34	0.34	0.00	0.34	0.00
amniotic membrane cells, donor3	12237-129G5	72.18	2.95	1.47	2.65	1.47	0.88	0.29
amygdala - adult, donor10196	10167-103B5	104.35	10.67	8.30	9.49	2.37	2.37	3.56
amygdala, adult, donor10252	10151-102I7	124.70	6.49	8.31	7.10	3.85	3.85	2.84
amygdala, newborn, donor10223	10360-105E9	61.00	4.52	2.58	1.29	1.61	0.32	0.32
anaplastic carcinoma cell line:8305C	10428-106D5	81.87	4.07	4.33	2.93	1.78	1.66	1.15
anaplastic large cell lymphoma cell line:Ki-JK	10795-110I3	65.97	9.05	6.18	4.85	3.31	1.10	2.65
anaplastic squamous cell carcinoma cell line:RPMI 2650	10805-111A4	84.85	6.68	5.01	5.34	1.67	2.67	2.00
aorta, adult, pool1	10052-101G7	28.44	1.57	0.00	0.00	0.39	0.00	0.00
appendix, adult	10189-103D9	118.38	1.94	1.16	0.78	0.78	0.00	0.00
argyrophil small cell carcinoma cell line:TC-YIK	10589-108D4	78.76	9.63	6.88	4.82	2.41	1.38	0.69
artery, adult	10190-103E1	92.39	5.43	2.72	1.36	0.00	1.36	0.00
astrocytoma cell line:TM-31	10425-106D2	99.67	5.07	4.93	3.33	1.59	1.59	1.30
b cell line:RPMI1788	10427-106D4	100.08	9.67	8.33	6.54	2.53	1.64	2.23
basal cell carcinoma cell line:TE 354.T	10702-109G9	40.78	3.05	1.11	3.33	0.28	0.55	0.28
bile duct carcinoma cell line:HuCCT1	10432-106D9	94.87	4.76	4.56	2.88	2.18	0.69	0.60
bile duct carcinoma cell line:TFK-1	10496-107C1	74.48	6.53	8.20	5.19	2.18	2.18	1.51
biphenotypic B myelomonocytic leukemia cell line:MV-4-11	10718-109I7	52.57	2.24	4.47	2.24	1.12	0.00	0.56
bladder, adult, pool1	10011-101C2	148.84	3.69	2.72	1.74	1.30	0.43	0.76
blood, adult, pool1	10053-101G8	6.64	0.00	2.21	0.00	0.00	0.00	0.00
bone marrow stromal cell line:StromaNKtert	10686-109F2	156.71	0.86	1.71	0.86	0.00	0.00	0.00
bone marrow, adult	10192-103E3	79.63	14.85	4.72	9.45	4.05	0.67	2.70
brain, adult, donor1	10084-102B3	13.33	0.00	0.00	1.03	0.00	0.00	0.00
brain, adult, pool1	10012-101C3	85.08	4.01	3.56	2.45	1.11	1.00	1.34
brain, fetal, pool1	10085-102B4	13.36	0.00	0.00	0.00	0.00	0.00	0.00
breast carcinoma cell line:MCF7	10482-107A5	160.23	4.29	3.30	3.63	0.66	0.33	1.32
breast carcinoma cell line:MDA-MB-453	10419-106C5	146.17	3.62	2.62	4.24	2.00	1.00	1.50
breast, adult, donor1	10080-102A8	32.20	0.00	0.63	0.00	0.00	0.00	0.63
bronchial squamous cell carcinoma cell line:KNS-62	10760-110E4	54.25	5.59	3.81	4.07	1.78	1.40	0.38
bronchioalveolar carcinoma cell line:NCI-H358	10709-109H7	89.06	8.66	5.26	6.49	2.16	1.24	0.31
bronchioalveolar carcinoma cell line:NCI-H650	10715-109I4	136.75	10.82	11.51	9.44	5.06	1.84	1.61
bronchogenic carcinoma cell line:ChaGo-K-1	10710-109H8	96.35	12.35	10.65	7.02	6.05	1.94	1.69
carcinoid cell line:NCI-H1770	10703-109H1	40.90	1.88	2.82	1.88	0.00	0.47	0.47
carcinoid cell line:NCI-H727	10735-110B6	136.73	3.83	2.95	2.52	0.55	0.98	0.98
carcinoid cell line:SK-PN-DW	10719-109I8	70.03	6.34	5.39	5.07	3.17	0.95	1.27
carcinosarcoma cell line:JHUCS-1	10642-109A3	56.43	6.92	5.32	3.73	1.33	1.60	0.80
caudate nucleus - adult, donor10196	10177-103C6	150.82	4.61	4.61	6.91	3.45	2.30	3.45
caudate nucleus, adult, donor10252	10164-103B2	93.70	7.20	7.20	5.19	2.51	2.18	2.18
caudate nucleus, adult, donor10258	10379-105H1	68.01	6.88	6.88	5.35	3.06	1.53	0.76
caudate nucleus, newborn, donor10223	10354-105E3	79.11	1.10	0.73	1.10	0.37	0.73	0.00
cerebellum - adult, donor10196	10173-103C2	177.71	5.83	0.00	2.91	0.00	8.74	0.00
cerebellum, adult, donor10252	10166-103B4	186.18	16.65	22.85	15.80	8.54	6.62	4.70
cerebellum, adult, pool1	10083-102B2	46.57	4.14	3.45	2.41	0.69	2.07	1.03
cerebellum, newborn, donor10223	10357-105E6	137.00	9.96	7.47	7.47	1.66	2.49	1.66
cerebral meninges, adult	10188-103D8	84.72	2.77	1.26	2.02	0.76	0.76	0.00
cerebrospinal fluid, donor2	10294-104G6	107.44	8.04	1.46	3.65	0.00	0.00	0.00
cervical cancer cell line:D98-AH2	10552-107I3	71.46	2.73	2.44	3.02	1.15	1.15	0.72
cervical cancer cell line:ME-180	10553-107I4	78.88	3.15	4.31	1.16	0.83	0.99	1.16
cervix, adult, pool1	10013-101C4	114.54	5.14	3.67	3.04	1.36	1.05	0.73
cholangiocellular carcinoma cell line:HuH-28	10536-107G5	39.71	0.84	0.84	0.28	0.42	0.00	0.00
chondrosarcoma cell line:SW 1353	10700-109G7	152.83	0.00	0.00	1.31	1.31	0.00	0.00
choriocarcinoma cell line:BeWo	10423-106C9	126.02	13.17	10.94	7.33	3.11	1.86	1.62
choriocarcinoma cell line:SCH	10785-110H2	55.32	7.02	5.05	4.44	2.71	1.72	1.23
choriocarcinoma cell line:T3M-3	10618-108G6	145.86	2.85	2.37	4.51	0.71	1.66	0.71
chorionic membrane cells, donor1	12238-129G6	37.32	1.99	1.99	1.71	0.85	0.28	0.57
chorionic membrane cells, donor2	12239-129G7	52.80	1.19	0.99	0.70	0.40	0.30	0.30
chorionic membrane cells, donor3	12240-129G8	43.41	4.40	1.10	2.20	0.55	1.10	0.55
chronic lymphocytic leukemia (T-CLL) cell line:SKW-3	10416-106C2	40.39	6.06	2.02	2.02	2.02	1.01	0.00
chronic myeloblastic leukemia (CML) cell line:KCL-22	10801-110I9	76.65	6.53	4.23	5.96	1.54	1.34	1.73
chronic myelogenous leukemia (CML) cell line:MEG-A2	10766-110F1	76.66	1.48	1.69	3.17	0.42	0.42	0.42
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep1	10824-111C5	203.13	12.07	6.68	5.91	2.31	1.28	2.05
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep2	10825-111C6	218.17	11.37	5.56	7.74	3.14	3.14	0.97
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep3	10826-111C7	243.92	11.81	5.90	10.18	3.26	2.44	2.24
chronic myelogenous leukemia cell line:K562	10454-106G4	173.14	18.85	14.72	7.66	5.01	4.12	4.71
chronic myelogenous leukemia cell line:KU812	10409-106B4	212.41	12.51	6.78	9.90	3.39	2.61	1.30
clear cell carcinoma cell line:JHOC-5	10638-108I8	61.72	10.74	5.94	4.34	2.06	2.74	1.37
clear cell carcinoma cell line:TEN	10636-108I6	57.26	2.26	2.78	1.39	1.04	1.21	0.69
colon carcinoma cell line:CACO-2	10513-107D9	109.64	3.84	4.21	2.75	1.46	1.28	0.55
colon carcinoma cell line:COLO-320	10420-106C6	182.44	12.16	10.64	11.40	3.80	4.94	3.80
colon, adult, donor1	10082-102B1	21.42	0.00	0.00	0.00	0.00	0.00	0.00
colon, adult, pool1	10014-101C5	111.16	1.53	0.94	1.41	0.47	0.47	0.35
colon, fetal, donor1	10070-101I7	32.14	0.62	0.62	3.71	0.00	0.00	0.62
common myeloid progenitor CMP, donor1	12130-128D6	187.92	0.00	0.00	0.00	0.00	0.00	0.00
common myeloid progenitor CMP, donor2	12134-128E1	0.00	0.00	0.00	0.00	0.00	0.00	0.00
cord blood derived cell line:COBL-a 24h infection(-C)	10452-106G2	78.19	1.27	0.42	1.27	0.85	0.42	0.42
cord blood derived cell line:COBL-a 24h infection	10453-106G3	72.60	1.36	3.32	1.66	1.21	0.30	1.21
cord blood derived cell line:COBL-a untreated	10449-106F8	90.39	3.53	4.23	2.96	2.26	1.13	0.71
corpus callosum, adult, pool1	10042-101F6	59.48	2.10	2.43	1.77	0.88	0.22	0.66
cruciate ligament, donor2	10295-104G7	133.73	6.48	3.24	2.43	0.81	0.00	0.81
diaphragm, fetal, donor1	10069-101I6	60.99	1.61	1.61	0.00	0.00	0.00	0.00
diencephalon, adult	10193-103E4	84.96	4.80	3.36	1.68	1.68	1.20	1.20
diffuse large B-cell lymphoma cell line:CTB-1	10631-108I1	84.73	16.30	10.79	10.10	4.36	3.90	2.76
ductal cell carcinoma cell line:KLM-1	10438-106E6	134.63	4.10	3.59	1.80	0.00	1.03	0.51
ductal cell carcinoma cell line:MIA Paca2	10488-107B2	107.60	14.68	12.28	10.35	4.81	3.61	3.61
ductus deferens, adult	10196-103E7	84.72	3.49	2.99	3.49	1.00	1.00	0.50
duodenum, fetal, donor1, tech_rep1	10071-101I8	36.01	5.76	5.76	2.88	1.44	0.00	0.00
duodenum, fetal, donor1, tech_rep2	10071-101I8	86.81	6.62	3.68	2.94	2.21	2.94	0.00
dura mater, adult, donor1	10041-101F5	70.86	1.40	0.91	0.99	0.50	0.17	0.33
embryonic kidney cell line: HEK293/SLAM infection, 24hr	10451-106G1	89.72	2.22	1.55	1.11	0.22	0.00	0.44
embryonic kidney cell line: HEK293/SLAM untreated	10450-106F9	80.82	2.58	2.58	1.15	1.72	0.43	0.43
embryonic pancreas cell line:1B2C6	10604-108F1	168.34	2.47	1.85	0.62	0.00	0.00	0.62
embryonic pancreas cell line:1C3D3	10605-108F2	41.47	1.82	1.51	0.61	0.00	0.30	0.00
embryonic pancreas cell line:1C3IKEI	10606-108F3	139.55	2.47	0.93	0.93	0.00	0.62	0.00
embryonic pancreas cell line:2C6	10603-108E9	152.36	3.94	0.00	1.31	0.00	0.00	0.00
endometrial carcinoma cell line:OMC-2	10497-107C2	126.37	2.35	3.69	3.02	1.01	0.67	0.00
endometrial stromal sarcoma cell line:OMC-9	10448-106F7	55.64	12.32	12.14	6.89	3.26	2.72	2.54
endometrioid adenocarcinoma cell line:JHUEM-1	10643-109A4	45.35	6.27	5.63	4.18	1.61	1.13	0.48
epidermoid carcinoma cell line:A431	10426-106D3	131.72	5.22	4.89	3.56	1.45	1.22	0.78
epidermoid carcinoma cell line:Ca Ski	10431-106D8	152.77	10.12	6.93	7.26	2.86	3.41	1.87
epididymis, adult	10197-103E8	83.93	2.93	2.30	2.30	2.30	0.63	0.00
epithelioid sarcoma cell line:HS-ES-1	10443-106F2	69.19	15.26	10.47	6.03	2.48	2.13	2.48
epithelioid sarcoma cell line:HS-ES-2R	10495-107B9	43.65	3.15	2.75	0.79	0.79	0.79	0.79
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep1	10815-111B5	131.57	14.55	14.81	8.65	3.67	3.01	1.83
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep2	10816-111B6	118.20	12.11	12.40	9.15	5.81	3.64	3.15
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep3	10817-111B7	135.00	12.55	13.89	6.39	3.81	2.80	2.35
esophagus, adult, pool1	10015-101C6	112.12	3.40	2.23	0.64	1.17	0.42	0.64
extraskeletal myxoid chondrosarcoma cell line:H-EMC-SS	10410-106B5	131.25	3.26	4.51	3.01	1.00	1.63	0.88
eye - muscle inferior rectus, donor1	10272-104E2	173.85	7.24	2.41	2.41	0.00	0.00	0.00
eye - muscle lateral, donor2	10298-104H1	185.17	6.31	6.31	0.00	4.21	4.21	2.10
eye - muscle medial, donor2	10299-104H2	223.23	4.46	2.98	4.46	0.00	4.46	0.00
eye - muscle superior, donor2	10297-104G9	147.90	2.29	1.15	1.15	0.00	0.00	0.00
eye - vitreous humor, donor1	10268-104D7	75.78	4.37	0.00	4.37	1.46	0.00	0.00
eye, fetal, donor1	10054-101G9	31.27	4.07	2.80	0.76	0.25	0.51	0.51
fibrosarcoma cell line:HT-1080	10758-110E2	74.50	8.98	5.26	6.67	1.54	1.54	0.38
fibrous histiocytoma cell line:GCT TIB-223	10711-109H9	85.71	6.17	6.41	3.32	1.66	0.47	1.19
frontal lobe, adult, pool1	10040-101F4	78.72	3.00	3.94	2.72	1.50	0.56	1.03
gall bladder carcinoma cell line:TGBC14TKB	10470-106I2	177.15	28.22	21.32	15.61	6.91	3.60	9.31
gall bladder carcinoma cell line:TGBC2TKB	10415-106C1	119.78	3.75	3.11	2.38	0.91	0.73	0.46
gall bladder, adult	10198-103E9	60.36	1.93	1.93	0.24	0.24	0.48	0.24
gamma delta positive T cells, donor1	11937-126A2	57.44	0.00	3.22	0.54	0.54	0.00	0.54
gamma delta positive T cells, donor2	11938-126A3	46.31	0.00	0.37	0.37	0.37	0.37	0.37
gastric adenocarcinoma cell line:MKN1	10614-108G2	52.38	7.39	6.55	6.13	2.53	1.06	0.63
gastric adenocarcinoma cell line:MKN45	10612-108F9	77.95	8.32	6.00	2.51	2.13	1.93	1.35
gastric cancer cell line:AZ521	10549-107H9	97.88	2.95	4.43	3.28	1.48	1.15	0.98
gastric cancer cell line:GSS	10560-108A2	64.98	6.41	3.66	3.66	2.75	2.75	0.00
gastrointestinal carcinoma cell line:ECC12	10615-108G3	155.35	27.19	12.34	10.28	5.48	2.74	2.51
giant cell carcinoma cell line:LU65	10487-107B1	84.79	7.00	5.16	4.25	3.10	0.80	1.26
giant cell carcinoma cell line:Lu99B	10433-106E1	145.70	7.70	5.74	4.62	2.24	2.38	0.56
glassy cell carcinoma cell line:HOKUG	10688-109F4	75.32	2.49	2.74	3.49	0.50	0.50	1.25
glioblastoma cell line:A172, tech_rep1	10444-106F3	114.63	4.33	5.38	3.27	2.53	0.74	1.16
glioblastoma cell line:A172, tech_rep2	10444-106F3	105.75	7.16	6.88	4.49	2.81	1.40	2.81
glioblastoma cell line:T98G	10485-107A8	64.24	6.07	4.53	3.53	2.43	2.10	0.55
glioma cell line:GI-1	10413-106B8	54.18	2.93	3.22	3.51	1.17	0.29	0.29
globus pallidus - adult, donor10196	10175-103C4	104.23	2.92	2.19	1.46	3.64	0.00	0.73
globus pallidus, adult, donor10252	10161-103A8	210.17	13.91	13.43	10.74	5.61	4.15	3.17
globus pallidus, adult, donor10258	10367-105F7	94.48	6.85	0.00	2.74	0.00	1.37	2.74
globus pallidus, newborn, donor10223	10364-105F4	52.23	1.07	0.53	1.60	0.00	0.00	0.53
granulocyte macrophage progenitor, donor1	12131-128D7	183.54	0.00	0.00	0.00	0.00	0.00	0.00
granulocyte macrophage progenitor, donor2	12135-128E2	0.00	0.00	0.00	0.00	0.00	0.00	0.00
granulocyte macrophage progenitor, donor3	12139-128E6	0.00	0.00	0.00	0.00	0.00	0.00	0.00
granulosa cell tumor cell line:KGN	10624-108H3	33.60	2.24	0.64	1.60	0.96	0.32	0.32
hIPS +CCl2, biol_rep1	14383-156B9	140.49	12.86	1.38	6.89	1.84	0.46	0.00
hIPS +CCl2, biol_rep2	14384-156C1	119.80	11.43	1.37	4.57	0.91	1.83	1.37
hIPS +CCl2, biol_rep3	14385-156C2	114.00	12.24	3.86	5.15	1.29	1.93	0.64
hIPS, biol_rep1	14380-156B6	94.86	7.19	0.00	0.00	0.00	0.00	0.00
hIPS, biol_rep2	14381-156B7	71.33	5.49	0.69	1.37	1.37	1.37	1.37
hIPS, biol_rep3	14382-156B8	101.52	11.03	1.10	11.03	1.10	2.21	1.10
hairy cell leukemia cell line:Mo	10712-109I1	90.80	10.92	10.06	8.05	3.74	2.87	2.59
heart - mitral valve, adult	10205-103F7	142.61	3.59	1.79	2.69	0.30	0.30	0.60
heart - pulmonic valve, adult	10206-103F8	221.21	14.90	9.15	15.43	6.01	1.31	3.14
heart - tricuspid valve, adult	10207-103F9	218.98	7.49	3.33	4.16	1.67	1.67	2.50
heart, adult, diseased post-infarction, donor1	10050-101G5	32.85	4.29	2.45	1.84	0.00	0.41	0.61
heart, adult, diseased, donor1	10051-101G6	26.83	1.28	2.13	0.43	0.00	0.00	0.00
heart, adult, pool1	10016-101C7	243.55	0.46	0.46	0.92	0.00	0.00	0.00
heart, fetal, pool1	10046-101G1	68.90	1.03	1.03	0.51	0.51	0.10	0.21
hepatic mesenchymal tumor cell line:LI90	10778-110G4	45.66	3.70	0.93	1.23	0.00	0.31	0.62
hepatoblastoma cell line:HuH-6	10633-108I3	486.37	5.95	2.38	3.57	2.38	0.00	3.57
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep1	10818-111B8	220.77	19.01	20.99	13.15	5.86	5.52	3.76
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep2	10819-111B9	221.99	21.48	16.99	12.99	4.73	4.49	4.49
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep3	10820-111C1	250.51	25.06	25.67	19.30	9.20	6.47	4.95
hepatoma cell line:Li-7	10484-107A7	80.30	5.45	4.78	3.11	2.56	1.11	0.78
hereditary spherocytic anemia cell line:WIL2-NS	10808-111A7	107.84	8.14	8.64	5.43	2.71	1.91	1.31
hippocampus - adult, donor10196	10169-103B7	129.65	5.68	8.52	8.52	4.73	1.89	3.79
hippocampus, adult, donor10252	10153-102I9	147.97	12.25	12.04	9.80	3.88	3.67	5.31
hippocampus, adult, donor10258	10374-105G5	105.07	11.45	2.99	1.99	0.00	0.00	0.50
hippocampus, newborn, donor10223	10363-105F3	47.94	0.70	2.11	1.06	0.35	0.35	0.00
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep1	13421-144D1	109.25	13.43	10.38	4.88	3.05	1.22	1.83
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep2	13425-144D5	57.53	8.64	7.85	2.16	1.57	1.18	0.59
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep3	13429-144D9	86.83	6.09	6.86	5.08	1.52	1.27	0.51
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep1	13422-144D2	37.78	1.69	2.82	0.56	0.56	0.00	0.56
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep2	13426-144D6	46.74	8.26	5.16	2.07	0.52	0.26	0.52
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep3	13430-144E1	48.59	4.93	1.14	1.52	1.14	0.38	0.00
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep1	13423-144D3	56.64	3.21	1.75	1.17	1.17	0.00	0.00
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep2	13427-144D7	55.80	4.52	5.82	2.15	1.94	0.65	0.86
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep3	13431-144E2	56.72	1.25	2.09	0.83	0.42	0.42	0.42
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep1	13424-144D4	44.28	1.42	1.42	1.18	0.47	0.47	0.47
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep2	13428-144D8	48.38	4.82	4.02	3.05	1.77	0.96	0.48
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep3	13432-144E3	40.40	0.67	0.67	0.00	0.00	0.00	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep1	13433-144E4	66.82	8.45	10.64	3.60	2.50	1.88	0.78
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep2	13437-144E8	79.59	12.28	6.39	4.91	1.97	2.46	1.47
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep3	13441-144F3	88.15	6.11	5.24	6.11	0.87	0.87	1.75
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep1	13434-144E5	42.38	5.15	4.39	1.72	0.95	1.15	0.19
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep2	13438-144E9	42.74	5.23	3.49	3.05	0.87	0.87	1.31
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep3	13442-144F4	59.97	2.00	2.50	1.00	0.50	0.00	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep1	13435-144E6	31.46	1.70	2.83	1.32	0.94	0.94	0.19
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep2	13439-144F1	32.74	3.18	2.27	0.91	0.45	0.00	0.45
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep3	13443-144F5	32.58	1.25	1.25	0.63	0.31	0.63	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep1	13436-144E7	39.36	3.27	3.59	1.80	1.31	0.33	0.49
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep2	13440-144F2	40.35	1.74	2.61	2.03	0.87	0.29	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep3	13444-144F6	37.96	2.09	2.09	0.60	0.90	0.60	0.60
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep1	13445-144F7	65.77	7.02	9.79	4.06	2.22	0.74	1.29
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep2	13449-144G2	56.49	5.71	5.71	3.42	1.43	1.71	1.43
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep3	13453-144G6	85.75	6.12	8.98	2.86	2.45	1.22	1.63
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep1	13446-144F8	53.87	5.28	2.82	1.76	1.41	0.35	0.70
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep2	13450-144G3	39.91	3.48	3.80	0.95	0.63	0.63	0.32
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep3	13454-144G7	37.83	2.42	2.72	1.82	0.61	0.30	0.30
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep1	13447-144F9	48.09	2.07	1.03	1.55	1.03	0.52	0.52
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep2	13451-144G4	29.22	2.66	1.99	1.99	0.00	0.00	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep3	13455-144G8	54.38	1.03	1.80	0.77	0.00	0.51	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep1	13448-144G1	40.39	2.56	3.58	1.53	1.28	0.77	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep2	13452-144G5	43.16	3.79	0.76	1.51	0.76	0.76	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep3	13456-144G9	52.42	1.34	1.01	0.67	1.01	0.00	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep1	13457-144H1	68.59	8.21	7.00	1.69	1.21	1.93	0.48
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep2	13461-144H5	97.15	6.24	4.46	4.90	0.89	0.89	1.78
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep3	13465-144H9	76.10	4.39	2.44	1.46	1.95	0.98	0.98
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep1	13458-144H2	47.68	3.36	4.28	1.83	2.75	0.61	0.61
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep2	13462-144H6	348.10	26.03	16.27	9.76	3.25	9.76	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep3	13466-144I1	51.30	3.31	5.30	1.32	0.99	0.00	0.66
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep1	13459-144H3	49.80	2.74	2.74	0.00	1.09	0.55	0.55
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep2	13463-144H7	45.60	2.17	1.45	0.72	1.09	1.81	0.72
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep3	13467-144I2	41.99	0.71	1.07	1.07	0.36	0.36	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep1	13460-144H4	26.25	1.19	4.77	1.19	1.19	3.58	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep2	13464-144H8	75.70	2.71	1.35	3.11	1.08	0.27	0.14
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep3	13468-144I3	38.25	1.89	1.62	0.54	0.00	0.27	0.54
immature langerhans cells, donor1	11904-125F5	84.99	1.45	0.73	0.73	0.24	0.24	0.00
immature langerhans cells, donor2	11905-125F6	27.72	0.00	0.00	0.00	0.00	0.79	0.79
insula, adult, pool1	10039-101F3	36.34	0.38	0.66	0.28	0.28	0.28	0.00
keratoacanthoma cell line:HKA-1	10791-110H8	23.74	2.28	0.33	1.63	0.98	0.65	0.33
kidney, adult, pool1	10017-101C8	116.95	4.21	5.51	3.70	1.80	1.80	1.10
kidney, fetal, pool1	10045-101F9	28.79	0.50	0.21	0.35	0.00	0.21	0.07
large cell lung carcinoma cell line:IA-LM	10509-107D5	139.32	1.28	1.56	1.28	0.71	0.14	0.28
large cell lung carcinoma cell line:NCI-H460	10839-111E2	33.04	1.80	1.66	1.11	0.55	0.14	0.28
large cell non-keratinizing squamous carcinoma cell line:SKG-II-SF	10692-109F8	60.55	1.83	0.73	0.92	0.00	0.00	0.18
left atrium, adult, donor1	10079-102A7	49.58	7.08	5.45	5.45	1.09	2.18	1.63
left ventricle, adult, donor1	10078-102A6	69.27	3.03	1.52	1.52	1.52	0.00	1.01
leiomyoblastoma cell line:G-402	10721-110A1	143.92	6.84	4.92	5.47	1.92	1.37	1.09
leiomyoma cell line:10964C	10569-108B2	20.12	2.16	0.72	0.36	0.00	0.00	0.36
leiomyoma cell line:15242A	10570-108B3	14.67	1.09	1.09	0.54	0.00	0.00	0.54
leiomyoma cell line:15425	10571-108B4	28.90	2.67	1.46	0.97	0.73	0.00	0.24
leiomyosarcoma cell line:Hs 5.T	10722-110A2	57.14	0.00	0.00	0.00	0.00	0.00	0.00
lens epithelial cell line:SRA 01/04	10647-109A8	35.55	2.09	1.05	0.00	1.05	0.00	0.00
leukemia, chronic megakaryoblastic cell line:MEG-01	10752-110D5	201.88	21.01	20.07	15.47	6.97	6.14	4.01
liposarcoma cell line:KMLS-1	10782-110G8	60.92	2.50	2.81	2.03	1.41	0.94	0.47
liposarcoma cell line:SW 872	10726-110A6	43.01	2.92	1.83	1.71	0.85	0.49	0.85
liver, adult, pool1	10018-101C9	97.24	5.02	3.73	3.08	1.78	0.49	0.49
liver, fetal, pool1	10086-102B5	13.17	0.00	0.00	0.00	0.00	0.00	0.00
locus coeruleus - adult, donor10196	10182-103D2	143.78	8.02	9.04	9.62	3.94	1.75	2.33
locus coeruleus, adult, donor10252	10165-103B3	99.47	7.57	8.49	4.80	1.66	2.58	2.58
locus coeruleus, adult, donor10258	10375-105G6	50.22	3.39	2.54	2.82	1.41	0.85	2.26
locus coeruleus, newborn, donor10223	10362-105F2	166.14	7.99	8.41	8.41	4.63	0.42	1.68
lung adenocarcinoma cell line:A549	10499-107C4	75.70	0.28	1.11	0.42	0.28	0.69	0.14
lung adenocarcinoma cell line:PC-14	10408-106B3	351.60	2.07	0.69	2.07	0.00	2.07	0.00
lung adenocarcinoma, papillary cell line:NCI-H441	10742-110C4	102.55	3.43	1.85	2.11	0.79	0.26	1.19
lung, adult, pool1	10019-101D1	88.36	1.42	0.95	1.77	0.35	0.24	0.47
lung, fetal, donor1	10068-101I5	228.33	4.57	0.29	2.57	0.86	0.57	0.57
lung, right lower lobe, adult, donor1	10075-102A3	37.57	3.67	5.50	0.92	1.37	0.46	0.46
lymph node, adult, donor1	10077-102A5	36.92	3.79	3.31	3.31	0.47	0.47	0.00
lymphangiectasia cell line:DS-1	10727-110A7	53.04	4.60	4.82	1.32	1.53	0.66	0.66
lymphoma, malignant, hairy B-cell cell line:MLMA	10775-110G1	123.31	4.08	4.53	4.68	3.32	1.96	1.21
malignant trichilemmal cyst cell line:DJM-1	10412-106B7	216.62	2.55	5.10	1.70	0.85	0.85	0.00
mature adipocyte, donor1	12231-129F8	89.24	0.00	0.00	0.44	0.00	0.00	0.00
mature adipocyte, donor2	12232-129F9	67.86	0.42	0.42	0.00	0.00	0.00	0.00
mature adipocyte, donor3	12233-129G1	94.35	0.47	0.24	0.24	0.24	0.47	0.47
mature adipocyte, donor4	12234-129G2	79.49	0.53	0.53	0.00	0.00	0.00	0.00
maxillary sinus tumor cell line:HSQ-89	10414-106B9	231.35	4.29	4.29	4.77	1.19	1.19	0.48
medial frontal gyrus - adult, donor10196	10170-103B8	85.73	6.77	5.64	13.54	3.38	2.26	5.64
medial frontal gyrus, adult, donor10252	10150-102I6	114.39	8.46	11.22	10.48	5.15	4.97	4.41
medial frontal gyrus, adult, donor10258	10368-105F8	78.47	4.77	2.86	3.49	1.27	1.59	0.32
medial frontal gyrus, newborn, donor10223	10352-105E1	130.08	5.54	5.97	4.69	3.84	1.71	0.85
medial temporal gyrus - adult, donor10196	10183-103D3	105.98	11.31	6.58	6.58	3.38	2.19	1.52
medial temporal gyrus, adult, donor10252	10156-103A3	141.55	10.19	13.37	11.88	6.58	2.55	4.24
medial temporal gyrus, adult, donor10258, tech_rep1	10376-105G7	80.90	5.78	1.93	1.93	0.00	0.00	0.00
medial temporal gyrus, adult, donor10258, tech_rep2	10376-105G7	2684.13	401.90	416.25	660.27	301.43	143.54	200.95
medial temporal gyrus, newborn, donor10223	10353-105E2	49.17	1.08	2.87	1.08	0.72	0.72	0.00
medulla oblongata - adult, donor10196	10174-103C3	116.82	4.54	2.60	2.60	1.95	0.65	0.65
medulla oblongata, adult, donor10252	10155-103A2	141.03	10.06	10.99	8.36	4.02	2.63	4.02
medulla oblongata, adult, pool1	10038-101F2	41.39	0.49	0.24	0.24	0.00	0.16	0.08
medulla oblongata, newborn, donor10223	10361-105F1	68.05	2.08	1.74	1.04	0.69	0.69	0.00
medulloblastoma cell line:D283 Med	10838-111E1	151.00	15.72	14.17	13.06	4.43	2.21	4.43
medulloblastoma cell line:ONS-76	10759-110E3	70.92	5.26	4.65	3.06	1.22	0.98	0.86
melanoma cell line:COLO 679	10514-107E1	46.57	1.58	2.59	1.15	1.44	0.72	0.14
melanoma cell line:G-361	10465-106H6	74.65	11.67	11.40	11.13	5.97	3.26	4.07
meningioma cell line:HKBMM	10691-109F7	41.61	2.53	3.62	1.81	1.09	0.54	0.54
merkel cell carcinoma cell line:MKL-1	10843-111E6	198.26	19.39	6.17	7.93	5.29	1.76	0.00
merkel cell carcinoma cell line:MS-1	10844-111E7	100.58	6.48	3.37	2.33	2.33	1.04	0.52
mesenchymal precursor cell - adipose, donor1	11747-123G1	51.55	4.91	1.69	1.84	1.23	1.07	0.77
mesenchymal precursor cell - adipose, donor2	11748-123G2	37.99	3.64	1.45	0.91	1.27	0.73	0.55
mesenchymal precursor cell - adipose, donor3	11749-123G3	46.79	5.80	1.66	0.83	0.41	0.41	1.24
mesenchymal precursor cell - bone marrow, donor1	11750-123G4	42.14	4.35	1.40	1.69	0.42	0.84	0.70
mesenchymal precursor cell - bone marrow, donor2	11751-123G5	37.74	2.70	0.77	1.54	0.77	0.39	0.00
mesenchymal precursor cell - bone marrow, donor3	11840-124H4	47.89	2.78	1.39	0.00	0.00	1.39	0.00
mesenchymal precursor cell - cardiac, donor1	11752-123G6	23.86	1.20	0.69	0.51	0.34	0.17	0.17
mesenchymal precursor cell - cardiac, donor2	11753-123G7	37.04	2.88	1.50	1.15	0.81	0.46	0.69
mesenchymal precursor cell - cardiac, donor3	11754-123G8	38.60	3.18	1.33	1.59	0.80	0.66	0.66
mesenchymal precursor cell - cardiac, donor4	11755-123G9	51.32	4.46	2.30	2.30	0.81	1.08	0.54
mesenchymal precursor cell - ovarian cancer left ovary, donor1	11756-123H1	53.92	5.12	1.99	2.99	1.71	0.71	0.43
mesenchymal precursor cell - ovarian cancer left ovary, donor2	11833-124G6	40.18	1.65	0.99	0.66	0.99	0.33	0.00
mesenchymal precursor cell - ovarian cancer left ovary, donor3	11760-123H5	36.53	1.38	1.11	1.11	0.55	0.14	0.42
mesenchymal precursor cell - ovarian cancer left ovary, donor4	11836-124G9	59.69	5.59	5.59	3.84	1.05	1.05	2.09
mesenchymal precursor cell - ovarian cancer metastasis, donor1	11758-123H3	35.52	2.25	0.41	0.82	0.41	0.61	0.00
mesenchymal precursor cell - ovarian cancer metastasis, donor2	11835-124G8	37.74	2.88	2.52	1.80	0.72	0.36	0.00
mesenchymal precursor cell - ovarian cancer metastasis, donor3	11762-123H7	26.69	1.55	1.03	0.62	0.21	0.62	0.41
mesenchymal precursor cell - ovarian cancer metastasis, donor4	11838-124H2	38.07	3.42	4.56	2.05	0.68	0.00	0.68
mesenchymal precursor cell - ovarian cancer right ovary, donor1	11757-123H2	91.88	9.65	3.78	3.36	1.26	2.10	0.84
mesenchymal precursor cell - ovarian cancer right ovary, donor2	11759-123H4	36.16	3.29	0.75	1.94	0.60	0.75	0.60
mesenchymal precursor cell - ovarian cancer right ovary, donor3 (SOC-57-02)	11761-123H6	33.44	3.06	1.40	1.14	0.61	0.70	0.88
mesenchymal precursor cell - ovarian cancer right ovary, donor3 (SOC-57-02-G)	11842-124H6	32.77	2.58	0.74	1.47	0.74	0.74	0.37
mesenchymal precursor cell - ovarian cancer right ovary, donor4	11837-124H1	47.79	6.01	4.01	2.86	1.43	0.86	0.86
mesenchymal stem cell line:Hu5/E18	10568-108B1	44.63	8.00	4.63	3.37	0.84	0.42	1.26
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep1	13229-141I7	26.03	0.46	0.91	1.37	0.46	1.37	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep2	13230-141I8	34.79	2.05	1.79	1.02	0.51	1.02	0.51
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep3	13231-141I9	32.98	1.05	1.05	0.79	0.79	0.79	0.79
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep1	13232-142A1	40.36	2.46	3.39	2.16	2.46	0.62	0.31
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep2	13233-142A2	36.24	1.18	1.41	1.88	0.47	0.71	0.47
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep3	13234-142A3	32.49	1.35	1.02	0.34	0.34	0.34	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep1	13235-142A4	29.87	2.75	3.14	0.79	0.79	0.39	0.39
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep2	13236-142A5	33.83	3.24	2.32	1.39	0.93	0.46	0.93
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep3	13237-142A6	0.00	0.00	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep1	13238-142A7	47.30	2.02	2.31	1.73	2.02	0.00	1.15
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep2	13239-142A8	33.02	1.56	1.12	0.67	0.67	0.45	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep3	13240-142A9	29.80	1.68	1.20	1.92	0.96	0.24	0.72
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep1	13241-142B1	48.40	0.00	0.73	0.73	0.73	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep2	13242-142B2	30.54	1.68	0.34	0.67	0.34	0.34	0.67
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep3	13243-142B3	27.43	4.09	1.23	0.41	0.00	0.82	0.41
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep1	13244-142B4	35.22	1.29	2.15	0.43	0.43	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep2	13245-142B5	24.61	2.73	0.00	2.73	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep3	13246-142B6	36.15	10.33	5.16	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep1	13247-142B7	39.62	0.97	2.60	0.32	0.65	0.32	0.32
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep2	13248-142B8	39.28	0.00	0.00	0.00	1.45	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep3	13249-142B9	28.25	1.07	0.53	1.07	1.07	1.60	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep1	13250-142C1	31.89	2.45	0.82	0.82	0.00	0.82	1.64
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep2	13251-142C2	38.48	3.50	4.28	0.39	0.78	0.39	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep3	13252-142C3	25.18	2.10	2.10	0.00	0.00	0.00	2.10
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep1	13253-142C4	42.72	0.99	1.99	0.99	0.99	0.00	0.99
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep2	13254-142C5	33.37	4.77	4.77	4.77	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep3	13255-142C6	40.32	0.00	1.78	0.00	0.59	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep1	13256-142C7	21.93	6.09	1.22	2.44	0.00	0.00	1.22
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep2	13257-142C8	54.10	0.00	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep3	13258-142C9	29.14	0.63	0.63	0.00	0.63	1.27	1.27
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep1	13259-142D1	19.66	1.03	1.03	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep2	13260-142D2	17.19	4.30	0.00	2.15	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep3	13261-142D3	3.99	0.00	0.00	0.00	0.00	7.98	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep1	13262-142D4	13.78	3.44	3.44	6.89	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep2	13263-142D5	16.30	1.22	1.22	1.22	0.41	2.04	0.41
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep3	13264-142D6	22.24	1.59	0.79	0.79	0.79	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep1	13265-142D7	22.40	3.54	7.07	1.77	2.36	0.59	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep2	13266-142D8	21.20	1.25	2.18	0.94	0.31	0.62	0.31
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep3	13267-142D9	16.04	10.69	9.36	1.34	1.34	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep1	13268-142E1	37.85	2.37	1.18	4.73	0.00	2.37	1.18
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep2	13269-142E2	33.38	5.14	7.70	7.70	0.00	2.57	2.57
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep3	13270-142E3	48.19	7.57	7.57	3.44	1.38	1.38	0.69
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep1	13271-142E4	32.66	5.44	8.41	2.47	1.48	2.47	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep2	13272-142E5	12.34	2.24	2.24	1.12	1.12	1.12	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep3	13273-142E6	27.99	6.36	6.36	1.91	3.18	0.00	0.64
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep1	13274-142E7	11.28	0.81	2.01	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep2	13275-142E8	8.72	0.00	2.18	0.00	2.18	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep3	13276-142E9	16.47	0.00	1.27	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep1	13277-142F1	20.63	0.61	0.61	1.21	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep2	13278-142F2	18.08	9.04	4.52	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep3	13279-142F3	22.24	5.77	3.29	0.82	0.00	0.82	0.00
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep1	13280-142F4	17.26	0.40	0.20	0.00	0.20	0.20	0.00
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep2	13281-142F5	16.55	1.30	0.97	0.00	0.32	0.00	0.00
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep3	13282-142F6	20.37	5.09	6.11	3.06	1.02	2.04	0.00
mesodermal tumor cell line:HIRS-BM	10696-109G3	119.93	0.77	0.00	0.00	0.00	0.00	0.00
mesothelioma cell line:ACC-MESO-1	10493-107B7	137.02	3.07	1.89	2.13	0.94	0.24	0.00
mesothelioma cell line:ACC-MESO-4	10494-107B8	68.81	2.55	1.85	2.55	1.16	1.16	0.46
mesothelioma cell line:Mero-14, tech_rep1	10849-111F3	68.38	21.37	17.09	8.55	12.82	4.27	0.00
mesothelioma cell line:Mero-14, tech_rep2	10849-111F3	57.95	3.08	2.06	3.90	2.47	1.13	0.72
mesothelioma cell line:Mero-25	10850-111F4	26.10	2.27	2.04	1.13	0.68	0.23	0.23
mesothelioma cell line:Mero-41	10851-111F5	71.88	9.29	5.38	5.38	0.98	2.93	1.71
mesothelioma cell line:Mero-48a	10852-111F6	67.31	10.63	7.97	8.19	1.55	1.77	0.89
mesothelioma cell line:Mero-82	10853-111F7	50.98	11.56	5.26	6.83	3.15	2.10	1.31
mesothelioma cell line:Mero-83	10854-111F8	59.75	7.15	7.15	7.83	3.06	0.51	1.53
mesothelioma cell line:Mero-84	10855-111F9	16.43	2.02	0.25	0.00	0.25	0.25	0.25
mesothelioma cell line:Mero-95	10856-111G1	30.64	2.90	2.69	1.24	0.62	0.62	0.41
mesothelioma cell line:NCI-H2052	10847-111F1	116.95	13.75	8.94	9.44	5.47	3.81	2.15
mesothelioma cell line:NCI-H226	10846-111E9	53.75	8.51	4.16	3.98	3.44	1.09	0.72
mesothelioma cell line:NCI-H2452	10848-111F2	71.06	8.03	5.98	7.17	2.05	0.85	1.71
mesothelioma cell line:NCI-H28	10845-111E8	80.67	10.43	6.62	4.83	2.54	2.54	1.78
mesothelioma cell line:No36	10857-111G2	37.84	6.52	3.91	3.91	0.98	1.63	1.30
mesothelioma cell line:ONE58	10858-111G3	43.35	8.13	2.17	3.25	2.17	0.81	0.54
migratory langerhans cells, donor1	11901-125F2	42.22	1.92	1.54	2.30	0.38	0.38	0.38
migratory langerhans cells, donor2	11902-125F3	22.59	0.37	0.12	0.00	0.00	0.12	0.00
migratory langerhans cells, donor3	11903-125F4	65.33	2.87	2.69	2.15	0.90	1.44	0.18
mixed mullerian tumor cell line:HTMMT	10689-109F5	30.69	7.18	4.90	4.24	1.31	0.00	0.98
mucinous adenocarcinoma cell line:JHOM-1	10648-109A9	14.62	0.85	1.06	1.06	0.42	0.85	0.42
mucinous cystadenocarcinoma cell line:MCAS	10784-110H1	129.46	2.07	1.61	2.30	1.15	0.00	0.00
mycosis fungoides, T cell lymphoma cell line:HuT 102 TIB-162	10744-110C6	28.73	2.66	2.66	0.76	0.95	1.14	1.33
myelodysplastic syndrome cell line:SKM-1	10772-110F7	126.21	6.28	7.21	8.69	3.88	3.14	1.48
myeloma cell line:PCM6	10474-106I6	34.59	3.36	3.56	2.17	1.98	1.78	0.79
myxofibrosarcoma cell line:MFH-ino	10600-108E6	136.97	2.54	1.52	4.57	0.51	0.51	0.51
myxofibrosarcoma cell line:NMFH-1	10684-109E9	48.84	2.75	1.77	2.16	0.39	0.59	0.39
nasal epithelial cells, donor1, tech_rep1	12226-129F3	26.07	0.22	0.45	0.45	0.33	0.33	0.00
nasal epithelial cells, donor1, tech_rep2	12226-129F3	23.24	0.37	0.44	0.07	0.00	0.22	0.07
nasal epithelial cells, donor2	12227-129F4	43.06	0.00	0.00	0.55	0.55	0.00	0.00
neuroblastoma cell line:CHP-134	10508-107D4	207.74	3.45	5.06	3.68	1.15	1.38	0.23
neuroblastoma cell line:NB-1	10539-107G8	112.25	4.12	5.43	3.55	1.68	0.75	0.94
neuroblastoma cell line:NBsusSR	10607-108F4	48.08	7.17	4.85	3.80	0.42	2.11	0.42
neuroblastoma cell line:NH-12	10555-107I6	105.47	13.79	9.50	6.71	2.42	3.35	1.86
neuroectodermal tumor cell line:FU-RPNT-1	10637-108I7	52.19	11.86	9.49	6.88	3.56	1.90	3.08
neuroectodermal tumor cell line:FU-RPNT-2	10663-109C6	51.16	7.60	5.07	3.64	1.90	2.06	0.48
neuroectodermal tumor cell line:TASK1	10774-110F9	55.15	5.03	4.43	3.82	1.81	2.01	1.01
neuroepithelioma cell line:SK-N-MC	10728-110A8	169.75	1.91	0.64	0.64	0.00	1.27	1.27
neurofibroma cell line:Hs 53.T	10729-110A9	27.42	1.33	0.00	0.53	0.27	0.00	0.00
neutrophil PMN, donor1	12133-128D9	14.87	0.00	0.00	0.00	0.00	0.00	0.00
neutrophil PMN, donor2	12137-128E4	13.28	0.00	0.00	0.00	0.00	0.00	0.00
neutrophil PMN, donor3	12141-128E8	9.47	0.00	0.00	0.00	0.00	0.00	0.00
non T non B acute lymphoblastic leukemia (ALL) cell line:P30/OHK	10430-106D7	197.87	13.70	16.24	11.33	4.57	4.40	3.04
non-small cell lung cancer cell line:NCI-H1385	10730-110B1	57.64	0.80	0.80	0.00	0.00	0.00	0.00
normal embryonic palatal mesenchymal cell line:HEPM	10813-111B3	22.12	1.28	0.96	0.64	0.64	0.64	0.32
normal intestinal epithelial cell line:FHs 74 Int	10812-111B2	33.11	4.20	2.10	0.00	1.31	0.79	0.79
nucleus accumbens, adult, pool1	10037-101F1	46.78	1.50	0.56	1.12	0.47	0.66	0.09
occipital cortex - adult, donor10196	10172-103C1	177.19	12.36	6.18	6.18	2.06	6.18	2.06
occipital cortex, adult, donor10252	10163-103B1	158.07	8.32	12.34	9.39	4.56	2.95	1.61
occipital cortex, newborn, donor10223	10355-105E4	66.60	1.82	1.09	1.09	0.73	1.09	0.00
occipital lobe, adult, donor1	10076-102A4	48.02	1.05	0.52	0.26	0.79	0.00	0.26
occipital lobe, fetal, donor1	10073-102A1	53.21	3.86	3.00	3.00	0.43	0.86	0.43
occipital pole, adult, pool1	10036-101E9	20.89	0.16	0.24	0.08	0.08	0.00	0.00
olfactory region, adult	10195-103E6	89.60	8.22	10.32	6.30	2.10	3.44	2.48
optic nerve, donor1	10277-104E7	256.13	4.00	4.00	2.00	2.00	0.00	0.00
oral squamous cell carcinoma cell line:Ca9-22	10434-106E2	59.46	3.30	3.08	3.76	0.91	1.25	0.91
oral squamous cell carcinoma cell line:HO-1-u-1	10550-107I1	99.88	2.20	2.61	2.75	0.82	1.10	0.41
oral squamous cell carcinoma cell line:HSC-3	10545-107H5	119.20	18.29	13.55	10.84	3.05	3.56	2.03
oral squamous cell carcinoma cell line:SAS	10544-107H4	48.86	7.28	2.89	2.43	0.81	0.69	0.58
osteoclastoma cell line:Hs 706.T	10704-109H2	31.45	0.29	1.18	0.00	0.29	0.29	0.00
osteosarcoma cell line:143B/TK^(-)neo^(R)	10510-107D6	288.71	1.87	0.00	2.80	0.93	0.00	0.00
osteosarcoma cell line:HS-Os-1	10558-107I9	102.00	3.82	4.67	2.76	1.48	1.06	2.54
ovary, adult, pool1	10020-101D2	86.04	2.88	2.71	1.66	0.44	0.87	0.35
pagetoid sarcoma cell line:Hs 925.T	10732-110B3	52.25	4.77	2.20	3.48	1.47	1.28	0.18
pancreas, adult, donor1	10049-101G4	21.63	1.88	0.00	0.00	0.00	0.00	0.00
pancreatic carcinoma cell line:NOR-P1	10698-109G5	61.78	3.91	3.35	3.63	0.28	0.84	1.12
papillary adenocarcinoma cell line:8505C	10437-106E5	53.15	10.05	6.47	6.81	2.21	1.02	1.02
papillotubular adenocarcinoma cell line:TGBC18TKB	10417-106C3	116.57	5.13	6.13	3.64	1.82	0.50	1.16
paracentral gyrus, adult, pool1	10035-101E8	35.05	2.20	1.01	1.10	0.18	0.18	0.09
parietal cortex, adult, donor10258	10373-105G4	104.96	16.15	4.40	8.07	2.94	0.00	0.73
parietal lobe - adult, donor10196	10171-103B9	96.87	9.40	3.76	15.05	4.70	3.76	1.88
parietal lobe, adult, donor10252	10157-103A4	112.30	13.11	9.69	10.55	3.71	2.85	5.42
parietal lobe, adult, pool1	10034-101E7	32.25	0.62	0.70	0.62	0.79	0.18	0.26
parietal lobe, fetal, donor1	10072-101I9	71.77	9.70	7.76	6.79	3.88	0.97	1.94
parietal lobe, newborn, donor10223	10356-105E5	71.03	2.99	2.99	3.36	2.24	0.37	2.24
parotid gland, adult	10199-103F1	90.03	3.70	1.23	1.85	1.23	0.62	0.00
penis, adult	10200-103F2	90.77	10.21	6.45	8.06	3.22	1.07	0.54
peripheral neuroectodermal tumor cell line:KU-SN	10697-109G4	126.62	19.15	7.44	5.95	1.67	0.93	0.93
pharyngeal carcinoma cell line:Detroit 562	10723-110A3	89.46	10.20	7.87	6.26	3.21	3.21	0.73
pineal gland - adult, donor10196	10179-103C8	129.65	0.65	0.65	1.94	0.65	0.00	0.65
pineal gland, adult, donor10252	10160-103A7	124.36	2.37	8.29	5.33	1.18	1.78	3.55
pineal gland, adult, donor10258	10377-105G8	72.74	3.76	2.51	0.63	1.25	0.00	0.63
pituitary gland - adult, donor10196	10180-103C9	149.75	5.06	9.11	9.11	3.04	3.04	2.02
pituitary gland, adult, donor10252	10162-103A9	214.73	13.03	11.99	6.25	6.25	3.65	3.13
pituitary gland, adult, donor10258	10378-105G9	82.57	10.21	3.40	5.11	4.26	0.00	0.00
placenta, adult, pool1	10021-101D3	98.80	1.94	2.04	1.40	0.86	0.32	0.54
plasma cell leukemia cell line:ARH-77	10840-111E3	106.07	7.68	5.83	5.16	2.12	2.12	1.59
pleomorphic hepatocellular carcinoma cell line:SNU-387	10706-109H4	80.78	0.93	2.02	1.40	0.62	0.47	0.16
pons, adult, pool1	10033-101E6	98.29	4.05	4.39	2.93	2.24	1.29	1.29
postcentral gyrus, adult, pool1	10032-101E5	24.58	0.61	0.35	0.17	0.00	0.00	0.00
promyelocytes/myelocytes PMC, donor1	12132-128D8	102.48	0.00	0.00	0.00	0.00	0.00	0.00
promyelocytes/myelocytes PMC, donor2	12136-128E3	27.54	0.00	0.00	0.00	0.00	0.00	0.00
promyelocytes/myelocytes PMC, donor3	12140-128E7	0.00	0.00	0.00	0.00	0.00	0.00	0.00
prostate cancer cell line:DU145	10490-107B4	62.49	7.57	7.57	4.81	2.77	2.04	1.75
prostate cancer cell line:PC-3	10439-106E7	174.60	20.51	23.05	12.89	4.90	5.08	3.81
prostate, adult, pool1	10022-101D4	95.68	1.72	1.90	1.09	0.54	0.54	0.36
putamen, adult, donor10196	10176-103C5	116.14	10.86	11.33	8.26	5.43	2.12	4.25
putamen, adult, donor10252	10152-102I8	143.13	3.92	3.92	5.88	0.00	0.00	0.00
putamen, adult, donor10258, tech_rep1	10372-105G3	90.70	8.74	1.09	4.37	2.19	2.19	0.00
putamen, adult, donor10258, tech_rep2	10372-105G3	87.95	10.39	8.70	7.01	3.87	2.66	1.69
putamen, newborn, donor10223	10365-105F5	134.94	5.25	6.75	3.00	3.75	0.75	2.25
rectal cancer cell line:TT1TKB	10469-106I1	154.49	5.24	5.82	4.36	1.45	2.04	1.45
rectum, fetal, donor1	10067-101I4	54.25	4.17	2.78	0.00	1.39	1.39	0.00
renal cell carcinoma cell line:OS-RC-2	10411-106B6	60.42	3.60	3.18	2.54	1.27	0.42	1.06
renal cell carcinoma cell line:TUHR10TKB	10471-106I3	48.88	9.94	8.28	7.04	3.31	1.24	2.90
retina, adult, pool1	10030-101E3	37.67	0.89	1.59	0.70	0.50	0.50	0.40
retinoblastoma cell line:Y79	10475-106I7	136.92	12.73	16.37	12.73	8.83	3.90	3.12
rhabdomyosarcoma cell line:KYM-1	10787-110H4	85.57	8.85	5.16	5.04	2.58	1.48	0.86
rhabdomyosarcoma cell line:RMS-YM	10477-106I9	422.08	7.03	9.84	8.44	2.81	3.09	1.69
sacrococcigeal teratoma cell line:HTST	10695-109G2	87.15	0.00	2.27	2.27	0.00	0.76	0.76
salivary acinar cells, donor1	11771-123I7	88.21	13.76	11.17	5.99	4.86	2.10	2.59
salivary acinar cells, donor2	11772-123I8	66.64	11.29	7.71	5.09	1.79	1.51	1.24
salivary acinar cells, donor3	11773-123I9	280.05	5.96	3.97	6.62	0.00	1.99	1.32
salivary gland, adult, pool1	10093-102C3	31.46	0.00	0.00	0.00	0.00	0.00	0.00
schwannoma cell line:HS-PSS, tech_rep1	10442-106F1	81.28	5.23	5.73	2.70	2.53	1.77	0.34
schwannoma cell line:HS-PSS, tech_rep2	10442-106F1	71.59	5.64	5.41	3.64	2.70	2.00	1.18
seminal vesicle, adult	10201-103F3	122.22	5.29	3.17	3.17	2.12	0.00	1.59
serous adenocarcinoma cell line:JHOS-2	10639-108I9	41.78	3.89	1.94	2.19	0.24	0.73	0.24
serous adenocarcinoma cell line:SK-OV-3-R after co-culture with SOC-57-02-G, biol_rep1	11843-124H7	22.14	0.25	0.50	0.75	0.50	0.00	0.25
serous adenocarcinoma cell line:SK-OV-3-R, biol_rep1	11841-124H5	57.20	6.02	2.01	1.00	0.00	1.00	0.00
serous cystadenocarcinoma cell line:HTOA	10693-109F9	84.08	11.15	10.21	5.24	1.75	2.15	0.81
signet ring carcinoma cell line:Kato III	10436-106E4	51.28	1.88	3.21	2.21	1.44	0.99	0.55
signet ring carcinoma cell line:NUGC-4	10483-107A6	115.74	2.71	1.03	1.42	1.42	0.26	0.13
skeletal muscle - soleus muscle, donor1	10282-104F3	407.16	13.48	8.51	12.06	6.38	3.55	2.84
skeletal muscle, adult, pool1	10023-101D5	211.45	3.24	3.36	3.48	1.68	1.20	0.72
skeletal muscle, fetal, donor1	10066-101I3	12.06	1.01	0.00	0.00	0.00	0.00	1.01
skin, adult, donor1	10074-102A2	33.93	0.00	0.00	0.00	0.00	0.00	0.00
skin, fetal, donor1	10065-101I2	69.43	4.42	1.26	3.16	1.89	1.89	0.63
small cell cervical cancer cell line:HCSC-1	10800-110I8	47.36	4.00	3.34	1.33	1.33	0.67	0.00
small cell gastrointestinal carcinoma cell line:ECC10	10610-108F7	145.31	30.26	18.28	15.76	10.09	7.56	4.10
small cell lung carcinoma cell line:DMS 144	10841-111E4	104.47	5.01	3.28	3.85	1.16	0.77	0.19
small cell lung carcinoma cell line:LK-2	10541-107H1	124.11	3.96	5.60	3.30	1.65	0.99	0.82
small cell lung carcinoma cell line:NCI-H82	10842-111E5	154.58	16.25	14.96	11.42	5.15	3.70	2.73
small cell lung carcinoma cell line:WA-hT	10562-108A4	71.69	8.72	5.67	4.14	0.87	0.87	0.65
small intestine, adult, pool1	10024-101D6	98.30	1.91	2.39	1.31	1.31	1.19	0.72
small intestine, fetal, donor1	10064-101I1	50.86	10.07	8.85	4.18	4.42	1.72	0.98
small-cell gastrointestinal carcinoma cell line:ECC4	10609-108F6	54.88	6.67	6.67	5.13	1.03	1.03	0.51
smooth muscle, adult, pool1	10048-101G3	103.90	8.01	4.91	2.58	2.84	1.55	1.29
somatostatinoma cell line:QGP-1	10781-110G7	136.96	2.14	2.14	1.61	0.80	0.54	0.54
spinal cord - adult, donor10196	10181-103D1	142.46	13.08	6.88	7.80	2.52	2.29	1.84
spinal cord, adult, donor10252	10159-103A6	212.12	6.70	10.25	8.28	5.13	1.58	3.55
spinal cord, adult, donor10258	10369-105F9	211.69	14.53	2.08	6.92	0.00	2.77	0.69
spinal cord, fetal, donor1	10056-101H2	45.74	3.66	1.83	3.05	0.00	0.00	0.61
spinal cord, newborn, donor10223	10359-105E8	145.57	8.27	7.81	5.05	2.30	0.92	0.46
spindle cell sarcoma cell line:Hs 132.T	10737-110B8	57.95	1.94	1.79	1.79	0.15	0.60	0.00
spleen, adult, pool1	10025-101D7	103.64	3.30	3.85	2.53	0.99	0.33	0.88
spleen, fetal, pool1	10044-101F8	31.07	0.40	0.32	0.24	0.00	0.00	0.00
splenic lymphoma with villous lymphocytes cell line:SLVL	10424-106D1	117.28	12.84	10.77	8.59	4.04	2.69	2.07
squamous cell carcinoma cell line:EC-GI-10	10463-106H4	126.65	7.60	8.73	4.75	3.23	2.66	2.28
squamous cell carcinoma cell line:JHUS-nk1	10646-109A7	52.42	9.09	5.59	5.94	1.75	2.10	0.70
squamous cell carcinoma cell line:T3M-5	10616-108G4	63.33	4.30	0.78	2.35	1.17	0.39	0.78
squamous cell lung carcinoma cell line:EBC-1	10486-107A9	108.39	7.77	8.78	6.64	5.07	2.36	2.25
squamous cell lung carcinoma cell line:LC-1F	10457-106G7	50.83	5.08	5.93	2.97	1.27	2.12	0.42
squamous cell lung carcinoma cell line:RERF-LC-AI	10501-107C6	77.42	4.23	4.23	4.65	2.12	1.69	0.85
stomach, fetal, donor1	10062-101H8	153.79	5.34	2.14	0.00	0.00	0.00	0.00
submaxillary gland, adult	10202-103F4	107.10	3.42	2.28	0.57	2.28	1.14	0.57
substantia nigra - adult, donor10196	10178-103C7	2333.79	1139.76	759.84	922.66	651.29	271.37	542.74
substantia nigra, adult, donor10252	10158-103A5	119.64	11.84	14.95	7.69	3.74	4.78	1.87
substantia nigra, adult, donor10258	10371-105G2	103.45	10.86	3.10	2.59	1.55	0.00	1.55
substantia nigra, newborn, donor10223	10358-105E7	79.14	1.41	1.41	1.41	0.71	0.00	0.71
synovial sarcoma cell line:HS-SY-II	10441-106E9	212.30	27.28	28.89	20.18	11.00	9.40	7.57
temporal lobe, adult, pool1	10031-101E4	21.28	0.08	0.34	0.25	0.17	0.08	0.08
temporal lobe, fetal, donor1, tech_rep1	10063-101H9	70.51	4.99	4.99	2.14	1.42	2.14	0.71
temporal lobe, fetal, donor1, tech_rep2	10063-101H9	61.97	3.96	2.64	2.64	1.76	0.88	1.76
tenocyte, donor1	11763-123H8	62.84	10.82	4.19	2.79	1.75	2.44	1.05
tenocyte, donor2	11765-123I1	25.56	1.53	1.53	2.67	0.00	0.38	0.38
tenocyte, donor3	11768-123I4	40.40	5.56	3.34	2.59	1.48	1.48	0.37
teratocarcinoma cell line:NCC-IT-A3	10790-110H7	163.84	21.08	12.07	10.03	4.93	4.08	2.38
teratocarcinoma cell line:NCR-G1	10798-110I6	53.49	6.47	4.62	5.24	0.77	1.85	1.85
teratocarcinoma cell line:PA-1	10807-111A6	72.06	6.51	6.20	5.73	2.79	3.10	1.39
testicular germ cell embryonal carcinoma cell line:ITO-II	10786-110H3	72.49	5.20	4.06	3.81	1.27	1.40	0.76
testicular germ cell embryonal carcinoma cell line:NEC14	10591-108D6	167.53	7.94	12.10	9.45	4.92	3.40	1.51
testicular germ cell embryonal carcinoma cell line:NEC15	10593-108D8	138.18	7.74	2.73	4.58	2.84	1.85	1.20
testicular germ cell embryonal carcinoma cell line:NEC8	10590-108D5	144.29	28.66	17.26	10.75	4.56	4.23	2.93
testis, adult, pool1	10026-101D8	75.27	2.47	1.93	1.61	0.54	0.43	0.32
testis, adult, pool2	10096-102C6	58.19	7.67	6.32	4.06	1.35	0.90	0.90
thalamus - adult, donor10196	10168-103B6	136.89	3.31	1.10	8.83	2.21	0.00	0.00
thalamus, adult, donor10252	10154-103A1	168.00	16.57	15.78	12.19	7.50	5.00	4.69
thalamus, adult, donor10258, tech_rep1	10370-105G1	160.12	4.62	0.00	1.54	1.54	1.54	0.00
thalamus, adult, donor10258, tech_rep2	10370-105G1	42.16	2.96	1.65	3.95	0.66	0.49	0.33
thalamus, newborn, donor10223	10366-105F6	71.91	1.73	1.73	4.03	0.58	0.00	0.00
throat, adult	10209-103G2	99.12	4.74	0.75	3.00	1.75	1.75	0.50
throat, fetal, donor1	10061-101H7	51.50	5.79	5.48	3.05	0.91	1.22	0.91
thymic carcinoma cell line:Ty-82	10803-111A2	100.76	5.37	6.16	6.36	1.59	2.19	1.79
thymus, adult, pool1	10027-101D9	76.75	2.39	1.69	1.79	0.30	0.40	0.50
thymus, fetal, pool1	10043-101F7	52.26	0.94	1.45	0.52	0.52	0.42	0.21
thyroid carcinoma cell line:KHM-5M	10776-110G2	49.73	2.93	2.39	1.46	1.20	1.06	0.40
thyroid carcinoma cell line:TCO-1	10783-110G9	50.99	6.15	5.03	4.61	0.84	0.56	0.98
thyroid, adult, pool1	10028-101E1	83.33	2.24	1.21	1.03	0.28	0.19	0.56
thyroid, fetal, donor1	10060-101H6	43.77	8.70	4.75	4.75	2.11	2.37	1.05
tongue epidermis (fungiform papillae), donor1	10288-104F9	264.85	0.00	0.00	9.24	0.00	3.08	3.08
tongue, adult	10203-103F5	95.82	9.77	6.05	4.42	2.33	1.63	1.40
tongue, fetal, donor1	10059-101H5	65.42	9.46	6.31	5.12	2.76	4.34	0.79
tonsil, adult, pool1	10047-101G2	40.67	0.70	0.70	0.10	0.00	0.00	0.00
trachea, adult, pool1	10029-101E2	112.80	3.11	1.31	1.55	0.65	0.82	0.25
trachea, fetal, donor1	10058-101H4	44.62	5.00	2.31	2.31	0.38	1.15	0.38
transitional cell carcinoma cell line:Hs 769.T	10707-109H5	54.56	3.90	4.61	5.67	1.77	0.00	1.77
transitional-cell carcinoma cell line:5637	10418-106C4	104.76	3.24	3.04	2.33	1.32	1.22	0.81
transitional-cell carcinoma cell line:JMSU1	10492-107B6	170.16	20.21	22.88	17.08	7.52	3.76	3.92
tridermal teratoma cell line:HGRT	10694-109G1	351.97	1.90	5.71	0.00	3.81	0.00	0.00
tubular adenocarcinoma cell line:SUIT-2	10797-110I5	50.54	4.32	3.72	3.22	1.19	1.02	0.59
umbilical cord, fetal, donor1	10057-101H3	41.73	6.26	4.17	2.09	0.00	0.00	2.09
uterus, adult, pool1	10100-102D1	55.45	0.68	0.17	0.34	0.17	0.17	0.00
uterus, fetal, donor1	10055-101H1	53.75	3.58	2.56	0.51	1.54	2.05	2.56
vagina, adult	10204-103F6	113.08	1.94	0.65	0.65	0.65	0.00	0.65
vein, adult	10191-103E2	51.29	1.53	1.97	1.10	0.66	0.88	0.00
xeroderma pigentosum b cell line:XPL 17	10563-108A5	60.88	8.55	5.07	2.67	1.34	2.40	1.07